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INTRODUCTION 
The cardiovascular system, composed of the heart and blood vessels, is responsible 
for the transport and distribution of nutrients, oxygen and other essential 
substances to the entire body. It is also responsible for removing the associated 
metabolic products. Blood flows through arteries, capillaries and veins, allowing a 
rapid exchange between tissues and vessels. Therefore, a fine control of both heart 
and blood vessels is crucial to maintain the entire body homeostasis. When this 
homeostasis is spontaneously disrupted due to heart or vascular disorders, 
compensatory mechanisms activate to physiologically restore homeostasis. 
However, when the problem persists or when the organism is not capable to adapt, 
pathological changes occur leading to cardiovascular diseases, such as chronic 
cardiac failure, heart attack, stroke and hypertension, among others. Blood vessels 
play a significant role in keeping the homeostatic equilibrium, due to their 
involvement in the control of blood flow and arterial pressure. 
 
1. The Vascular wall 
The vascular wall of arteries and veins is a heterogeneous, three-layered structure 
comprising the tunica intima, the tunica media and the tunica adventitia (Figure I1), 
surrounded by perivascular adipose tissue (PVAT). Each layer presents specific 
histological, biochemical and functional properties, providing different mechanisms 
and signaling pathways that contribute to the maintenance of vascular homeostasis 
and to the regulation of vascular responses in cardiovascular pathologies. 
Moreover, there are changes in the relative amount of each layer related to arterial 
size, which also determines the vessel function. Large, conduit arteries are an 
elastic pressure reservoir, showing a strong adventitia with abundant elastic fibers. 
On the contrary, resistance vessels (small arteries and arterioles of 100-500 μm and 
10-100 μm of diameter in humans, respectively) have a diminished adventitia and a 
very well developed tunica media.  The strong muscular wall of resistance vessels is 
particularly important due to their capability to alter blood flow in response to 
metabolic needs. 
Tunica adventitia 
The tunica adventitia is the complex and heterogeneous outer layer of vascular 
walls consisting of an extracellular matrix scaffold which contains fibroblasts, 
lymphatic and blood vessels (“vasa vasorum”), nerves, progenitor cells and immune 
cells. The adventitia layer regulates many vascular responses in an outside-in way 
by sensing different cues and directing responses to adventitial cells as well as to 
media and intima cells (Stenmark et al., 2013). Of special interest is the presence of 
sympathetic neuronal nerve endings containing varicosities, where Noradrenaline 
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(NA) and other neurotransmitters are released to regulate local contractility and 
blood flow (Herring and Paterson, 2018). 
Tunica media 
In peripheral vessels, the tunica media is located under the adventitia, separated 
from it by the fenestrated outer elastic lamina (mainly composed by elastin). In 
arterioles, the tunica media consists of a single layer of smooth muscle cells, while 
in resistance arteries of larger caliber, cells are arranged in multiple layers 
organized in spiral form (McGrath et al., 2005). In addition, the tunica media is in 
close contact with endothelia through myoendothelial gap junctions, providing a 
functional interaction between both layers (Levy and Pappano, 2007). 
Tunica intima 
The tunica intima is separated from the media by a fenestrated inner elastic lamina 
and is composed by a monolayer of endothelial cells. Endothelial cells play crucial 
roles in many vascular functions, such as vascular permeability, local vascular 
control, angiogenesis and homeostasis regulation. Therefore, endothelial 
dysfunction induces several pathological disorders including hypertension, 
atherosclerosis, stroke and inflammatory syndromes (Herring and Paterson, 2018). 
 
 
Figure I1. Structure of arterial vascular wall showing tunica adventitia, 
tunica media and tunica intima with their associated principal cells 
(adapted from Martinez-Lemus, 2012). 
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2. Biology of Vascular Smooth Muscle Cells (VSMCs) 
The vascular wall is an adapting structure that can respond to mechanical, 
hemodynamic, and neurohumoral challenges. In this way, there is an active control 
of tissue blood flow that relies largely on the role of the vascular smooth muscle 
cells (VSMCs). Owing to their contractile properties, VSMCs are responsible for 
determining the diameter of resistance vessels, controlling blood flow and 
contributing to the regulation of blood pressure and vascular tone.  
2.1 Structure of VSMCs 
To carry out their function, VSMCs present several specific structures with different 
physiological roles: the contractile unit, the sarcoplasmic reticulum, cell junctions 
and caveolae (Figure I2). 
Contractile unit 
The cytosol of VSMCs contains thin actin filaments whose endings are interweaved 
with thick myosin filaments. Unlike the well aligned sarcomeric structure of cardiac 
or skeletal myocytes, actin filaments in VSMCs are disposed in a lengthwise way 
and are anchored to both plasma membrane and cytoplasm through dense bands 
and dense bodies, respectively. These dense bands and bodies, in turn, are linked 
by intermediate filaments composed of desmin and vimentin proteins. In addition, 
dense bands are attached to the extracellular matrix by integrins. Altogether, this 
cytoskeleton structure allows VSMCs to distribute the contraction force through 
the entire vascular wall (Aaronson, Ward and Wiener, 2004; Gunst and Zhang, 
2008). Furthermore, the contractile unit allows VSMCs to maintain a partial 
contracted state, giving rise to the physiological basal tone that determines vessel 
resting diameter. Modulation of such tone upon stimulation leads to vasodilator or 
vasoconstrictor responses. 
Sarcoplasmic reticulum (SR) 
In VSMCs, SR occupies ~2-6% of cell volume and contains high concentrations of 
Ca2+ (~50 mM). Elements of SR are in close proximity to areas of cell membrane, 
where several types of ion channels and proteins involved in excitation-contraction 
coupling have been found (Aaronson, Ward and Wiener, 2004). 
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Cell junctions and caveolae 
Plasma membrane of VSMCs presents numerous tiny invaginations or caveolae 
involved in cell signaling. Moreover, gap junctions connecting adjacent VSMCs 
allow the transmission of depolarizations between cells, so that VSMCs form a 
functional syncytium. In addition, myoendothelial junctions allow the transmission 
of regulatory signals from endothelial to VSMCs and vice versa, providing complex 
integrated signaling mechanisms to the control of contractility and vascular tone 
(Herring and Paterson, 2018). 
 
Figure I2. Structure of a vascular smooth muscle cell. 
 
2.2. Vascular smooth muscle function and regulation 
The vascular system plays very important roles in the regulation of the nutrients 
and oxygen distribution through the entire body. Propelled by the cardiac force, 
blood flows through arteries, arterioles and capillaries to get to the most distant 
cells and tissues. Total blood flow (L·min-1) in the cardiovascular system, which is 
known as cardiac output (CO), represents the blood flow pumped out by the heart. 
CO depends on the gradient of pressure generated by the heart and on the 
resistance that the whole vascular system offers to flow. This relationship is known 
as Darcy´s Law (Herring and Paterson, 2018): 
𝐶𝑂 =
(?̅?𝑎 − 𝐶𝑉𝑃)
𝑇𝑃𝑅
 
Where ?̅?𝑎  is the mean arterial pressure (mmHg), 𝐶𝑉𝑃  is the central venous 
pressure and 𝑇𝑃𝑅 is the total peripheral resistance. Since 𝐶𝑉𝑃 is nearly zero, this 
expression can be simplified to the following equation: 
𝐶𝑂 =
?̅?𝑎
𝑇𝑃𝑅
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Arterial pressure rises steeply and reaches its maximum with the ventricle ejection. 
This is called systolic pressure (𝑃𝑠). After that, it gradually declines to a minimum 
that matches the end of the diastole. This is called diastolic pressure (𝑃𝑑). Since 
diastole is longer than systole, mean arterial pressure (?̅?𝑎) can be defined as 
follows: 
?̅?𝑎 = 𝑃𝑑 + (𝑃𝑠 − 𝑃𝑑)/3 
𝑇𝑃𝑅 is defined as the resistance to laminar flow and following Poiseuille´s Law, 
which describes the hydraulic resistance of a tube: 
𝑅 = 8𝜂 ∙ 𝐿/𝜋𝑟4 
Where, 𝑅 is the resistance to a laminar flow of a fluid of 𝜂 viscosity through a tube 
of 𝐿  length and 𝑟  radius. Although Poiseuille´s Law was deduced from the 
behaviour of Newtonian fluids with laminar flow in rigid tubes, it properly defines 
the factors that determine 𝑅 in the circulation, so that it can also be applied with 
some restrictions to blood vessels. Combining this equation with Darcy´s Law and 
rearranging terms, 
∆𝑃𝑎 = 𝑄 ∙
8𝜂 ∙ 𝐿
𝜋𝑟4
 
From this equation it is evident that small changes in radius result in big effects on 
mean arterial pressure, constituting an extremely powerful mechanism by which 
blood vessels regulate both local blood flow and mean arterial pressure (Herring 
and Paterson, 2018). Smooth muscle cells in the tunica media are the cells 
responsible for changes in the vascular radius through their contraction-relaxation 
capabilities. Since the vascular tone defines the vessel radius, VSMCs finely control 
both ?̅?𝑎 and blood flow. 
2.3. Smooth muscle control of vascular tone. 
As mentioned before, vascular tone is defined as the state of contractile tension in 
the vessel walls, which can be maintained even in the absence of sympathetic 
innervation. The molecular mechanisms underlying this contractile state are very 
dependent on the fine control on the membrane potential (Vm) of VSMCs. K+ 
channels and L-type Ca2+ channels (LTCCs, the most dominant isoforms of voltage-
operated Ca2+ channels (VOCCs) in VSMCs) are the main channels participating in 
this control. K+ channels closing leads to membrane depolarizations, causing LTCCs 
channels-dependent Ca2+ influx, increase of intracellular calcium concentrations 
([Ca2+]i) and vasoconstriction, while opening of K
+ channels causes 
hyperpolarization, LTCCs closing, decrease in [Ca2+]i and vasodilation (Jackson, 
2000; Tykocki, Boerman and Jackson, 2017). 
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Figure I3. Regulation of vascular tone by K
+
 channels and VOCCs channels. In VSMCs 
(top), K
+
 channels-triggered Vm changes regulate VOCCs-mediated Ca
2+
 influx, causing 
changes in [Ca
2+
]i that lead to vasoconstriction or vasodilation (bottom) of vessels, 
thus regulating basal vascular tone (adapted from Jackson, 2000). 
 
In addition to voltage dependent K+ and Ca2+ channels, VSMCs have additional 
channels involved in the autoregulation of vascular tone. Several members of 
different K+ channels families, Ca2+-conducting channels, Cl- channels, non-selective 
cation channels and receptor-operated channels (ROCs) expressed in VSMCs have 
been found to be relevant in this regard (Figure I4). The negative membrane 
potential of VSMCs (~-50-60 mV) is defined by the intracellular and extracellular 
[K+], [Na+] and [Cl-] and their relative permeability (~10:4:2, respectively). K+ 
channels play crucial roles in the control of vascular tone by influencing membrane 
potential and so the activity of Ca2+ channels. Interestingly, the high [Cl-]i in VSMCs 
(~30-50 mM) determines an ECl (-26 mV) above the membrane potential, so that 
activation of chloride channels has a depolarizing effect  (Kitamura and Yamazaki, 
2001). In the case of ROCs, the main pathway present in VSMCs starts with the 
activation of a phospholipase-C (PLCβ) dependent of Gq/11 coupled receptors. 
Membrane PIP2 is cleaved by the phospholipase into IP3 and DAG. IP3 activates its 
specific IP3R receptor on the SR leading to Ca
2+ release to the cytosol 
(pharmacomechanical coupling). DAG activates ROCs both, directly and through 
the PKC signaling pathway, leading to membrane depolarization, VOCCs opening 
and a further increase of [Ca2+]i and contraction. Ca
2+ released from the SR can also 
activate Ca2+-activated channels (K+ and Cl-), finely tuning the changes in Vm 
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(electromechanical coupling) and therefore the activation of VOCCs, the final level 
of [Ca2+]i and the magnitude of contraction (Herring and Paterson, 2018). The 
structure, function and role of K+, Ca2+, Cl- and ROCs families of channels in the 
vasculature will be discussed in detail in the next sections. 
 
Figure I4. Contribution of vascular smooth muscle channels to electromechanical and pharmacological 
coupling in VSMCs. 
 
Since vascular tone is the key determinant of vessel diameter, it is fine-tuned by 
intrinsic and extrinsic mechanisms that regulate vessels resistance by inducing the 
appropriate vasoconstriction or vasodilation. The intrinsic mechanisms are those 
driven by the vascular wall itself and include smooth muscle- and endothelium-
derived self-adjusting mechanisms, while extrinsic mechanisms are driven by 
extravascular mechanisms such as perivascular vasomotor nerves and endocrine 
factors. 
Intrinsic control of vascular tone 
Among the intrinsic mechanisms that regulate vascular basal tone, temperature, 
myogenic response (defined as the vasoconstriction in response of an increase in 
the arterial pressure), endothelial-derived molecules (NO, PGI2, endothelium-
derived hyperpolarizing factor -EDHF-, and endothelin) and vasoactive autacoids 
constitute the main ones. NO is synthesized from L-arginine by endothelial nitric 
oxide synthase (eNOS) and diffuses into smooth muscle where it activates guanylyl 
cyclase (GC) which in turn catalyzes cyclic guanosine monophosphate (cGMP) 
production from guanosine triphosphate (GTP). cGMP then activates protein kinase 
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G (PKG) which reduces [Ca2+]i causing vasodilation. PGI2, produced from arachidonic 
acid, and EDHF act as potent vasodilators on smooth muscle, while endothelin 
causes vasoconstriction (Herring and Paterson, 2018). 
Extrinsic control of vascular tone 
Extrinsic control of vascular tone is mainly due to the activity of vasomotor nerves 
and circulating hormones. 
The sympathetic vasoconstrictor nerves contain many varicosities that release NA, 
adenosine triphosphate (ATP) and neuropeptide Y. NA and ATP acting mainly 
through α-adrenergic Gq-protein coupled receptors (GPCRs) and purinergic 
ionotropic receptors, respectively, promote vasoconstrictor responses (Herring and 
Paterson, 2018, see below). Likewise, a fall in the sympathetic activity causes 
vasodilation. In addition, in a limited number of tissues, the resistance arteries are 
innervated by vasodilator fibers together with the ubiquitous sympathetic 
vasoconstrictor fibers. These vasodilator fibers can be sympathetic, 
parasympathetic or sensory fibers (Herring and Paterson, 2018). In this regard, it is 
well established that cutaneous substance P-containing sensory fibers are 
associated with blood vessels and are, at least in part, responsible for mediating 
antidromic phenomena such as vasodilation and plasma extravasation. Stimulation 
of nociceptive C-fibers causes vasodilation due to the release of substance P and 
calcitonin gene-related peptide (CGRP), leading to the flare responses to a damage. 
The stimulation of these fibers leads also to mast cells stimulation and histamine 
release, which potentiates the flare response by increasing microvascular 
permeability. This spreading flare, together with the local redness and swelling is 
an important component of the Lewis triple response (the reaction of skin to a mild 
trauma). 
Regarding circulating hormones, the main ones involved in the control of vascular 
tone are: Adrenaline, Vasopressin, Angiotensin II (Ang II) and atrial natriuretic 
peptide (ANP). Adrenaline induces vasoconstriction through activation of vascular 
smooth muscle α-adrenergic receptors (or vasodilation in the skeletal muscle 
through activation of β-adrenergic receptors); vasopressin, also called antidiuretic 
hormone, is a potent vasoconstrictor; angiotensin II, produced by the renin-
angiotensin-aldosterone system (RAAS), acts directly as a vasoconstrictor agent on 
vascular smooth muscle and indirectly by enhancing sympathetic activity. It also 
has an extensive cross-talk with endothelial factors, which is crucial for the 
angiotensin converting enzyme (ACE) signaling pathway. Finally, ANP acts as a 
potent vasodilator (Herring and Paterson, 2018). 
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Therefore, a complex system of different intercommunicated signaling mechanisms 
is constantly activated to regulate the contractility of VSMCs. The failure of this 
integrated system leads to specific cardiovascular disorders (v.g. heart attack, 
stroke, hypertension) or contributes to aggravate systemic syndromes such as 
obesity or diabetes. The relationships between these diseases and vasculature are 
complex and multifaceted, including changes in the vessels that directly contribute 
to the progression of the disease, changes  that result from disease progression, 
and even changes that represent compensatory mechanisms (Tykocki, Boerman 
and Jackson, 2017). 
 
3. Hypertension 
Hypertension is a multifactorial cardiovascular disorder characterized by a chronic, 
usually progressive, raise in the arterial mean pressure that if it is not properly 
treated leads to multi-organ lesions in heart, brain and kidneys. Since individual 
pressure measurements vary individually, repeated values of Ps and Pd exceeding 
140/90 mmHg, respectively, are used to diagnose chronic hypertension (Table I1). 
Classification 
Ps 
(mmHg) 
 
Pd 
(mmHg) 
Normotension <120 and <80 
Elevated 120-129 and <80 
Grade 1 hypertension 130-139 or 80-89 
Grade 2 hypertension ≥140 or ≥90 
Table I1. Classification of adult blood pressure (adapted from 
Whelton et al., 2018). 
Hypertension can be divided into essential or primary hypertension, involving 90% 
of cases, and secondary hypertension, involving the remaining 10%. Essential 
hypertension is a symptomless, multifactorial genetic disorder, in which inheritance 
of abnormal genes predisposes an individual to high blood pressure, especially if 
environmental influences are present, such as salt and alcohol intake, sedentary 
lifestyle and obesity (Aaronson, Ward and Wiener, 2004). In contrast, secondary 
hypertension has an identifiable pathologic cause, including hyperaldosteronism 
and renovascular diseases, which impair volume regulation and activation of renin-
angiotensin-aldosterone system; pheochromocytoma, which raises pressure 
through α-adrenoceptor activation; and pre-eclamptic toxemia, which develops 
during pregnancy (Herring and Paterson, 2018). 
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3.1. Etiology of hypertension 
Arterial pressure rises because of an imbalance between cardiac output (CO) and 
total peripheral resistances (TPR). In the early stages, hypertension could be 
associated with a CO increase with normal or slightly raised TPR, but over time CO 
reverts to normal values while TPR becomes permanently increased. The 
molecular, functional and structural changes that lead to this chronic elevation of 
TPR are not fully understood. Several hypothesis including neurogenic induced 
hypertension through augmented sympathetic innervation, and also renin-
angiotensin-aldosterone induced hypertension have been suggested (Herring and 
Paterson, 2018). Due to the crucial roles that vascular ion channels play in the 
control of vascular tone and contractility through their contribution to set resting 
Vm, the altered expression and function of these VSM channels may contribute to 
vascular dysfunction and to the pathogenesis of hypertension. However, it is not 
clear whether these changes occur as part of the disease progression or as 
compensatory mechanisms to maintain homeostasis. Although there is a huge 
knowledge about the contribution of VSM channels to the pathophysiology of 
hypertension, our understanding of their specific roles in vascular dysfunction 
remains unclear. Some of the difficulties arise from the lack of specific 
pharmacological blockers against some channels, the huge macromolecular 
complexes where these channels interact with a wide range of additional proteins, 
and the broad heterogeneity between vascular tissues and species. Understanding 
the specific role of a given ion channel to the pathogenesis of hypertension 
requires the selection of a suitable animal model and the use of multiple 
approaches. 
3.2. Animal models used to study essential hypertension 
Due to the complexity of essential hypertension disease, different animal models 
have been developed to study the molecular mechanisms involved in the 
hypertension etiology and treatment. These models can be grouped into genetic 
and non-genetic (Table I2). 
Genetic models are in turn divided in genotype-driven models, created by gene 
overexpression (transgenic) or deletion (knockout) to focus in a gene involved in 
hypertension, and phenotype-driven models, which involve selective breeding of 
hypertensive strains and their maintenance over generations. The latter models 
include the spontaneously hypertensive rat (SHR) model, the salt-sensitive Dahl rat 
model and the blood pressure high (BPH) mouse model (Lerman et al., 2005). 
Non-genetic models have been broadly used to study the effects of induced 
hypertension on end-organ damage in different species. These models include: 1) 
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surgically induced hypertension, such as the hypertensive models developed by 
unilateral constriction of renal artery (1K1C and 2K1C models); 2) 
pharmacologically induced hypertension, such as deocorticosterone (DOCA)-salt rat 
model, Angiotensin II- and other vasoactive peptide-infused models; and 3) 
environmental-induced hypertensive models, such as salt diet- and stress-induced 
hypertensive models (Lerman et al., 2005). 
  Animal model 
Pa increase 
(mmHg) 
Time to 
establish 
(weeks) 
Hypertension type 
G
e
n
e
ti
c 
M
o
d
e
ls
 
 
Genotype-driven 
 
Transgenic 
 
Variable 
 
Variable 
 
Essential 
Phenotype-driven 
 
 
SHR 40-60 4-6 
Essential Salt-Dahl rats >30 2 
BPH mice >30 birth 
N
o
n
-G
e
n
e
ti
c 
M
o
d
e
ls
 
Surgically-induced 2KIC >50 4 Vascular renal 
disease 
1KIC >70 4 
Pharmacologically-
induced 
 
DOCA-salt >20-35 3 Hyperaldosteronism 
Angiotensin II >40-50 4-10 days Essential 
NOS inhibitors >5-25 4-6 Essential 
Environmentally-
induced 
 
 
High salt diet-
induced 
>10 4-5 days 
Essential 
Stress-induced 10-20 4-6 months 
Cold-induced 20-40 3 
Table I2. Different experimental animal models to study hypertension (Lerman et al., 2005). 
 
BPH mice as a model of essential hypertension 
Among these possible models to study hypertension and due to the interest of our 
research group in the study of the pathophysiology of essential hypertension, we 
chose the BPN/BPH. The phenotype-driven hypertensive (BPH/2J) mouse model of 
essential hypertension and its normotensive control (BPN/3J) was early developed 
by crossbreeding of eight different mouse strains showing high and normal blood 
pressure measured by the tail-cuff method. Early studies using the high blood 
pressure (BPH) mouse strain also showed increased heart rate and early mortality 
(Schlager, 1981; Schlager and Sides, 1997), and later studies found a reduction in 
the NA content in hypothalamus, amygdala and cerebellum (Schlager, Freeman and 
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El Seoudy, 1983) and greater contents in the preoptic area and in the superior 
cervical ganglion (Denoroy et al., 1985), consistent with a neurogenic form of 
hypertension. Furthermore, evidences of an overactive sympathetic nervous 
system (SNS) in the BPH strain associated with circadian rhythms confirmed the 
involvement of neurogenic mechanisms leading to hypertension (Davern et al., 
2009, 2010). Additionally, changes in the expression pattern of genes involved in 
hypertension-related systems, such as adrenal catecholamines and sympathetic 
function, steroid hormone synthesis and sensitivity, oxidative stress and 
intermediary metabolism have been described. Some of these gene expression 
profiles shared a common direction of expression in the two different hypertensive 
SHR and BPH models, while other revealed differences between the two models, 
such as adrenal catecholamines synthesis (depressed in SHR, but enhanced in BPH), 
and the glucocorticoid dependence of SHR (Friese et al., 2005). Furthermore, 
findings of genes differentially expressed between males and females in the BPH 
strain suggested that differences in sex hormones influenced the mechanisms that 
are involved in the onset of hypertension in this mouse model (Chiu et al., 2014), 
reinforcing the multifactorial and complex nature of hypertension. These 
observations, together with the existence of a good control strain of the BPH strain 
(BPN strain), indicate that BPH is a suitable model to study essential hypertension. 
The examination in detail of the gene expression profile and its associated 
functional properties in this BPH mouse model could contribute to unravel the 
mechanisms associated with human essential hypertension. 
 
4. Ion channels in VSMCs. 
VSMCs exhibit a large variety of ion channels in their membrane that are involved 
in the autoregulation of contractility and vascular tone (Tykocki, Boerman and 
Jackson, 2017). These channels can be grouped in several families: K+-channels, 
including voltage-dependent (KV), Ca
2+-activated (KCa) and inward rectifying K
+ 
channels (KIR or classical inward rectifiers, and KATP or ATP-dependent); Ca
2+ 
channels, including L-type (LTCCs), T-type, N-type, P/Q-type and R-type subfamilies 
of channels; receptor-operated channels (ROCs) and stretch-activated channels 
(SOCs), including transient receptor potential channels (TRPs); and Cl--channels. 
4.1. K+-channels 
In resting VSMCs, [K+]i is higher than [K
+]o due to the electrogenic activity of the 
Na+-K+ pump (~150 mM vs. 5 mM). Driven by this electrochemical gradient, 
outward K+ flux contribute to set the negative Vm of VSMCs due to the relative 
 - 13 - 
INTRODUCTION 
large permeability to K+ in resting conditions, thus influencing vascular tone by 
controlling Vm. Up to four families of K+ channels have been found in VSMCs. 
4.1.1. Voltage-dependent K+ channels (KV) 
KV channel family comprises up to twelve members (KV1-12) arranged in the plasma 
membrane as tetramers of four pore forming α-subunits. Each subunit has six 
transmembrane α-helices (S1-S6), with S4 containing the voltage sensor and the P-
loop between S5 and S6 forming the channel pore (Figure I5). The N- and C-termini 
reside in the cytosol and are related with fast and slow channel inactivation, 
respectively. Differences in the functions of KV channels depend not only on the 
structural differences of each family member, but also on their ability to form 
heteromultimers or to associate with accessory and regulatory subunits (Gutman et 
al., 2005). These channels are activated in response to membrane depolarizations 
leading to the K+ efflux responsible of the consequent return to resting Vm. 
Therefore, KV channels can contribute to control the resting Vm and vascular tone. 
In addition, several vasodilators can activate KV channels through cAMP-PKA, 
cGMP-PKG and other endothelium-dependent signaling pathways. They are also 
responsible of the effect of several vasoconstrictors that close KV channels through 
protein Gq/11-mediated PKC activation and [Ca
2+]i increase. 
The role of KV channels expression and function in the development of 
hypertension remains unclear. Electrophysiological and expression studies have 
reported increased, decreased and no changes in expression and KV channels 
mediated currents, however, the bulk of literature points to a reduced expression 
and function of these channels in hypertension, depending on the animal model, 
vascular bed and type of hypertension (Cox, Folander and Swanson, 2001; Berg, 
2003; Cox et al., 2008; Moreno-Domínguez et al., 2009; Jepps et al., 2011). 
 
Figure I5. Structure of the α-subunit of voltage-dependent K
+
 
channels (KV) showing the membrane domains S1-S6 with the 
voltage sensor in S4 and the pore forming P-loop between S5 and 
S6 (adapted from Jackson, 2017). 
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4.1.2. Inward rectifying K+ channels (KIR) 
Inward rectifying K+ channels (KIR) derive their name from the characteristic 
rectification that appears in the current-voltage (I/V) relationship of the currents 
they carry out (Figure I6). Inward currents (obtained at Vm more negative than the 
EK) are much larger than outward currents (obtained at Vm more positive than EK). 
This family of K+ channels comprises the large conductance inward rectifiers (KIR) 
and the ATP dependent channels (KATP) (Hibino et al., 2010). 
4.1.2.1. Large conductance KIR channels 
Large conductance KIR channels are tetramers constituted by four α-subunits, all of 
which are formed by two transmembrane α-helices (M1 and M2) linked by a P-loop 
which constitutes the ion-conducting pore. The N- and C-termini domains are 
localized in the cytosol. The C domain is involved, along with the M2 helix, in the 
blockade of outward K+ flux by intracellular Mg2+ and polyamines at Vm more 
depolarized than EK. Among the seven subfamilies of KIR channels, only KIR2.1 
(KCNJ2) and KIR 2.2 (KCNJ12) have been found to be highly expressed in VSMCs 
(Bradley et al., 1999; Zaritsky et al., 2000; Smith et al., 2008). 
It is known that several vasoconstrictors acting on the Gq/11-coupled PLCβ-DAG-PKC 
signaling cascade can block KIR channels, enhancing vasoconstrictors-induced 
depolarization and contraction of VSMCs. On the other hand, KIR channels located 
at the endothelium could also amplify small hyperpolarizations caused by other 
channels or by small increases in extracellular K+  concentration, , contributing to 
the vasodilator response of some stimuli (William F. Jackson, 2017). Although KIR 
channels are named for the inward rectification of current, it is the small outward 
“hump” in the current-voltage relationship (i.e., the region of negative slope 
conductance, figure I6) that is present between the EK and the resting Vm (~−40 to 
−30 mV) of endothelial cells that is important for their physiological function. This 
negative slope conductance allows outward KIR current to be activated by 
membrane hyperpolarization, permitting KIR channels to amplify hyperpolarization 
induced by other K+ channels and ion transporters. Also, increases in extracellular 
K+ concentration activate KIR channels, which transduce this change into membrane 
hyperpolarization. As endothelial cells have high membrane resistance at resting 
membrane potential, activation of only a few KIR channels can effectively modulate 
their membrane potential. 
In general, reduced expression and function of KIR channels have been reported in 
hypertension, although in some cases this KIR channels dysregulation has been 
accompanied by compensatory mechanisms to maintain homeostasis (Tajada et al., 
2012). 
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Figure I6. Structure of inward rectifying K
+
 channels (KIR) showing the α-subunit composed by the 
two membrane domains M1 and M2 linked by P-loop (left) and the top view of four α-subunits 
with K
+
 ion in the middle of the tetramer (bottom). The associated KIR channels behavior depending 
on the Vm is also depicted (right) (adapted from Jackson, 2017). 
 
4.1.2.2. ATP-dependent K+ channels (KATP) 
ATP-dependent K+ channels (KATP) are named for their sensitivity to ATP, linking 
membrane excitability and metabolism. A decrease in the [ATP]i induces the 
opening of KATP channels and the consequent hyperpolarization. However, their 
functional activity can be modulated by additional signaling pathways in an ATP 
independent manner. The structure of KATP channels consists of a hetero-octamer 
composed of a tetramer of pore-forming KIR6.1 subunits associated with a tetramer 
of sulphonylurea receptors (SURs) 2B. SUR2B monomers are formed by seventeen 
transmembrane α-helices clustered in three groups (TMD0, TMD1 and TMD2) with 
two intracellular nucleotide-binding fold domains (NBF1 and NBF2) and N- and C-
termini outside and inside the cell, respectively (Figure I7) (Babenko, Aguilar-Bryan 
and Bryan, 1998; Hibino et al., 2010).The KIR6.1 subunits have two transmembrane 
spans and form the channel’s pore. The SUR subunits allow nucleotide (ATP and 
ADP)-mediated regulation of the channel through their NBFs, and are critical in the 
role of the channel as a sensor of metabolic status. These SUR subunits are also 
sensitive to sulfonylureas, MgATP, and some other pharmacological channel 
openers (Foster and Coetzee, 2016). Besides intracellular ATP, KATP channel activity 
can be inhibited by vasoconstrictors through several mechanisms: 1) PKC-triggered 
alteration of channel gating and channel internalization; 2) calcineurin (PP2B)-
induced dephosphorylation and 3) Gi-triggered adenylate cyclase (AC) inhibition. 
Moreover, KATP channels can also contribute to the action of vasodilators through 
the cAMP-PKA and cGMP/PKG signaling pathways (Tykocki, Boerman and Jackson, 
2017). Several evidences suggest a contribution of the reduced expression and 
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function of KATP channels to the genesis of hypertension (Tajada et al., 2012), 
although another set of studies showed no changes in KATP channels function in 
some hypertensive animal models (Tykocki, Boerman and Jackson, 2017). 
 
Figure I7. Structure of ATP-dependent K
+
 channels (KATP). Four KIR6.1 subunits associated to four 
SUR2B subunits comprise the functional hetero-octamer of a KATP channel (adapted from Babenko, 
Aguilar-Bryan and Bryan, 1998; Jackson, 2017). 
 
4.1.3. Ca2+-activated K+ channels (KCa) 
KCa are K
+ channels activated by increases in [Ca2+]i. KCa channels comprises two 
subfamilies according to single channel conductance, voltage sensitivity and 
pharmacological properties: 1) The large-conductance Ca2+- and voltage-activated 
channels (BKCa), which are the most abundant K
+ channels expressed in VSMCs, and 
2) the small-conductance Ca2+-activated channels (SKCa), also found in several 
vascular beds and mainly expressed in the endothelium . An additional subfamily of 
intermediate-conductance Ca2+-activated channels (IKCa) has been reported, but 
they are only expressed in proliferating VSMCs (Tykocki, Boerman and Jackson, 
2017). The structure of the pore-forming α-subunit of BKCa channels consists of 
seven transmembrane α-helices (S0-S6) with the P-loop between S5 and S6 forming 
the ion-conducting pore and several charged residues in S2, S3 and S4 determining 
the voltage sensor. N-terminus faces the outside of cell, while C-terminus is 
localized in the cytosol and shows two, tandem regulator of conductance K+ 
domains (RCK1 and RCK2) which constitute the Ca2+ sensor. Moreover, additional 
regulatory subunits, such as β1- and γ-subunits, have been reported to associate 
with BKCa channels (Figure I8). β1-subunits enhance the Ca
2+ sensitivity and 
trafficking of α-subunit and the channel activation, while γ-subunits, which are 
leucine-rich-repeat containing proteins (LRRCs), increase the voltage and channel 
activators sensitivities (Tykocki, Boerman and Jackson, 2017). KCa channels play a 
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central role in the control of membrane potential and vascular tone and 
contractility as a coupled unit with VOCCs and Ryanodine receptor (RyR) channels 
in many VSMCs. Considering the close proximity between plasma and SR 
membranes, Ca2+ influx through VOCCs channels locally activates RyR channels 
leading to unitary Ca2+ release events (Ca2+ sparks) from SR. These Ca2+ sparks have 
been shown to regulate KCa channel open probability leading to K
+ efflux in the 
form of spontaneous transient outward currents (STOC), causing membrane 
hyperpolarization, VOCCs channels closing and global [Ca2+]i decrease. Therefore, 
this Ca2+ spark-STOC pathway seems to be an important negative feedback system 
in the regulation of membrane potential, vascular tone and contractility (Nelson et 
al., 1995; Jaggar et al., 1998). Likewise, despite several controversial studies, 
evidences showed a BKCa contribution not only to the resting Vm both in health and 
disease, but also to agonists-induced vasoconstriction by preventing vasospasm in 
a negative feedback way (Jackson, 2000). In hypertensive animal models, both 
increase and decrease in the expression and functions of BKCa channels have been 
reported to be dependent on animal strains, vascular beds and methodological 
differences (Tajada et al., 2013; Tykocki, Boerman and Jackson, 2017). 
 
Figure I8. Structure of large-conductance K
+
 channels (BKCa). α-subunit showing its seven 
membrane domains (S0-S6) with the voltage sensor in S2, S3 and S4, and its Ca
2+
 sensor in C-
terminus along with the regulator conductance K
+
 domains (RCK1 and RCK2). Additional 
regulatory β1- and γ-subunits are also depicted (adapted from Jackson, 2017). 
 
4.1.4. K+ channels remodeling in BPH mice 
Using BPN and BPH mice, our group has previously determined the functional 
expression of K+ channels and their contribution to VSMC excitability. Our results 
showed that in mesenteric VSMCs of BPH mice there is a remodeling of Kv2 
currents, leading to a decreased Kv mediated current amplitude which contributes 
to the hypertensive phenotype (Moreno-Domínguez et al., 2009). However, while 
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VSMCs from BPH mice were significantly more depolarized than BPN VSMCs, there 
were no changes in the contribution of Kv currents to resting Vm, suggestng that 
the remodeling of Kv2 currents was an adaptative mechanism to prevent larger 
vasoconstrictor responses. In adition, we found that VSMCs from BPH mesenteric 
arteries exhibited a significant decrease in the mRNA expression of KIR2.1, KIR4.1, 
KIR6.x and SUR2, and a decrease in the current amplitudes mediated by both KIR and 
KATP channels. The decreased expresion of both channels did contribute to the 
more depolarized resting Vm of BPH cells, but only the response to KATP channel 
blockers and activators was impaired when arterial tone was tested. Altogether, 
our data indicate that changes in KATP channels in resistance arteries could be an 
important determinant of the hypertensive phenotype in the BPH model (Tajada et 
al., 2012). 
4.2. Voltage-operated Ca2+ channels (VOCCs) 
Voltage-operated Ca2+ channels (VOCCs) are broadly distributed in many tissues 
and cells. They transduce membrane depolarization into an increase in [Ca2+]i by 
activating a Ca2+ influx down its large electrochemical gradient. By increasing [Ca2+]i, 
VOCCs play important roles in the regulation of contractility, vascular tone and 
gene expression in VSMCs (Jackson, 2000; Ghosh et al., 2017). 
4.2.1. Classification of VOCCs 
VOCCs were first divided in six different families according to their pharmacology 
and the electrophysiological characteristics of their currents. L-type Ca2+ currents 
present relative high voltage of activation (from -40 to -30 mV), high single channel 
conductance, slow voltage-dependent inactivation and are blocked mainly by 
dihydropyridines. T-type Ca2+ currents present more negative voltage of activation 
(from -70 to -60 mV), rapid voltage-inactivation, small single channel conductance 
and are relatively insensitive to organic Ca2+ blockers. The additional N-, P-, Q- and 
R-type Ca2+ currents, less common in VSMCs, present intermediate currents 
between L- and T-type and are sensitive to the blockade with several toxins, except 
R-type currents. These different types of currents have been grouped, in turn, into 
three subfamilies according to the genes encoding the α1-subunit responsible of 
carrying the currents: 1) the CaV1 subfamily comprising four members (CaV1.1-1.4) 
and carrying the high-voltage-activated, long lasting L-type Ca2+ currents; 2) the 
CaV2 subfamily, including channels carrying P/Q-(CaV2.1), N-(CaV2.2) and R-type 
(CaV2.3) currents; and 3) the CaV3 subfamily including members (CaV3.1-3.3) 
carrying low-voltage-activated, transient T-type Ca2+ currents (Tykocki, Boerman 
and Jackson, 2017). 
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4.2.2. Structure of VOCCs 
The general structure of VOCCs consists of a complex of α1, α2, β, γ and δ subunits 
in such a way that the principal α1-subunit (190 kDa) associates with a disulfide-
linked α2δ dimer (170 kDa), an intracellular phosphorylated β-subunit (55 kDa) and 
a transmembrane γ-subunit (33 kDa) (Figure I9) (Catterall, 2011). 
The α1-subunit is organized in four repeated motifs (I-IV), each of which containing 
six transmembrane α-helices (S1-S6) with a loop between S5 and S6 forming the 
pore. The S4 helix of each motif serves as the voltage sensor and their 
conformational changes lead to channel opening. The intracellular β-subunit has no 
transmembrane segments and binds to the intracellular loop between I and II 
motifs of α1-subunit, while γ-subunit is a glycoprotein with four transmembrane 
domains and N- and C-termini in the cytosol. The extracellular α2-subunit is 
attached to the membrane through disulfide linkage to δ-subunit, which is 
anchored to the membrane through glycophosphatidylinositol. Although α1-
subunit is sufficient to render channel functionality, α2δ and specially β-subunits 
enhance the channel expression and confer more physiological gating properties 
(Catterall, 2011). 
 
Figure I9. Structure of L-type Ca
2+
 channels (LTCCs) showing the pore forming α1-subunit, the 
intracellular regulatory β-subunit, the extracellular disulfide-linked α2δ dimer and the 
transmembrane γ-subunit (adapted from Catterall, 2011).  
 
4.2.3. Function of L-type and T-type Ca2+ channels in VSMCs 
As previously mentioned, L-type Ca2+ channels constitute the dominant VOCC 
channel expressed in VSMCs cells, although evidences of functional T-type Ca2+ 
channels have been also reported. The principal role of these channels is their 
contribution to the regulation of vascular tone by Vm: depolarizations open L-type 
Ca2+ channels leading to Ca2+ influx, increase in [Ca2+]i and vasoconstriction, 
whereas hyperpolarization closes these channels, decreases [Ca2+]i and causes 
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vasodilation. In addition, L-type Ca2+ channels play important roles in the control of 
myogenic tone and vasomotion (Tykocki, Boerman and Jackson, 2017, see for 
refrences). Moreover, these channels are regulated not only by changes in Vm but 
also by additional signaling mechanism, including vasoconstrictor- and vasodilator-
dependent signaling pathways. Several evidences showed a directly Gq/11-induced 
activation of L-type Ca2+ channels independently of changes in Vm and likely 
through PKC-induced increase of their open-state probability, thus enhancing the 
agonists-induced vasoconstriction (Del Valle-Rodríguez, López-Barneo and Ureña, 
2003; Ureña, del Valle-Rodríguez and López-Barneo, 2007). On the other hand, 
both activation and blockade of L-type Ca2+ channels have been reported in the 
presence of vasodilators. While, cGMP-PKG signaling pathways appears to block L-
type Ca2+ channels contributing to vasodilation, vasodilator-induced cAMP-PKA-
dependent mechanisms lead to both activation and inhibition of L-type Ca2+ 
channels (Xiong and Sperelakis, 1995). 
4.2.4. Remodeling of L-type Ca2+ Channels in BPH mice 
Strong evidences support an increased expression and function of CaV1.2 channels 
in hypertension that contributes to the increased myogenic tone and contractility 
and to the decreased vasodilator activity, all of which contributing to the increased 
peripheral vascular resistances. The molecular mechanisms by which hypertensive 
patients show increased functional expression of LTTCs channels remains unclear, 
but may be related to an increased trafficking of α-subunit to cell membrane 
through an increased expression of the modulatory α2δ and β subunits and also 
through the activation of PiP3K-γ mediated by G12/13-coupled receptors (Bannister 
et al., 2012; Kharade et al., 2013; Tykocki, Boerman and Jackson, 2017). Using the 
BPH mouse model, we found a decrease in the global smooth muscle Ca2+ influx 
due to fewer CaV1.2 channels. However, these CaV1.2 channels were hyperactive in 
BPH cells, leading to a larger local Ca2+ influx at rest that triggered an increased Ca2+ 
release from intracellular stores (sparks). Moreover, since BKCa channels from BPH 
myocytes showed reduced Ca2+ sensitivity, their activation by the increased [Ca2+]i 
was impaired. The decreased CaV1.2 currents but higher CaV1.2 triggered sparks 
found in BPH VSMCs have been related to differences in the subunit composition of 
these channels (Tajada et al., 2013). Our results suggest that changes in the 
molecular composition of both CaV1.2 and BKCa channels could explain vascular 
dysfunction during hypertension in BPH mice. 
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4.3. Other channels: Receptor-operated (ROCs) and stretch-operated (SOCs) 
channels and Cl--conducting channels 
In addition to the important roles that both, K+-conducting channels and voltage-
dependent Ca2+ channels play to the contribution of membrane potential, vascular 
tone and contractility, many other families of ion channels have been found to be 
functionally expressed in VSMCs. In this context, non-selective cation channels and 
Cl--conducting channels have been the principal families of ion channels widely 
studied both, in health and disease. 
Non-selective cation channels comprise several families of agonists-activated and 
stretch-activated channels which are permeable only to cations (K+, Na+ and Ca2+). 
Both, the agonist or the stretching stimulus can activate the channel either directly 
or indirectly. In the direct activation, the channel is the receptor itself, such as the 
P2X ATP receptors. In contrast, the indirect activation involves a second messenger 
chain triggered by an agonist-activated receptor. In this context, several GPCR 
receptors and the transient receptor potential (TRP) channels, which behave as 
ROCs, are widely expressed in VSMCs and have been found to be involved in the 
physiopathology of the vascular system. Receptor activation increases [Ca2+]i (see 
above, section 2.3), and the consequent activation of Ca2+ sensitive channels 
modulate membrane potential, the activity of VOCCs and the final contractile 
responses. As described above, KCa channels behave as brakes, hyperpolarizing Vm 
and limiting VOCCs activation. However, Ca2+ sensitive Cl- channels have the 
opposite effect, producing a membrane depolarization or amplifying in some cases 
the depolarization induced by ROCs activation, potentiating the activation of VOCCs 
and generating in some cases action potentials (v.g. in the portal vein). This role of 
Cl--conducting channels in the VSMCs arises from the fact that these cells present a 
high [Cl-]i and then, a more depolarized ECl (above membrane potential) compared 
to other cell types. Thus, activation of Cl--conducting channels results in Cl- efflux 
and VSMCs depolarization. 
Since this Thesis focuses on TRP channels, Ca2+ activated Cl- channels and Purinergic 
signaling in BPN/BPH mice, a more detailed description of the structure, function 
and action mechanisms of these receptors and channels will be discussed in the 
following sections. 
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5. Receptor-dependent contraction signaling pathways 
It has been broadly described that the transmitters released from perivascular 
nerves and also several factors released from endothelial cells dually contribute to 
vascular tone control. Most of these molecules modulate vascular tone through the 
activation of both metabotropic and ionotropic receptors (see above, section 2.3). 
Although several differences in the regulatory mechanisms have been found in 
different vascular beds and in different species, the purinergic signaling has an 
important dual role in the control of vascular tone and remodeling. Purine and 
pyrimidine nucleotides lead to complex integrated responses due to the activation 
of the nineteen different types of purinergic receptors characterized so far, which 
are divided in two main families: adenosine P1 and P2 receptors (Burnstock, 1978, 
1980). 
5.1 Adenosine P1 receptors 
Adenosine P1 family comprises A1, A2A, A2B and A3 receptors and are coupled to Gi/o 
(A1 and A3) and to Gαs (A2A and A2B) proteins, leading to a reduced and increased 
cAMP production, respectively. However, evidences showed A1, A2B and A3 
receptors couple also to Gq/11 leading to PLCβ signaling cascade activation. A1 and 
A3 receptors display a ~49% of sequence identity, while A2A and A2B receptors are 
~45% identical. Adenosine receptors present a typical GPCR structure, consisting in 
an extracellular N-terminus, seven α-helical membrane spanning domains and an 
intracellular C-terminus. Consensus sites for N-glycosilation and cysteine containing 
sites are localized in the extracellular loops. An additional cysteine residue localized 
in the C-terminus of A1, A2B and A3, but not A2A, has been found to be post-
transcriptionally modified. Additionally, the intracellular third loop plays an 
important role in the AC activity and in the receptor internalization (Olah and Stiles, 
2000). Besides the differences on species and vascular beds, all adenosine P1 
receptors have been found in perivascular nerves, smooth muscle and endothelial 
cells with A2A and A2B receptors being the most commonly expressed. P1 receptors 
contribute mostly to vasodilation responses via inhibitory, pre-junctional 
modulation and also enhancing cAMP-mediated NO production (Burnstock and 
Ralevic, 2013). 
5.2 Purine and pyrimidine P2 receptors 
Since the first description of the purinergic signaling by Drury and Szent-Györgyi in 
1929 and the first definition of purinergic receptors by Burnstock in 1976, several 
studies have focused on a possible receptor subdivision based on pharmacological 
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approaches. Purinergic receptor were divided into P1 and P2 families by Burnstock 
in 1978 and some time later the P2 family was subdivided into ionotropic P2X 
receptors and G-protein-coupled P2Y receptors (Burnstock and Kennedy, 1985). 
5.2.1 P2X receptors 
P2X receptors comprise P2X1-7 isoforms, all of which having intracellular N- and C-
termini linked by two transmembrane domains (TM1, involved in channel gating; 
and TM2, lining the ion pore) and a extracellular loop (Brake, Wagenbach and 
Julius, 1994; Valera et al., 1994; Burnstock, 2007). P2X receptors are ligand-gated 
channels with variable affinity for ATP and variable conductance for Na+, K+ and 
Ca2+. P2X activation causes widespread cellular responses depending on their 
cellular subtype expression and on the homo and/or heteromeric structures they 
form (P2X2/P2X3, P2X4/P2X6, P2X1/P2X5) (North and Surprenant, 2000). Among P2X 
receptors, P2X1 is the protein most expressed in smooth muscle, followed by P2X2, 
P2X4 and P2X7, while P2X3, P2X5 and P2X6 receptors are usually absent. In contrast, 
all the P2X isoforms have been found in endothelial cells with P2X4 receptors being 
the dominant protein (Ralevic and Dunn, 2015). 
5.2.2 P2Y receptors 
P2Y family comprises eight isoforms grouped according to their sequence similarity 
and to their G-protein selectivity (Table I3): P2Y1-like receptors (P2Y1, P2Y2, P2Y4, 
P2Y6 and P2Y11) present a 28-52% sequence identity and couple mainly with Gq, 
while P2Y12-like receptors (P2Y12, P2Y13 and P2Y14) share 45-50% sequence identity 
and couple mainly with Gi/o. However, most of the Gq receptors link also to other G-
proteins, such as Gi/0 and G12/13 or Gs (P2Y11) and show a complex cross-talk with 
other membrane receptors and channels (Erb and Weisman, 2012). 
The structure of P2Y receptors consists of an extracellular N-terminus, seven 
transmembrane spanning domains involved in the ligand binding, three 
intracellular loops involved in the G-protein coupling and an intracellular C-
terminus containing several protein kinases binding sites. 
P2Y receptors are broadly expressed in different tissues and cellular subtypes so 
that their cellular responses vary based on their ligand specificity, G protein 
coupling and second messenger system. P2Y1, P2Y2, P2Y4 and P2Y6 receptors are 
commonly expressed in smooth muscle cells and their coupling to Gq/11 protein 
leads to PLC-mediated [Ca2+]i increase and contraction. In endothelial cells, P2Y1, 
P2Y2 and P2Y6 are the most abundant receptors, with some vessels expressing P2Y4, 
and are related to [Ca2+]i increase and subsequently NO, EDHF and PGI2 co-
releasing, leading to vasodilation. However, vasoconstrictor effects mediated by 
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P2Y receptors expressed in the endothelial cells have been also described when the 
endothelium is damaged, leading to local vasospasm (Burnstock and Ralevic, 2013) 
Ligand-stimulated activation of P2Y receptors is rapidly desensitized and proteins 
internalized due to the GPCR kinases (GRK1-7) mediated phosphorylation of 
intracellular Ser/Thr residues, which are then targeted by β-arrestins (β-Arr1-4) 
leading to receptor endocytosis and recycling. Although all P2Y receptors are β-Arr 
desensitized and internalized, several differences have been found based on the 
receptor subtype: all P2Y receptors interact with β-Arr2, while P2Y2 and P2Y4 
receptors interact with both β-Arr1 and β-Arr2 (Hoffmann et al., 2008). 
The variabilities in the ligand specificity, in the G-protein coupling and the 
possibility to form homo- or heteromers with P2Y receptors and other proteins 
lead to a wide variety of P2Y receptor mediated cellular processes, many of them 
quite relevant in cardiovascular, inflammation and neurotransmission disorders. 
P2YRs Agonist G protein- Main effector 
P2Y1 ADP Gq- PLCβ, Rac, Rho 
activation 
P2Y2 UTP=ATP Gq- PLCβ activation 
Go- PLCβ, Rac activation 
G12- Rho activation 
P2Y4 UTP=ATP Gq- PLCβ activation 
Go- PLCβ activation 
P2Y6 UDP Gq- PLC activation 
G12/13- Rho activation 
P2Y11 ATP Gq- PLCβ activation 
Gs- AC activation 
P2Y12 ADP Gi/o- AC inhibition; PLCβ, 
RhoA activation 
P2Y13 ADP Gi/o- AC inhibition; PLCβ, 
RhoA activation 
P2Y14 UDP-Glucose Gi/o- AC inhibition; PLCβ 
activation 
Table I3. P2Y receptors subtypes, their main agonists and G-
protein coupling. 
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5.3 Role of P2X and P2Y receptors in the control of vascular tone 
Because of the differences found in the expression of purinergic receptors in VSMC 
and endothelial cells, purinergic signaling can elicit both vasoconstrictor and 
vasodilator responses. Common to most vessels is that ATP co-released with 
noradrenaline (NA) from the sympathetic perivascular nerves produces vascular 
constriction. However, ATP released from endothelium leads to NO and 
endothelium-derived hyperpolarizing factor (EDHF) production and vasodilation. In 
addition, UTP and UDP co-released from platelets and damaged endothelial cells 
lead to vasoconstriction. Obviously, the final response depends on the balance 
among all these pathways. 
ATP and NA are separately co-stored in the perivascular nerves varicosities and are 
released to the adventitia layer as co-transmitters in variable proportions. ATP is 
released earlier than NA and induces the initial phase of contraction, while NA is 
responsible of the long-lasting vasoconstrictions (Burnstock and Ralevic, 2013). 
Although there are evidences of the expression of both P2X and P2Y receptors in 
vascular smooth muscle, the availability of good pharmacological tools and the 
development of genetic KO mice have allowed to describe P2X1 receptors as the 
main mediators of the fast vasoconstrictor response to ATP released from 
sympathetic perivascular nerves (Vial and Evans, 2002; Burnstock and Ralevic, 
2013). In addition, clusters of P2X1 receptors have been found in close proximity to 
sympathetic nerve varicosities (Hansen et al., 1999). The ATP-triggered P2X1 
activation leads to channel opening, increase of Na+, K+ and Ca2+ conductance, 
membrane depolarization and subsequent VOCCs channels-mediated Ca2+ entry 
and contraction, whereas NA triggered responses are slower due to the G-protein 
coupling and second messenger involvement. Furthermore, both pressure and 
vessel size are important determinants of the magnitude of the purinergic 
response: P2X1-triggered contractions dominated in small and medium size 
arteries, whereas the noradrenergic component dominated in large vessels 
(Gitterman and Evans, 2001). Likewise, the ATP component in the constriction 
response was significantly reduced at low arterial pressures (Rummery et al., 2007). 
The rapid smooth muscle depolarizations arising from the actions of 
neurotransmitters are known as fast excitatory junction potentials (EJPs) and are 
maintained by the continuously release of ATP quanta, while slow depolarizations 
have a noradrenergic component (Ralevic and Dunn, 2015). On the other hand, NA 
acting on α1-adrenergic receptors can promote additional ATP release from smooth 
muscle cells through pannexin-1 channels (Figure I10), contributing to the 
integrated complex vasoconstriction response (Billaud et al., 2011). Some of the 
ATP released can directly act through pre-junctional, inhibitory autoreceptors, such 
as P2Y receptors and  A1 adenosine receptors, the latter after being rapidly 
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metabolized to adenosine by ectonucleotidase triphosphate diphosphohydrolases 
(E-NTPDases) of the VSMCs membrane (Kauffenstein et al., 2010) and by soluble 
ATPases released from the sympathetic nerves (Figure I10) (Burnstock and Ralevic, 
2013). 
Purines released from perivascular nerves can also activate endothelial cells via P2Y 
and P2X4 receptors, leading to NO, EDHF and PGI2 release, vasodilation and 
inhibition of platelet aggregation. Furthermore, ATP-triggered ATP release in 
endothelial cells by shear stress and hypoxia can also activate this vasodilation 
response in a paracrine way (Figure I10) (Burnstock and Ralevic, 2013). Evidences 
showed that endothelial dysfunction promotes platelets aggregation and 
leukocytes accumulation, leading to ATP, ADP and UTP release, which induces local 
vasospasm through smooth muscle P2Y receptors (Burnstock and Ralevic, 2013). 
Smooth muscle cells also express P2Y receptors, which are activated by pyrimidine 
nucleosides and nucleotides. Although several isoforms (P2Y1,2,4,6) have been found 
in smooth muscle, evidences point to an important contribution of P2Y2 and mainly 
P2Y6 to the UTP- and UDP-triggered vasoconstrictions (Figure I10) (Vial and Evans, 
2002; Bar et al., 2008; Koltsova, Maximov, et al., 2009). Of note, P2Y6 involvement 
in the control of vascular tone has been recently related to its dimerization with 
AT1 receptors, promoting Ang II-induced hypertension dependent on age 
(Nishimura et al., 2016). As in the case of ATP, UTP causes vasodilation when acting 
in endothelial cells through P2Y2 and P2Y4, but not P2Y6 receptors, via EDHF 
mechanism (Burnstock and Ralevic, 2013). 
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Figure I10. Summary of the purinergic signaling control of vascular tone. 1, ATP co-released with NA 
from varicosities enhances EJPs and induces P2X1-mediated depolarization, VOCCs activation, [Ca
2+
]i 
increase and vasoconstriction. 2, ATP released is rapidly metabolized by E-NTPDases to adenosine, 
which has pre-junctional, inhibitory activities via P2Y and A1 autoreceptors. 3, ATP is also released 
from smooth muscle cells via pannexin1. 4, UDP and UTP contribute to vasoconstriction via G-protein 
coupled P2Y2,4,6 receptors. 5, ATP acting on P2Y and P2X1,4 receptors in endothelia has vasodilator 
effects via AC activation of cAMP-triggered NO, EDHF and PGI2 production. 6, ADP, ATP and UTP 
released from endothelial and platelets cells contributes to endothelia-mediated vasodilation. 
However, purines and pyrimidines released from aggregating platelets cause P2X- and P2Y-triggered 
vasoconstriction. 8, ADP, ATP and UTP have inhibitory effects on platelets in a paracrine way. 
 
5.4 Role of purinergic signaling in hypertension 
Using different in vitro and in vivo models of hypertension, evidences have shown 
the physiological contribution of different components of the purinergic signaling 
to the control of vascular tone, rendering purinergic signaling components as new 
possible therapeutic targets. In this context, several different evidences support a 
contribution of the purinergic signaling to hypertension development: 
 Essential hypertension has been associated with an increased sympathetic 
nerve activity and with hyperplasia and hypertrophy of arterial walls. 
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Moreover, purinergic receptors expressed on neuronal tissues mediate 
sympathetic activity. Antagonists of these receptors are centrally acting 
potential agents to the treatment of hypertension (Burnstock and Ralevic, 
2013). 
 
 Both, the increased contribution of the ATP released from sympathetic 
perivascular nerves and the purinergic pre-junctional, inhibitory 
modulation caused EJPs enhancement and a subsequent augmented 
vasoconstriction. Conversion from a balanced contribution to a potentiated 
response of ATP over NA has been found in hypertensive subjects, leading 
to enhanced vasoconstrictions. These findings pointed to a possible use of 
P2X1 antagonists to the hypertension treatment (Burnstock and Ralevic, 
2013). 
 
 ATP released from endothelial cells during shear stress exerted by changes 
in blood flow acts as a vasodilator through endothelial P2X4 and P2Y 
receptors, providing new possible treatments to hypertension (S. Wang et 
al., 2015). 
 
 Recent studies pointed to P2X3 antagonists as promising tools for 
hypertension treatment by inhibiting sympathetic nerve activity involving 
the carotid body (Pijacka et al., 2016). Furthermore, P2X7 involvement in 
hypertension through increased inflammation have been described, 
pointing to P2X7 antagonists as clinical hypertensive agents (Burnstock, 
2017). 
 
 There are evidences showing that adenosine activates renin-angiotensin-
aldosterone (RAAS) system in hypertensive subjects. Considering 
differences in the G protein coupling of P1 receptors, adenosine A1 
antagonists and A2A and A2B agonists have been proposed as possible 
therapeutic agents to hypertension treatment (Nayak et al., 2015). 
 
 Changes in the functional expression of P1 and P2 receptors in smooth 
muscle, endothelial and even vascular circulating cells of hypertensive mice 
models evoked mainly potentiated vasoconstrictor responses. Extracellular 
purines and pyrimidines also contributed to the hypertensive phenotype 
not only by their increased release and receptor activation, but also by 
enhancing proliferation and hypertrophy (Burnstock and Ralevic, 2013). 
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6. TRP channels 
Since the first discovery and characterization of a transient receptor potential (trp) 
gene encoding a cation channel (TRP) related with defective vision in a Drosophila 
trp mutant, several efforts have demonstrated the biodiversity of these channels in 
terms of tissue distribution, physiological functions and their association with 
pathological disorders. Twenty-eight mammalian TRP homologs have been 
described so far and characterized as cationic non-specific channels involved in 
sensory and signal transduction processes in excitable and non-excitable cells. 
These TRP channels have been grouped into seven subfamilies, according to their 
sequence homology (Figure I11): TRPC (canonical), TRPV (vanilloid), TRPM 
(melastatin), TRPA (ankyrin), TRPML (mucolipin) and the TRPP (polycystin). The 
additional TRPN (NOMP-C homologues) subfamily is not found in mammals, but 
expressed in invertebrates and cold-blooded vertebrates (Earley and Brayden, 
2015). 
 
Figure I11. Phylogenetic tree of the mammal TRP family of channels 
(adapted from Nilius and Owsianik, 2011). 
 
6.1 Structure 
All TRP channels share a general transmembrane structure consisting of six 
spanning domains (S1-6) with a pore-forming loop between S5-S6. The intracellular 
N- and C-termini differ in length and amino acid sequence, providing several well-
described motifs involved in channel assembly, activation and regulation. While 
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numerous ankyrin motifs are present on the N-terminus of TRPC, TRPV and TRPA 
subunits, calmodulin/IP3R-binding motifs, Ca
2+-binding EF hands, serine-threonine 
kinase motifs and even a PDZ motif (TRPC4) are present in the C-terminus (Figure 
I12). 
Functional channels arise from the association of four TRP subunits in a homomeric 
or heteromeric way. The TRPC subfamily has been the most widely studied in terms 
of subunit assembly: TRPC1 can heteromultimerize with TRPC3, TRPC4, TRPC5, 
TRPC6 or TRPC7 subunits; TRPC4 and TRPC5 can form heteromultimeric channels as 
can combinations of TRPC3, TRPC6 and TRPC7 subunits (Hofmann et al., 2002; 
Earley and Brayden, 2015). Functional associations between TRPV5/TRPV6, 
TRPM6/TRPM7, and TRPML1/TRPML3 have been also reported. On the other hand, 
association between subunits of different subfamilies, such as TRPC1/TRPV4 and 
TRPV1/TRPA1, have also been reported with less supported evidence (Earley and 
Brayden, 2015). 
 
Figure I12. Membrane topology of the different TRP subfamilies of 
cationic channels (adapted from Minghui, Yong and Jian, 2011). 
 
With the electron microscopy advances, a detailed structure of members of 
different TRP subfamilies, such as TRPC3, TRPM2, TRPV1 and TRPV4 have been 
described. For TRPC3 subunit, cryoelectron microscopy studies showed an odd 
high-resolution structure compared to the other TRP channels studied. The overall 
structure of TRPC3 (200x200x240 Å, 388 kDa for protein and 40.8 kDa for attached 
glycan) is divided into two components: a dense globular inner core and a sparse 
outer shell with a mesh-like structure containing many aqueous spaces (Figure I13). 
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This expanded structure could explain the multi-modal activation, regulation and 
even association of TRPC3 subunits (Mio et al., 2007; Minghui, Yong and Jian, 
2011). 
 
Figure I13. Cryo-EM of TRPC3 structure. Blue lines indicate 
putative transmembrane region (Mio et al., 2007). 
 
6.2 Physiological roles of TRP channels in VSMCs 
TRP channels have an important role in several biological processes, such as muscle 
contraction, cell proliferation, secretion, nociception and many other important 
processes, by controlling the ion flux across the cell membrane. In addition, several 
TRP members (TRPP2, TRPM8, TRPV1 and TRPA1) are expressed in intracellular 
organelles, where participate as modulators of protein trafficking and vesicular 
ionic homeostasis (Earley and Brayden, 2015). Although TRP channels are described 
as non-selective cation channels, their relative permeability to different ions (PNa: 
PK: PCa) determine their functional role: while monovalent Na
+ and K+ cations are 
particularly important for the control of membrane potential and excitability, 
divalent Ca2+ and Mg2+ cations play important roles as second messengers and 
cofactors. Therefore, the activity of TRP channels can contribute to membrane 
potential regulation (TRPC, TRPM4), Ca2+ signaling (TRPC, TRPV and TRPA1) and 
Mg2+ homeostasis (TRPM6 and TRPM7). 
Many studies have identified the functional expression of members of TRPC 
(TRPC1,3,4,5,6), TRPV (TRPV1-4), TRPM (TRPM4,8), TRPA (TRPA1) and TRPP (TRPP2) 
families in smooth muscle and endothelial cells and their involvement in the 
control of vascular tone, reactivity, permeability and angiogenesis (Earley and 
Brayden, 2015). Again, TRP-triggered vascular responses depend on the vascular 
bed, cellular subtype and TRP family. Here we will focus on the roles of TRPC 
channels in the vasculature. 
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Membrane potential regulation 
Cation influx through TRPC channels promotes different and even opposite vascular 
responses depending on their cellular subtype expression. Usually, in smooth 
muscle cells, increased Na+ and Ca2+ permeabilities associated with TRPC channels 
activation results in membrane depolarization, leading to VOCC channels-triggered 
Ca2+ entry and contraction (Figure I14). TRPC1,3,4,5,6 are the principal channels found 
in VSMCs of different vascular beds and their GPCR receptor- and swelling (TRPC6)-
triggered activation have been associated to increased vascular contractility (Earley 
and Brayden, 2015). Interestingly, TRPC3 channels have been found to be 
constitutively active, further contributing to resting Vm and myogenic tone (Albert 
et al., 2006). On the other hand, TRPC1,3,4,5,6 channels found in endothelial cells 
induced endothelium-dependent vasodilation via eNOS-triggered NO production. 
 
Figure I14. Scheme of the TRPC-triggered control of vascular tone. 1, agonists-activated GPCRs 
induce PLC-triggered PIP2 cleavage leading to IP3 and DAG production. IP3 activates IP3R receptors 
on ER/SR leading to Ca
2+
 release to cytosol. DAG and also shear stress (2) directly activate 
TRPC3,6,7 leading to cation influx, membrane depolarization and LTTCs channels-mediated Ca
2+
 
influx. [Ca
2+
]i increase leads to contraction of VSMCs. 3, upon agonist stimulation, Ca
2+
-depleted 
stores induce SOCE through STIM1/Orai1 complex and TRPC channels. This TRPC-triggered SOCE 
has been also proposed to directly activate VSMC constriction. 4, in endothelial cells, TRPC-
mediated cation influx, specially Ca
2+
, leads to eNOS-induced NO, EDHF and PGI2 production 
leading to VSMC relaxation.    
 
Ca2+ signaling 
Changes in [Ca2+]i regulate many biological processes, such as muscle contraction, 
hormone secretion, gene expression and proliferation. Changes in [Ca2+]i are 
regulated by the extracellular Ca2+ influx, by Ca2+ release from intracellular 
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compartments and by Ca2+ extrusion performed by plasma and organelle 
membrane proteins. In this context, TRP channels with Ca2+ permeability influence 
[Ca2+]i and subsequent cellular processes acting as ionotropic, metabotropic or 
store-operated Ca2+ channels (Earley and Brayden, 2015). 
Agonist-induced GPCR receptor activation causes biphasic changes in [Ca2+]i: the 
initial transient increase results from the release of Ca2+ from the ER/SR, while the 
second sustained plateau phase is due to Ca2+ influx through ROCs. In this context, 
all members of TRPC family can be activated after stimulation of GPCR receptors 
and receptor tyrosine kinases (RTKs), through PLCβ and PLCγ, respectively 
(Clapham, 2003). The PLC-induced cleavage of membrane PIP2 produces IP3 and 
DAG. IP3 activates its specific IP3R receptor on ER/SR, leading to Ca
2+ release to 
cytosol, while DAG activates PKC and also TRPC3/6/7 channels and heteromeric 
channels including these subunits in a PKC-independent way (Figure I14) (Hofmann 
et al., 1999). 
SOCE, defined as store-operated Ca2+ entry, is another signaling pathway 
associated to TRP channels, consisting of the refilling of intracellular Ca2+ stores 
upon sustained stimulation of membrane receptors or pharmacologic agents-
induced blocking of SERCA. In this context, early studies described several 
members of the TRPC family, such as TRPC1, TRPC4 and TRPC5 as the SOCE 
channels. Other members of the TRPC family have also been reported to be 
involved in the SOCE signaling pathway, such as TRPC3 and TRPC6. However, after 
the discovery of the STIM1/Orai1 complex formation upon Ca2+ store depletion and 
their characterization as the responsible of SOCE, the consideration of TRPC as 
SOCE channels have been widely discussed. Later studies focused on the possibility 
of a direct or indirect interaction of STIM1/Orai1 complex with TRPC channels. 
Direct interactions between STIM1 and TRPC1, TRPC4 and TRPC5 have been 
described in different cellular subtypes. These studies described that upon Ca2+ 
stores depletion, the activation of STIM1 proteins lead to their migration toward 
plasma membrane and direct interaction with TRPC1, enhancing SOCE via TRPC1 
channels (Huang et al., 2006; López et al., 2006). On the other hand, indirect 
interaction between STIM1/Orai1 and TRPC channels has been described for TRPC3 
and TRPC6. In this case, STIM1 activation and membrane translocation induced the 
TRPC1/TRPC3 heteromultimerization, behaving as the SOCE channels. In the same 
way, TRPC4 and TRPC6 associations induced by the activation and membrane 
trafficking of STIM1 was also described, pointing to TRPC4/TRPC6 as SOCE 
channels. This study, however, specified that STIM1 is required only for activation 
of TRPC channels by agonists, but not for channel activity, thus proposing a new 
definition of SOCE as channels regulated by store depletion-mediated STIM1 
clustering. In this context, all TRPC channels, except TRPC7, behave as SOCE 
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channels (Yuan et al., 2009). However, another set of studies failed to demonstrate 
the TRPC involvement in STIM1/Orai1-triggered SOCE pathway, both in 
heterologous and native systems (Dehaven et al., 2009). Regarding differences 
obtained in different cell lines and animal models about the role of TRP channels as 
SOCE channels and their coupling to STIM1/Orai1 complex, more precise functional 
studies are required. Therefore, considering TRP family as SOCE channels is still in a 
controversial debate. 
6.3. TRPC channels and hypertension 
Evidences showed that TRPC3 and TRPC6 channels are the main TRPC members 
whose dysfunction plays an important role in essential hypertension. Several 
studies in hypertensive animal models reported a functional increased expression 
of TRPC3 (Liu et al., 2009; Chen et al., 2010; Noorani, Noel and Marrelli, 2011; 
Wang et al., 2017) and TRPC6 (Yu et al., 2004; Pulina et al., 2010; Zulian et al., 
2010) channels which correlate with enhanced agonists-induced Ca2+ influx and 
contraction. However, whether this increased expression of TRPC channels is cause 
or consequence of the hypertension remains unclear. 
Contrary to what it was expected, TRPC6-/- mice (Dietrich et al., 2005) showed 
increased vascular tone and increased sensitivity of smooth muscle to 
vasoconstrictor agonists that resulted in a higher increased mean arterial blood 
pressure. However, these mice exhibit a clear upregulation of TRPC3 channels that 
can compensate in different ways the TRPC6 knockout phenotype. TRPC channels 
also play essential roles in the regulation of myogenic tone, as it was shown by the 
involvement of TRPC6 channels to the pressure-induced depolarization in cerebral 
arteries (Welsh et al., 2002). Moreover, increased coupling between TRPC3 and 
TRPC6 channels with additional proteins, such as other TRP channels, IP3R 
receptors (Adebiyi et al., 2010, 2012), Ca2+-activated Cl- channels (Wang et al., 
2016) and many others, enhanced Ca2+ influx, contraction and subsequently blood 
pressure, while the coupling with serine-threonine kinase WNK4 reduced TRPC3-
triggered Ca2+ entry (Woo et al., 2011). 
Therefore, changes in the functional expression of some subtypes of TRPC channels 
could influence the mechanisms by which VSMCs control vascular tone and 
contractility, thus promoting vascular dysfunction and increased blood pressure, 
leading to hypertension. The development of selective pharmacological blockers of 
TRPC channels could present a potential strategy to prevent and treat essential 
hypertension (Earley and Brayden, 2015). 
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7. Chloride channels 
In contrast to ions like Na+ and K+, in many cell types the electrochemical gradient 
of Cl− across the plasma membrane is close to its electrochemical equilibrium, 
which is expected from a passive distribution across the plasma membrane. 
However, within VSMCs, the ECl is normally at a potential more positive than the 
resting Vm because of active Cl− accumulation. Hence, opening of Cl− channels in 
the plasma membrane causes Cl− efflux, membrane depolarization, and increased 
contractile force. VSM Cl− transporters and Cl− channels significantly contribute to 
the physiological regulation of vascular tone and arterial blood pressure, so that 
changes in their expression and activity could contribute to vascular 
pathophysiology. 
7.1 Classification and structure of Cl- channels 
Cl- channels are structurally very heterogeneous and no official classification exists. 
Therefore, following the International Union of Basic and Clinic Pharmacology 
(IUPHAR) Guides (Alexander et al., 2017), there have been described up to five 
different families: 
 Voltage-gated Cl- channels (ClC1-7, ClCKa and ClCKb). ClC1, ClC2 and the two 
ClCk isoforms are expressed in the plasma membrane. The rest are 
expressed in endomembranes and behave as Cl-/H+ exchangers. ClCs are 
mainly involved in cell excitability, transepithelial transport, extracellular 
ion homeostasis, endocytosis and lysosomal function (Jentsch, 2015; 
Poroca, Pelis and Chappe, 2017). 
 
 Cystic fibrosis transmembrane conductance regulator (CFTR). This channel 
is a membrane ATP-gated Cl- channel involved in the transepithelial 
transport of water and electrolyte whose dysfunction leads to cystic 
fibrosis (Linsdell, 2014). 
 
 Volume-regulated anion (VRAC) channels. This family of Cl- channels 
participates in the decrease of cell volume upon swelling stimuli by 
conducting Cl- efflux. They also participate in membrane excitability, 
transcellular Cl- transport, angiogenesis, cell proliferation and so many 
other cell functions (Nilius and Droogmans, 2003). 
 
 Large conductance (maxi) Cl- channels. This maxi-anion channel, which is 
widely expressed in many tissues, is activated by swelling stimuli and it has 
been involved in the control of membrane potential, secretion and cell 
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volume regulation. Additionally, due to its ability to release small amounts 
of ATP and glutamate molecules, it has been associated to signal 
transduction between cells (Sabirov and Okada, 2009). 
 
 Ca2+-activated Cl- channels (CaCC). This family comprises the anoctamin 
(ANO1-10) and bestrophin (BEST1-4) subfamilies. These subfamilies have been 
well characterized and are involved in numerous cellular functions, 
including transepithelial transport, control of neuronal and cardiac 
excitability and regulation of smooth muscle contraction (Matchkov, 
Boedtkjer and Aalkjaer, 2015). Their structure, vascular function and 
involvement in hypertension will be discussed in the next sections. 
These families of Cl- channels have been found to be widely expressed in the 
plasma cell membrane in many tissues, in intracellular membranes and in the 
cytosol together with an additional family of intracellular Cl- channels (ClIC1-4). This 
family comprises both soluble and integral membrane isoforms and are likely to 
have enzymatic and intracellular membrane structural functions (Edwards and 
Kahl, 2010; Littler Dene et al., 2010). 
7.2 CaCCs channels 
 
7.2.1 Bestrophins 
BEST channels have been found to form dimers, tetramers and pentamers. Each 
single protomer comprises four short transmembrane α-helices (TM1-4) and a long 
intracellular domain formed by five α-helices together with the C-terminus. N- and 
C-termini are localized in the cytosol, the latter likely involved in Ca2+ regulation 
(Figure I15 A). When pentamerizing, an hydrophilic single pore formed by TM2 
domain is followed by an hydrophobic neck involved in the channel gating (Yang et 
al., 2014). BEST channels are permeable to NO3
->Br->Cl- and permeability to SCN-, 
HCO3
-, GABA and even glutamate has also been reported (Dickson, Pedi and Long, 
2014). Of special interest is the BEST3 channel due to its expression in VSMCs from 
different vascular tissues and its role in the membrane potential regulation by 
coupling intracellular Ca2+ and NO/cGMP pathways through Cl- outward currents 
(Matchkov et al., 2008). 
7.2.2 Anoctamins 
Anoctamin family (ANO or also TMEM16) comprises ten different members, most 
of them behaving as Ca2+-dependent phospholipid scramblases. However, 
ANO1/TMEM16A and ANO2/TMEM16B are bona-fide Ca2+-activated Cl- channels 
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(CaCCs) (Whitlock and Hartzell, 2017). These CaCCs are formed by eight 
transmembrane domains with N- and C-termini in the cytosol. The N-terminus 
presents several calmodulin binding and dimerization motifs, while the C-terminus 
presents a highly conserved region of unknown functions called Anoctamin 
domain. Differences in the transmembrane domains linking loops have been 
proposed: the TM5-TM6 long extracellular loop which reenters the membrane 
early described has been questioned and replaced by another model proposing a 
long intracellular loop which also reenters the membrane between TM6-TM7 
(Figure I15 B). In any case, this loop have been proposed as the direct Ca2+ sensor of 
the channel (Pedemonte and Galietta, 2014). 
ANO1 (TMEM16A) and ANO2 (TMEM16B) appear as closely related members 
belonging to the same subfamily, while ANO3,4,9 (TMEM16C,D,J) and ANO5,6 
(TMEM16E,F) form two separated subgroups, and ANO7,8,10 (TMEM16G,H,K) are 
distant paralogs of ANO1 (Pedemonte and Galietta, 2014). Evidences showed that 
ANO channels are activated not only by cytosolic Ca2+, but also by membrane 
potential in a positive feedback way. More precisely, membrane depolarization 
enhanced Ca2+ sensitivity of the channels. 
 
 
Figure I15. Structures of BEST and ANO subfamilies of CaCC channels. A, structure of 
BEST protomer (left) and the outside membrane view (right) of the pentamer form 
(from Yang et al., 2014). B, structure of ANO1 channel based on the more recently 
proposed model (adapted from Pedemonte and Galietta, 2014). 
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7.3 CaCCs and NKCC cotransporters in vasculature 
In addition to the important role of VOCCs on the depolarization-triggered Ca2+ 
entry and contraction of VSMCs, Cl- conductance through VSMCs have been widely 
explored, although little is still known. As mentioned above, [Cl-]i (~50 mM) and Cl
- 
conductance in VSMCs are larger compared to other cells, such as skeletal and 
cardiac muscle cells. Intracellular Cl- accumulation is due in part, but not 
exclusively, to the activity of the sole isoform of cation-Cl--cotransporter found in 
VSMCs, the Na+/K+/2Cl--cotransporter NKCC1. The equilibrium potential for Cl- in 
VSMCs cells (~-26 mV) is less negative than their resting potential but is high 
enough to activate VOCCs and high enough to block spontaneously generated 
actions potentials in excitable cells. Many studies showed the role of Cl- 
conductance activated upon agonists stimulation in the smooth muscle contraction 
response, however, the exact mechanisms still remain unknown (Kitamura and 
Yamazaki, 2001). 
Both BEST and ANO families of CaCCs have shown to be expressed in vascular 
vessels, however, their relative contribution to agonists-triggered contraction are 
different. It has been shown that BEST downregulation has no effect on NA-induced 
vasoconstriction, suggesting their sole contribution to membrane potential, while 
downregulation and pharmacological inhibition of ANO1 abolished vasoconstrictor 
responses (Matchkov, Boedtkjer and Aalkjaer, 2015). Therefore, ANO family, and 
mainly ANO1 channel, have been the focus of the more recently studies about 
CaCCs in the vasculature and its associated disorders. 
Upon agonist-dependent stimulation, Ca2+ released from the intracellular stores 
activates Cl- efflux (IClCa) through ANO1 channels, contributing to membrane 
depolarization, LTTCs-triggered Ca2+ influx and further [Ca2+]i increase. In addition, 
ANO1 channels also influenced the stretch-activated Ca2+ influx, which is crucial for 
the myogenic tone response (Bulley et al., 2012). Moreover, the role of ANO1 
channels is largely influenced by phosphorylation mechanisms involving Ca2+-
dependent kinases and phosphatases, such as CaMKII and calcineurin, respectively, 
confirming the importance of the amplitude and kinetics of intracellular Ca2+ 
transients to ANO1 functions (Pedemonte and Galietta, 2014). However, it is not 
clear if a direct phosphorylation of ANO channels leads to IClCa or an additional 
regulatory subunit is involved. In this context, Cl- Channel Accessory (ClCa) family of 
proteins, such as ClCa1 and ClCa2, has been found to influence the Ca2+-dependent 
ANO1 activation. ClCa1, described in mammals as a secreted metalloprotease, have 
been found to enhance ANO1-dependent IClCa by directly engaging and stabilizing 
dimeric ANO1 proteins at the membrane surface without increasing its expression 
(Sala-Rabanal et al., 2015). In contrast, ClCa2 protein, which was found to be 
anchored to the plasma membrane through C-terminus, directly interacted with 
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STIM1/Orai1 complex, enhancing SOCE-activated ANO1-dependent IClCa (Sharma et 
al., 2018). Another protein-protein interaction involving ANO1 channels was found 
for TRPC6 channels in cerebral arteries (Wang et al., 2016). In this study, TRPC6 and 
ANO1 channels were found in close spatial proximity at the plasma membrane and 
agonist-induced TRPC6 activation lead to local Ca2+ signals that activated ANO1-
triggered IClCa and vasoconstriction. 
For NKCC1 cotransporter, its main roles in vascular physiology are related to [Cl-]i 
regulation. By controlling [Cl-]i/[Cl
-]o ratio, NKCC1 cotransporter regulates Vm and 
excitation-contraction coupling. Indeed, NKCC1 blockade attenuated basal tone, 
myogenic tone and agonists-induced vasoconstriction through Cl--dependent 
hyperpolarization and suppression of VOCCs activity (Orlov et al., 2015). These 
NKCC1-dependent vascular functions were also confirmed using NKCC1-/- KO mice, 
suggesting the important role of this cotransporter in the vasculature (Koltsova, 
Kotelevtsev, et al., 2009; Koltsova, Maximov, et al., 2009). 
In endothelial cells, IClCa contributes to cell volume and membrane potential. 
However, little is known about the endothelial [Cl-]i. Thus, the hyper- or 
depolarizing effects of endothelial-triggered IClCa in the intact vascular wall remains 
unclear (Matchkov, Boedtkjer and Aalkjaer, 2015). 
7.4 Role of ANO1 channels and NKCC1 cotransporter in hypertension 
Regarding the role of IClCa for vascular tone and contractility, several studies have 
identified some CaCCs, namely ANO1 channels, as potential targets to the 
treatment of hypertension, although the available data are contradictory. ANO1 
upregulation has been characterized and correlated to increases in blood pressure 
in two different rat models of pulmonary hypertension (Leblanc et al., 2015), as 
well as in spontaneous hypertension (B. Wang et al., 2015). On the other hand, 
hypertension-associated downregulation of ANO1 channels due to an increase in 
the activity of CaMKII was also reported (Wang et al., 2012). Finally, in a mouse 
model with smooth muscle-specific ANO1 KO, arterial blood pressure was 
decreased and the development of Ang II-induced chronic hypertension was less 
severe (Heinze et al., 2014). 
The role of NKCC cotransporters in the pathogenesis of hypertension have been 
differentiated according to primary and secondary hypertension. NKCC1 
cotransporter plays an important role in the physiopathology of primary 
hypertension since is the only isoform expressed in VSMCs, and several 
mechanisms underlying its role have been proposed. In SHR rats model, both 
NKCC1 mRNA and protein levels were increased, which involved the NKCC1-
dependent [Cl-]i regulation, affecting VSMCs contraction and SNS activity. Indeed, 
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bumetanide-induced NKCC1 blockade on α-adrenergic-dependent vasoconstriction 
were higher compared to normotensive controls (Lee et al., 2010). Moreover, the 
higher mRNA and proteins levels also observed in paraventricular nucleus of SHR 
rats correlated with the higher [Cl-]i found in these neurons, resulting in a 
decreased activity of GABAergic neurons in SHR, compared to controls (Ye et al., 
2012). Studies focused on epigenetic regulation of NKCC1 in SHR model concluded 
that hypomethylation of NKCC1 promoter resulted in its augmented expression and 
subsequently augmented [Cl-]i, membrane depolarization and contraction, leading 
to blood pressure increase (Lee et al., 2010). Moreover, increased activity of NKCC1 
cotransporter was also observed in erythrocytes from SHR rats and hypertensive 
patients, contributing to the long-term increase of blood-pressure. On the other 
hand, studies performed in NKCC1-/- KO mice revealed a significant decreased in the 
blood pressure of these animals (Meyer et al., 2002). 
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8. Hypothesis of study. 
Our group has been exploring the contribution of different VSM ion channels to the 
molecular mechanisms involved in the physiopathology of essential hypertension. 
Using a genetic, phenotype-driven mouse model of essential hypertension (BPH 
and their BPN control mice), the functional expression of different families of 
channels, including K+ channels and VOCCs, and their contribution to the 
hypertensive phenotype have been widely explored. However, the contribution of 
many other families of receptors and ion channels, such as ROCs and SOCs channels 
are still unknown. 
This Thesis aims to explore the role of some ROCs and some GPCR, specifically TRPC 
channels and P2Y receptors in the genesis of the hypertensive phenotype in 
BPN/BPH model of essential hypertension. 
Since sympathetic nerve activity is increased in this model (see section 3.2), we 
hypothesize that changes in the activation of the purinergic signaling pathway 
could be directly contributing to changes in the resting membrane potential and 
Ca2+ influx in VSMCs, leading to [Ca2+]i increase and promoting the subsequent 
increased vascular tone and contractility, characteristic of hypertension. The 
differences between of BPN and BPH in the purinergic response may be the result 
of changes in the purinergic receptors and/or may be generated by differences in 
the expression or/and functional activity of TRPC and Ca2+ activated Cl- channels, 
working downstream in the signaling pathway and fine-tuning the changes in Vm 
that activate VOCCs opening and vascular contraction. 
 
Figure I16. Scheme of the hypothesis of the purinergic signaling contribution to essential 
hypertension. 
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This Thesis explores the contribution of Receptor Operated Channels and G protein 
coupled receptors to the molecular mechanisms involved in hypertension using a 
genetic mouse model of essential hypertension, the BPN/BPH model. The study 
focuses specifically in the differences between BPN and BPH mice in the functional 
contribution of TRPC channels to the hypertensive phenotype at rest and in the 
context of the activation of the purinergic signaling pathway. The specific goals 
include: 
1. The characterization of ROCs contribution to modulate resting Vm and 
contractility of BPH mice.  To achieve this objective we explored: 
1.1. The functional expression of members of the TRPC family in BPN and 
BPH mice, and their contribution to vessel contractility. 
1.2. The heteromultimerization profile of TRPC3 and TRPC6 channels and 
their association with the hypertensive phenotype. 
1.3. The functional expression of members of CaCCs and Cl- conductance 
cotransporters involved in the control of Vm and contractility of VSMCs 
and their functional association with the hypertensive phenotype. 
2. The characterization of the purinergic signaling pathway in VSMCs and its 
relationship with the physiopathology of hypertension. To achieve this 
objective we explored: 
2.1. The expression profile of several members of P2X and P2Y families of 
purinergic receptors in VSMCs of BPN and BPH mice. 
2.2. The functional contribution of the purinergic receptors explored to the 
increased vascular tone and contractility of BPH compared to BPN 
mice. 
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1. Mouse model of essential hypertension 
Colonies of hypertensive mice BPH (Blood Pressure High) and their controls BPN 
(Blood Pressure Normal) from Jackson Laboratories (Jackson Laboratories, Bar 
Harbor, ME, USA) were maintained by inbreeding crossing  in the animal facility of 
the School of Medicine of Valladolid, under temperature controlled conditions 
(21°C) and with unlimited access to water and food. 
The development of the BPH and BPN strains was performed by crossbreeding of 
eight different mouse strains that were subjected to phenotypic selection 
performed by tail-cuff blood pressure measurements. BPH mice showed high blood 
pressure early in life compared to BPN, which was associated with strain 
differences in heart rate, heart weight, left ventricular mass, kidney weight and 
hematocrit (Schlager and Sides, 1997). The development of hypertension in these 
strains led to an increased heart and left ventricular size (compared to body 
weight) and an increased heart rate that represented adaptive mechanisms to cope 
with the increased arterial pressure maintaining the cardiac output. In addition, 
BPH mouse strain showed lower levels of renin, aldosterone and angiotensin and a 
short lifespan, compared to BPN (Schlager, 1981; Schlager and Sides, 1997). 
All animal protocols were approved by the Institutional care and Use Committee of 
the University of Valladolid and are in accordance with the European Community 
guiding principles with respect to the care and use of animals (Directive 
2010/63/UE) (Directive, 2010). 
 
2. Tail-cuff measurements 
To confirm that BPH and BPN mouse strains maintained their phenotype, blood 
pressure levels were measured using the CODA® High Throughput Noninvasive 
Blood Pressure system (Kent Scientific Corporation, Torrington, CT, USA, Figure 
M1). In addition to the CODA controller, the system has also a far-infrared warming 
platform, animal holders of different sizes, tail-cuff kits and a computer with 
database software. 
Briefly, aware mice were placed into the animal nose cone holder and carefully 
secured to avoid the animal being able to turn around, providing unrestricted 
breathing during measurements. Next, the holders were placed onto the warming 
platform and the tails were cuffed with the VPR (Volume Pressure Recording) 
sensor and the occlusion cuff kit without force. The VP recording method consists 
of inflating the occlusion tail cuff to occlude blood flow and while it is slowly being 
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deflated, the VPR cuff sensor measures the tail swelling. Systolic blood pressure (Ps) 
corresponds to the first appearance of tail swelling, while diastolic blood pressure 
(Pd) is calculated from the rate of tail swelling, and both are identified as the first 
and second inflections, respectively, of the recording line in the real-time blood 
pressure graph (Krege et al., 1995; Wang, Thatcher and Cassis, 2017). Mice were 
acclimated to 32-35°C during 15 min prior to data acquisition. Sessions of recorded 
measurements were carried out daily during 4-6 consecutive days at the same 
time. Each session consisted of a total of 40 cycles of inflating steps to a maximum 
occlusion pressure of 250 mmHg followed by deflating steps of 15 s. The first 5 
cycles were used for acclimation and were not included for the analysis. Values of 
15 μL were fixed as the minimum tail volume for data acquisition. Mice were first 
trained at least 2 days prior to data acquisition, as we found that this was enough 
to ensure extreme reliable and reproducible measurements from session to 
session.  
 
Figure M1. CODA® High Throughput Noninvasive Blood Pressure system 
 
3. Animals surgery 
BPN and BPH mice ranging from 16 to 58 weeks old (average 36.2 ± 2.4 weeks for 
BPN and 34.6 ± 1.7 weeks for BPH) and weighing 29.33 ± 0.23 g for BPN and 24.37 ± 
0.24 g for BPH (n=69-80, P<0.001) were anesthetized by isoflurane inhalation (5% 
O2 at 2.5 Lmin
-1) and sacrificed by cervical dislocation. Mesenteric arteries were 
obtained as described previously (Moreno-Domínguez et al., 2009). Briefly, a 
laparotomy was performed to obtain the small intestine, which was placed in a 
Sylgard®-coated plate filled with ice cold (4°C) oxygenated (95% O2-5% CO2) smooth 
muscle dissociation solution (SMDS)- 10μM Ca2+ (Table M1). 
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Composition 
SMDS 
(mM) 
SMDS 
10 μm Ca
2+
 
(mM) 
NaCl 120 120 
KCl 4.2 4.2 
NaCHO3 25 25 
KH2PO4 0.6 0.6 
MgCl2·6H2O 1.2 1.2 
Glucose 11 11 
CaCl2 - 0.010 
pH 7.4 
Table M1. Smooth muscle dissociation solution. 
 
Subsequently, arteries were cleaned of connective and adipose tissues under a 
dissecting microscope. The characteristic V-shaped intersection of arteries was 
taken into account to distinguish them from the veins (Figure M2). 2nd and 3rd 
order mesenteric arteries were collected and processed in different ways: 1) Frozen 
at -80°C for further RNA extraction, 2) used directly for myography studies and 3) 
used to obtain freshly isolated VSMCs. 
 
Figure M2.  V-and U-shaped intersection of artery and vein. 
 
 
 
4. RNA isolation and real-time PCR 
To explore the mRNA expression pattern of receptors and channels, real-time PCR 
was performed in mesenteric arteries from BPN and BPH mice. The protocols used 
consist of several consecutive steps: 
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a) RNA samples homogeneization and isolation 
Total RNA isolation was carried out using the TRIzol® Reagent (Ambion, Life 
Technologies Corporation) and the Precellys® (Bertin Instruments, France) 
homogenization methods followed by the PureLink® DNase treatment (Ambion, 
Life Technologies Corporation), following the manufacturer´s instructions (Figure 
M3). Briefly, 2nd and 3rd mesenteric arteries from 4-5 mice were denuded of 
endothelial layer by scraping with a pipette tip and cut in fragments less than 3 mm 
length. Then, samples were homogenized in TRIzol® Reagent using the CK14 and 
CK28 Precellys® kit, which consists of tubes containing two sizes of ceramic beads 
designed for hard tissue homogenization, and a Precellys® tissue homogenizer. By 
adding chloroform, RNA was then separated in an aqueous layer and precipitated 
using isopropanol. After washing twice, PureLink® DNase treatment (Ambion, Life 
Technologies Corporation) was carried out following the manufacturer´s 
instructions. Finally, RNA was stored at -80°C or used within the day to check the 
RNA purity and integrity. 
 
Figure M3. Total RNA isolation scheme. 
 
 
b) RNA quantification 
To obtain high efficiency and purity in RNA during the isolation step, many factors, 
such as the type of tissue, sample handling during surgery, extraction and storage, 
have to be considered. To check the correctness of these procedures, the quality of 
the purified RNA was confirmed both by agarose gel electrophoresis and by 
measuring the absorbance using a spectrophotometer (NanoDrop ND-1000, 
Thermo Scientific). The equation of Beer-Lambert correlates absorbance to 
concentration as following: 
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𝐴 = 𝐸 ∙ 𝑏 ∙ 𝑐 
Where, 𝐴 is the measured absorbance (or optical density, OD, in absorbance units 
A), 𝐸 is the molar extinction coefficient (in M-1 ·cm-1), 𝑏 is the sample thickness (in 
cm) and 𝑐 is the analyte concentration (mol·L-1). 
When measuring nucleic acids concentration, this equation is rearranged to: 
𝑐 =
𝐴 ∙ 𝑒
𝑏
 
Where 𝑐 is the nucleic acid concentration (in ng·μL-1), 𝐴 is the absorbance (in 
absorbance units, A), 𝑒 is the molar extinction coefficient (in ng·cm·μL-1) and 𝑏 is 
the sample lenght (in cm). 
Values of optical density ratio A260/280>2 are generally accepted as “pure RNA”, 
while ratio values less than 2 are indicative of contamination. Finally, quantified 
RNA was treated with RNAse-Free DNAse I (Ambion) to remove possible genomic 
DNA contamination from the samples. 
c) Reverse transcription 
The reverse transcription reaction was used to obtain cDNA (RT+) from purified RNA 
samples using the reverse transcriptase enzyme MuLvRT, allowing more stable 
samples to be obtained. With MuLvRt enzyme, a complementary cDNA strand of a 
single-stranded RNA template is created using the reaction mix described in table 
M2 (in PCR buffer): 
Composition 
RT
+
 
Reaction mix 
RT
-
 
Reaction mix 
Purified RNA 500-700 ng 200-350 ng 
Random hexamers 2.5 μM 2.5 μM 
MgCl2 5 mM 5 mM 
dNTPs 4 mM 4 mM 
RNAse inhibitor 1 u μL
-1
  
MuLvRT 2.5 u μL
-1
  
Table M2. Reaction mix for experiment (RT
+
) and genomic control (RT
-
) conditions. 
The final volume of the reaction was 80 µl for the RT
+
 and 20µl for RT
- 
 
 The reaction mixture was subjected to the following temperature-controlled 
reverse transcription cycle (Figure M4): 10 min at 25°C, 60 min at 42°C, and finally 5 
min at 99°C. The amplified cDNA (RT+) was immediately stored at -20°C. 
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Figure M4. cDNA synthesis protocol working scheme 
 
d) Amplification by real-time PCR 
Gene relative expression was explored by real-time PCR using the TaqMan Assay 
(Applied Biosystems, Life Technologies), which is based on the 5´ nuclease activity 
of the Taq polymerase on a fluorogenic-labeled probe (Figure M5). This TaqMan 
probe is constructed with a fluorescent dye and a quencher, both bound to the 5´ 
and 3´ ends, respectively. While the probe is intact, the quencher reduces the 
fluorescence emitted by the dye by fluorescence resonance energy transfer. When 
the probe anneals to the target DNA and the 5´ nuclease activity of Taq polymerase 
cleaves the reporter dye, the emitted fluorescence increases. This fluorescence 
intensity is proportional to the amount of target DNA accumulated during PCR 
reaction. 
 
Figure M5. TaqMan probe action mechanism. 
 
The previously obtained cDNAs were processed at the Genomic Service of the 
Parque Científico de Madrid (Spain) using TaqMan Low Density Arrays (TLDA, 
Applied Biosystems, Life Technologies Corporation). The selected receptor and ion 
channels genes to explore are described in Table M3. The array also included an 
endogenous control gene (18S rRNA) to correct for the amount of cDNA, and a 
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smooth muscle marker (calponin) and an endothelial cell marker (eNOS), to check 
the purity of smooth muscle tissue. 
Gen name Protein 
Applied Biosystems 
identification number 
P2rx1 P2RX1 Mm00435460_m1 
P2rx4 P2RX4 Mm00501787_m1 
P2ry1 P2RY1 Mm02619947_s1 
P2ry2 P2RY2 Mm00435472_m1 
P2ry2s1 P2RY2 Mm02619978_s1 
P2ry4 P2RY4 Mm00445136_s1 
P2ry6 P2RY6 Mm01275473_m1 
P2ry6s1 P2RY6 Mm02620937_s1 
Trpc1 TRPC1 Mm00441975_m1 
Trpc2 TRPC2 Mm00441984_m1 
Trpc3 TRPC3 Mm00444690_m1 
Trpc4 TRPC4 Mm00444284_m1 
Trpc6 TRPC6 Mm01176083_m1 
Trpc7 TRPC7 Mm00442606_m1 
Clca1 CLCA1 Mm01320697_m1 
Clca2 CLCA2 Mm00724513_m1 
Clcn3 CLCN3 Mm01348786_m1 
Slc12a2 NKCC1 Mm01265951_m1 
Tmem16a TMEM16A/ANO1 Mm00724407_m1 
Cnn1 (Calponin 1, smooth muscle) CNN1  Mm00487032_m1 
Gapdh (Glyceraldehide-3P-dehydrogenase) GAPDH Mm99999915_g1 
Nos3 (Nitric oxide synthase 3, endothelial) NOS3 Mm00435217_m1 
Gus (β-glucuronidase) Gus ** 
Table M3. Genes whose relative expression was explored using TLDA assay. ** Probes designed in 
our laboratory. 
 
 - 56 - 
 
MATHERIAL AND METHODS 
A small fraction of cDNAs were used to explore gene expression using TaqMan 
probes designed in our laboratory in a Rotor-Gene RG3000 (Corbett Life Science, 
Quiagen) and the results were then compared to those obtained using TLDA arrays. 
The designed primer sets and TaqMan probes were: 
mGAPDH Primer 5´-3´ 
Primer 3´-5´ 
5’‐TGTGTCCGTCGTGGATCTG‐3’ 
5’‐ GATGCCTGCTTCACCACCTT‐3 
TaqMan probe 
 
5’‐FAM‐TGGAGAAACCTGCCAAGTATGATGACATCA‐BHQ2‐3 
mGus 
 
Primer 5´-3´ 
Primer 3´-5´ 
5’‐CAATGGTACCGGCAGCC‐3’ 
5’‐AAGCTAGAAGGGACAGGCATGT‐3’ 
TaqMan probe 5’‐FAM‐TACGGGAGTCGGGCCCAGTCTTG‐BHQ2‐3 
   
RPL18 
 
Primer 5´-3´ 
Primer 3´-5´ 
5’‐CAATGGTACCGGCAGCC‐3’ 
5’‐AAGCTAGAAGGGACAGGCATGT‐3’ 
TaqMan probe 5’‐FAM‐TACGGGAGTCGGGCCCAGTCTTG‐BHQ2‐3 
 
Amplifications were performed in a total volume of 20 μL, using 10 μL of Absolute 
qPCR mix (ABgene, Thermo Fisher Scientific Inc.), 1 μL of each forward and reverse 
primers, 1 μL of probe and 1 μL of cDNA. The reaction conditions used were as 
indicated in Figure M6. 
 
 
Figure M6. Amplification protocol. 
 
e) Relative quantification and quality control 
For the analysis of the TaqMan assay, a cycle threshold (Ct) for each curve is 
determined.  At the beginning of the qPCR reaction, a basal unspecific fluorescence 
is detected. Setting a threshold over this background signal within the exponential 
phase of the amplification curve provides Ct, or the cycle number at which the 
emitted fluorescence surpasses (cuts) the threshold (Figure M7). Ct is defined as 
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the number of cycles required to produce a significant fluorescence increase 
compared to the baseline signal, and it is inversely proportional to the initial 
amount of cDNA. 
 
Figure M7. Example of 
qPCR amplification plots for 
the endogenous control 
RPL18 with serial dilution of 
a sample, providing a 
different starting number of 
cDNA copies. Fluorescence 
is plotted in a log scale and 
the threshold value can be 
manually adjusted. 
 
Data analysis was performed using the relative quantification method (Livak and 
Schmittgen, 2001), known as fold-increase method or 2-Ct, based on the 
comparison of the Ct values of different genes normalized to those of the 
endogenous controls (Housekeeping genes), such as rRNA 18S and Gapdh. 
∆𝐶𝑡 =  𝐶𝑡,𝑐ℎ𝑎𝑛𝑛𝑒𝑙 − 𝐶𝑡,𝑐𝑜𝑛𝑡𝑟𝑜𝑙 
In order to perform this normalization, the efficiency of the amplification of both, 
the experimental gene and the endogenous control must be close to 1 and differ 
less than 10%. An efficiency of 1 means that the amount of DNA template doubles 
in each cycle. To determine the efficiency of the reaction, we performed a PCR with 
serial dilutions of one sample and obtained the Ct value for each dilution. 
Representing Ct against the number of copies of each dilution, we can fit a line to 
these data and calculate its slope (Figures M7 and M8). From this slope, we obtain 
efficiency as described in figure M8. The expression TLDA assays used were 
validated by the manufacturer. According to their specifications, the efficiency of 
the amplification reactions for all genes was 1, and differed by less than 10%. 
 
 
 
Figure M8. An example of a standard 
curve showing the threshold cycle (Ct) 
on the y-axis and the starting quantity 
of cDNA target on the x-axis. Slope 
value is used to calculate the efficiency 
of the reaction as indicated in the 
equation. Gene studied was Gapdh. 
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After obtaining for each gene its relative expression (∆𝐶𝑡 value) in preparations, 
(BPN and BPH tissues) we compared them to get ∆∆𝐶𝑡 with the following equation: 
∆∆𝐶𝑡 =  ∆𝐶𝑡,𝑠𝑎𝑚𝑝𝑙𝑒 − ∆𝐶𝑡,𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑜𝑟 
Where the sample represents the experimental tissue (BPH) and the calibrator is 
the control tissue (BPN). With this quantification method, we define a calibrator (in 
our case BPN tissue) and we determine the changes in our “problem” preparation 
(the BPH samples) as fold increase or fold decrease with respect to the expression 
values of the calibrator. To represent these values, we used the logarithm of 2-Ct. 
Hence, a value of 0 means that there is no change in expression; whilst positive 
values indicate a higher expression in BPH and negative values indicate a higher 
expression in BPN tissue. 
For statistical comparisons, the ∆𝐶𝑡  obtained in each sample ( ∆𝐶𝑡,𝑐ℎ𝑎𝑛𝑛𝑒𝑙 −
 ∆𝐶𝑡,𝑐𝑜𝑛𝑡𝑟𝑜𝑙) were subtracted from the mean ∆𝐶𝑡 of the calibrator to provide S.E.M. 
Each data point was obtained from duplicate determinations from at least three 
different assays. In the cases where gene expression was not detected in one of the 
conditions, a 𝐶𝑡 value of 40 was used in order to do the comparisons. 
 
5. Pressure Myography 
 
5.1. Pressure Myography fundaments 
Pressure Myography is a technique that allows studying the pathophysiological 
properties and functions of vascular vessels in vitro. By cannulating a small 
segment of a vessel, pressure myography simulates the physiological conditions of 
temperature, pH and intraluminal pressure of in vivo vessels. Designing different 
protocols, this system allows investigation of myogenic tone, of effects of 
endothelial secretions or the pharmacological effects on vasoconstrictor and 
vasodilator responses to different drugs and stimuli. Although the pressure 
myography mounting procedure could stress the vascular tissue, the vessels still 
retain many of their in vivo characteristics, which allow extrapolating the results to 
the in vivo behavior of the entire vascular bed. 
In this study, the pressure myography technique has been applied to investigate 
the role of different molecular components of the VSMCs membrane to the 
vascular tone. Using pharmacological approaches, vascular responses of mouse 
mesenteric arteries were investigated under near physiological conditions. Both 
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constriction and dilation could be readily measured as changes in the vessel´s 
diameter via digital video-edge detection. 
5.2. Pressure Myography System 
The pressure myograph system (Danish Myo Technology, Aarhus, Denmark) used 
to study the functional responses of mesenteric arteries consists of several parts: 
myography pressure unit, pressure regulator interface, vacuum system, DMT 
microscope and DMT Software (Figure M9). 
 
Figure M9.  Scheme of the complete Pressure Myograph System (Model 111P). 
 
5.2.1. Myography pressure unit 
The pressure myography unit contains a bath chamber with two removable glass 
pipettes with a tip of 0.5 mm. Each pipette is connected to a pressure transducer 
(P1 and P2 in figure M10) that generates an electrical signal as a function of the 
pressure imposed by the liquid inside each pipette, based on a Wheatstone bridge 
circuit. The intraluminal liquid pressure is generated by the external pressure 
regulator interface connected to the perfusion inlet and outlet of the pressure unit. 
In addition, the force transducer coupled to the outlet pipette senses changes in 
the longitudinal force. Finally, the myo chamber cover includes ports for 
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superfusion, vacuum and oxygenation, also allowing the access for temperature or 
pH probes or application of reagents and drugs. 
 
Figure M10. Myography pressure unit scheme. 
 
5.2.2. Pressure regulator interface 
The perfusion flow is controlled by the Pressure Regulator via the Myo-interface 
and the MyoViewTM Software. The system consists of two separated circuits, one 
for air and the other one for buffer that transfers the flow and pressure setting 
signals from the Myo-interface to the pressure unit by the control of the air 
pressure in each circuit. 
5.2.3. Vacuum system 
The vacuum system includes a vacuum pump connected to the Myo chamber cover 
via a suction bottle, maintaining a constant Myo chamber volume of 6 ml. 
5.2.4. DMT microscope 
The DMT microscope (model 111P) is an inverted microscope equipped with a Zeiss 
Achromat 10X/0.25 objective and build-in CCD camera. The pressure unit is 
coupled above the DMT microscope and secured with a lever. The three micro 
positioners on the front adjust the objective focus in the X Y Z directions. The DMT-
microscope has a build-in infrared light source to avoid the influence of background 
light of the surroundings. 
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5.2.5. DMT Software 
The data acquisition and analysis was carried out using the MyoViewTM Software. 
This software obtains real-time images by measuring the differences in light 
intensity passing through the walls of a vessel mounted in the pressure unit. In 
addition, it allows controlling the pressure regulator interface, the force 
transducer, temperature and pH. 
5.3. Pressure Myography procedure 
Segments of 2nd and 3rd order of mesenteric arteries cleaned of connective and 
adipose tissues were mounted in the pressure myograph unit as following:  First, 
the Myo chamber was filled with preheated (37°C) and oxygenated (5% CO2-95% 
air) physiological saline Myography Solution (Table M4) and the inlet and outlet 
glass pipettes were purged of air by imposing a negative pressure using the vacuum 
system. Next, the arteries were cannulated and fixed to the P1 inlet pipette and, 
after removing the endothelial tissue by passing air bubbles through the artery 
segment, they were filled with Myography Solution. Then, the arteries were 
cannulated and fixed to the P2 outlet pipette avoiding stretching and stressing the 
vessels. After that, the pressure myograph unit was coupled to the DMT 
microscope and the Myo chamber cover was carefully placed. The oxygenated 
superfusion and the vacuum system were connected to control the final chamber 
volume (6 ml) and the temperature sensor was placed to maintain 37°C during the 
whole experiment. The arteries were slowly pressurized from 10 to 70 mmHg in 
oxygenated (5% CO2-95% air) Myography Solution. This gradually pressurization 
was carried out in 10 mmHg pressure increase steps every 5 min, reaching the final 
physiological pressure of 70 mmHg. We choose this value because it is a pressure 
slightly below the mean arterial pressure and most likely closed to the physiological 
pressure values in the mesenteric bed (Fenger-Gron, Mulvany and Christensen, 
1995). Then, the arteries were incubated at 37°C without intraluminal flow for at 
least 20 min to equilibrate before starting the data acquisition. 
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Composition 
Myography 
Solution 
(mM) 
Myography 
Solution-
60mM K
+
 
(mM) 
NaCl 120 65 
KCl 5 60 
NaCHO3 25 25 
Na2HPO4 1.18 1.18 
MgSO4 1.17 1.17 
Glucose 10 10 
EDTA 1 1 
CaCl2 2.5 2.5 
pH 7.4 
Table M4. Myography Solutions. 
 
The viability of the mounted arteries was evaluated by their vasoconstriction effect 
in response to Myography-60 mM KCl Solution or 0.5-1μM Phenylephrine, and 
endothelium removal was confirmed by the absence of dilation in response to 10 
μM Acetylcholine. 
5.4. Pressure Myography protocols 
The myography protocols performed in this study were based on the analysis of 
external diameter changes of the mounted arteries elicited by different drugs. To 
normalize the vasoconstrictor or vasodilator effects of the drugs, 10 μM of 
Nifedipine was added at the end of the experiment to determine the maximal 
vessel diameter upon relaxation and Myography-60 mM KCl Solution was used to 
determine the minimal diameter. When the vasoconstrictor response of drugs was 
tested, the following equation was used: 
𝑣𝑎𝑠𝑜𝑐𝑜𝑛𝑠𝑡𝑟𝑖𝑐𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑒𝑐𝑡 (%) =
𝐷𝑁𝑖𝑓𝑒𝑑𝑖𝑝𝑖𝑛𝑒 − 𝐷𝑥
𝐷𝑁𝑖𝑓𝑒𝑑𝑖𝑝𝑖𝑛𝑒 − 𝐷𝐾+
∙ 100 
Where 𝐷𝑁𝑖𝑓𝑒𝑑𝑖𝑝𝑖𝑛𝑒 is the maximal vessel diameter, 𝐷𝑥 is the diameter reached in 
presence of the drug and 𝐷𝐾+  is the diameter value reached by Myography-60 mM 
KCl Solution. 
To test the vasodilation response, a previous vasoconstriction state of the artery 
was performed using 1-10 μM Phe or UTP followed by the addition of the 
vasodilator drugs. In this case, the normalization was performed using the 
equation: 
𝑣𝑎𝑠𝑜𝑑𝑖𝑙𝑎𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑒𝑐𝑡 (%) =
𝐷𝑥 − 𝐷𝑃ℎ𝑒/𝑈𝑇𝑃
𝐷𝑁𝑖𝑓𝑒𝑑𝑖𝑝𝑖𝑛𝑒 − 𝐷𝑃ℎ𝑒/𝑈𝑇𝑃
∙ 100 
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Where 𝐷𝑥 is the diameter reached by the drug, 𝐷𝑃ℎ𝑒/𝑈𝑇𝑃 is the diameter value of 
the previous vasoconstriction state and 𝐷𝑁𝑖𝑓𝑒𝑑𝑖𝑝𝑖𝑛𝑒 is the maximal vessel diameter. 
The analysis of pressure myography data and the fitting of concentration-response 
curves of the drugs were performed using Origin® 7 Software. 
 
6. VSMC isolation 
Mesenteric arteries were subjected to a two sequential enzymatic incubations at 
37°C to obtain freshly isolated VSMCs, according with previously described 
protocols (Moreno-Domínguez et al., 2009; Tajada et al., 2012). After a first 
incubation in a 37°C preheated SMDS-Ca2+ free solution containing 0.8 mg·ml-1 
papain, 1 mg·ml-1 BSA and 1 mg·ml-1 dithiothreitol (Table M5, solution A) during 15 
min, arteries were transferred to a 37°C preheated SMDS-10 μM Ca2+ solution 
supplemented with 0.6 mg·ml-1 collagenase F and 1 mg·ml-1 BSA (Table M5, 
solution B) during 6 min. Then, arteries were washed three times with ice cold 
SMDS-10 μM Ca2+ solution and were mechanically dissociated using a wide-bore 
glass pipette to obtain freshly isolated VSM cells. Single cells were maintained at 
4°C and used within the same day for either protein expression assays or 
electrophysiological recordings. 
Composition 
A solution 
(mg ml
-1
 SMDS) 
B solution 
(mg ml
-1
 SMDS-10μM Ca
2+
) 
BSA 1 1 
DTT 1 - 
Papain 0.8 - 
Collagenase F - 0.6 
pH 7.4 
time 15’ 6’ 
Table M5.  A and B SMDS solutions to VSMCs dissociation. 
 
7. Protein expression 
The study of the protein expression profile of molecular components of the VSMCs 
contributes to elucidate their role in the vascular vessels properties and functions. 
Based on the specific strong association antibody-epitope, different antibodies 
have been used alone or in combination to investigate the protein expression, 
localization and association of several molecular components of VSMCs. The 
primary and secondary antibodies used are listed in Table M6. 
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Protein expression studies have been carried out both in native VSMCs and in 
heterologous expression systems (CHO: Chinese Hamster Ovary cell line). Several 
techniques have been used, including immunocytochemistry (ICC), co-
immunoprecipitation (coIP), Proximity Ligation Assay (PLA) and Ground State 
Depletion Superresolution (GSD). 
Antibody Source Reference Applications 
p
ri
m
ar
y 
anti-TRPC3 goat ACC-016 
(Alomone Labs) 
ICC, coIP, PLA, 
GSD 
anti-TRPC3 rabbit NBP1-70352 
(Novus Biologicals) 
PLA, GSD 
anti-TRPC6 Goat NBP1-00142 
(Novus Biologicals) 
PLA, GSD 
anti-TRPC6 rabbit ACC-017 
(Alomone Labs) 
ICC, coIP, PLA, 
GSD 
anti-P2Y6 rabbit APR-011 
(Alomone Labs) 
PLA, GSD 
anti-ANO1 (S-20) goat sc-69343 
(Santa Cruz Biotechnology) 
GSD 
se
co
n
d
ar
y 
Alexa 594 anti-rabbit goat 
 
A-11012 
Molecular Probes 
ICC 
Alexa 488 anti-goat donkey A-11055 
Molecular Probes 
ICC 
Alexa 568 anti-rabbit goat Molecular Probes GSD 
Alexa 647 anti-goat donkey Molecular Probes GSD 
Peroxidase-
conjugated 
anti-rabbit  
goat Dako coIP 
nuclei Hoechst  33342  (Life Technology) ICC, 
Table M6. Primary and secondary antibodies used. ICC: Immunocytochemistry; PLA: Proximity Ligation 
Assay; Co-IP: Co-Immunoprecipitation; GSD: Ground State Depletion. 
 
 
7.1. Immunocytochemistry 
The immunocytochemistry technique allows detecting protein expression pattern. 
In addition, nuclear staining with Hoechst facilitates interpretation of the image 
results. Using primary monoclonal or polyclonal antibodies that specifically 
recognize their epitopes and fluorescence-coupled secondary antibodies 
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recognizing the first ones, the signal can be amplified and easily detected. We used 
the following primary and secondary antibodies and the nuclei staining at the 
indicated concentrations: rabbit anti-TRPC3 (4.5 μg·ml-1), rabbit anti-TRPC6 (4.5 
μg·ml-1), rabbit anti-P2Y6 (4.5 μg·ml-1), goat Alexa 594 anti-rabbit (1:1000) and 
Hoechst 33342 (1:2000). 
7.1.1. Immunocytochemistry procedure 
For the staining of CHO cells overexpressing some of the proteins of interest, 
transfected CHO cells plated on 12 mm diameter poly-lysine coated coverslips were 
fixed with freshly made 4% paraformaldehyde in PBS for 15-20 min. After washing 
three times with PBS 1X, cells were permeabilized in PBTx (0.1% Triton X-100 in 
PBS) for 20 min and blocked with 1% BSA in PBTx during 10 min. Then, cells were 
incubated with the primary antibodies for 1-2 hour in a humidified chamber, 
washed three times with blocking solution and incubated with the secondary 
antibodies for 30-60 min protected from light, both incubations in blocking 
solution. After three washes with PBS and one with ddH2O, the nuclei were labelled 
with Hoechst 33342 and coverslips were mounted using Vectashield (Vector 
Laboratories, Inc., Burlingame, CA, USA). 
For native VSM cells, several modifications of the above protocol were introduced: 
1) Fresh isolated VSMCs were plated on 12 mm poly-lysine coverslips during 1 hour 
before starting. 2) After fixing the cells as described, samples were incubated in 100 
mM Glycine solution for 15 min before washing and permeabilization. 3) The 
blocking step was performed with PLA Blocking Solution (Duolink® In Situ Kit, 
Sigma-Aldrich) at 37°C for 1 hour. 4) Primary antibodies were diluted in 0.01% 
Odissey® Blocking Buffer in PBS and incubation was carried out overnight at 4°C.  
Samples were maintained at 4°C protected from light until visualization at the 
appropriate wavelengths using confocal microscopy. 
7.2. Co-immunoprecipitation (coIP) 
Co-immunoprecipitation (coIP) is an extension of the classical immunoprecipitation 
(IP) technique that allows detecting protein-protein interactions. Based on the 
strong protein-antibody interaction, natural protein associations or overexpressed 
complex can be jointly precipitated and analyzed with immunoblot. With proteins 
carrying an epitope tag that can be easily detected with commercially available 
antibodies or beds, coIP technique allows to easily purify the tag protein as well as 
other macromolecules bound to the target. Therefore, IP is focused on the primary 
target or antigen and coIP is focused on secondary targets or interacting proteins. 
 - 66 - 
 
MATHERIAL AND METHODS 
In this study, coIP assays were performed using agarose GFP-Trap_A beads 
(Chromotek, Planegg-Martinsried, Germany) that recognized the YFP of the 
hTRPC3-YFP fusion protein (see CHO cell line section). For the immunoblotting 
assays, the primary antibodies used were rabbit anti-TRPC3 (4.5 μg·ml-1) or rabbit 
anti-TRPC6 (4.5 μg·ml-1), and the secondary antibody used was horseradish 
peroxidase-conjugated anti-rabbit (dilution 1:20000). 
7.2.1. CoIP procedure 
CoIP assays were performed in CHO cells transfected with hTRPC3-YFP and TRPC6 
plasmids, alone or in combination, using agarose GFP-Trap_A beads following the 
manufacturer’s instructions (Chromotek, Planegg-Martinsried, Germany). CHO 
transfected cells were collected in Modified RIPA Buffer (MRB, Table M7) 
supplemented with Proteases Inhibitor Cocktail (Roche, Basel, Switzerland) and 
incubated on ice for 15 min. Then cells were centrifuged at 12000 g, at 4°C for 10 
min to obtain the CHO cell lysate. This cell lysate was incubated with gentle shaking 
at 4°C for 2-3 h with the GFP-Trap_A beads previously equilibrated in MRB. Cell 
lysate was washed with MRB (3x) and then with high NaCl-MRB buffer (3x) and 
stored in MRB buffer at -20°C. 
Composition 
MRB 
(mM) 
MRB-750 mM 
NaCl 
(mM) 
NaCl 150 750 
Tris pH 8 50 50 
NP-40 1% 1% 
Sodium deoxycholate 0.2% 0.2% 
pH 7.5 7.5 
Table M7. CoIP solutions. 
 
For the immunoblot analysis, the cell lysate was diluted in XT Reducing Agent and 
XT Sample Buffer (Bio-Rad, Hercules, CA, USA) and incubated at 95°C for 5 min. 
Then, a SDS-PAGE electrophoresis was carried out on 10% polyacrylamide gels to 
separate the different co-purified proteins. After that, proteins were transferred 
onto a nitrocellulose membrane and blocked with 5% non-fat dry milk in TTBS 
buffer (0.1% Tween 20 in Tris-buffered saline) for 1 h. Membranes were then 
incubated with primary antibodies at 4°C overnight and then with secondary 
antibodies for 1 h, both incubations in blocking solution. Finally, protein signals 
were detected using a VersaDoc 4000 Image System (Bio-Rad) with 
chemiluminiscence reagents (SuperSignal West Femto Maximum Sensitivity 
Substrate; Pierce, Rockford, IL, USA) and quantification was carried out by 
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densitometric analysis of each antibody band normalized to its corresponding β-
actin signal using Quantity One software (Bio-Rad). 
  
Cell lysate 
GFP-Trap 
beads 
incubation 
Centrifugation 
steps 
Immunoblot analysis 
Figure M11. CoIP working scheme. 
 
7.3. Proximity Ligation Assay (PLA) 
The Proximity Ligation Assay (PLA) is a technique for detection of protein or 
macromolecules associations. This technique identifies association of the target 
molecules in the order of zeptomoles (40·10-21 mol) (Fredriksson et al., 2002). In a 
more detailed way (Figure M12), samples are fixed, blocked and incubated with 
two primary antibodies against the targets raised in different species. When adding 
the secondary antibodies which have complementary PLA probes attached, if they 
are in close proximity (at least 40 nm), a hybridization using Ligase can be 
performed. Then, a rolling-circle amplification (RCA) reaction is performed using 
fluorescence labelled nucleotides and Polymerase. Finally, the signal from each pair 
of PLA probes can be easily detected as individual spots by fluorescence 
microscopy. 
    
Primary antibody 
incubation 
Secondary antibody 
incubation 
Ligation Amplification 
Figure M12. Working scheme of PLA assay technique. 
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PLA is a highly specific technique (Fredriksson et al., 2002) that can be used for 
detection and quantification of protein interactions. In this study, PLA technique 
has been used to identify the composition of multimeric channels (defining homo 
and heteromeric channel associations) as well as interactions between ion 
channels, receptors and cotransporters in native VSMCs. The primary antibodies 
and the working concentrations used were: rabbit anti-TRPC3 (4.5 μg·ml-1, 
Alomone), goat anti-TRPC3 (dilution 1:200, Novus Biologicals), rabbit anti-TRPC6 
(4.5 μg·ml-1, Alomone), goat anti-TRPC6 (dilution 1:200, Novus Biologicals), rabbit 
anti-P2Y6 (4 μg·ml
-1, Alomone), goat anti-ANO1 (dilution 1:200, Santa Cruz). 
7.3.1. PLA procedure 
Protein associations were explored with PLA technology using Duolink® In Situ Kit 
(Sigma-Aldrich) following the manufacturer´s instructions. Briefly, freshly isolated 
VSMCs were settled in 12 mm diameter coverslips, at room temperature for 1 
hour. Then VSMCs were fixed with 4% paraformaldehyde for 20 min and then 
treated with 100 mM Glycine during 15 min. After washing three times with PBS 
1X, cells were permeabilized using PBTx (0.1% Triton X-100 in PBS) during 20 min 
and then blocked with Duolink® In Situ Blocking Solution, at 37°C during 20 min. 
Afterwards, samples were incubated with two primary antibodies (dilution 1:200 in 
0.01% Odissey® Blocking Buffer in PBS) raised in different species, at 4°C overnight. 
For negative controls, samples were incubated only with one primary antibody. 
After washing three times with Wash Buffer A, cells were incubated with the 
Duolink® In Situ PLA Probes (PLUS and MINUS), at 37°C during 1 hour. Then, cells 
were washed three times with Wash Buffer A, 1U/μl Ligase was added (dilution 
1:40) and samples were incubated at 37°C during 30 min. After washing with PBS 
(3x), amplification was performed using 10U/μl Polymerase (1:80 dilution in 
Duolink® In Situ Detection Reagents Orange) at 37°C during 100 min. After that, 
samples were washed twice in wash Buffer B for 10 min and once in 0.01% wash 
Buffer B for 1 min. Finally, samples were completely dried, mounted using Duolink® 
In Situ Mounting Medium and kept at 4°C protected from light until visualization 
using confocal microscopy. 
The immunofluorescence image acquisition was performed using a SP5 Confocal 
Microscope (Leica Microsystems, Wetzlar, Germany) at the appropriate 
wavelength. For comparisons between different conditions, image acquisition was 
performed using the same settings for all the conditions studied. ImageJ (Fiji 1.51g) 
software was used for image analysis.  
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7.4. Ground State Depletion (GSD) Super-resolution microscopy 
 
7.4.1. GSD Super-resolution fundaments 
Ground State Depletion (GSD) microscopy is a super-resolution technique that 
allows localizing single molecules with high precision and create a high resolution 
image below the diffraction limit. The principle of single-molecule detection-based 
super-resolution is based on the different states of energy in which activated 
fluorophores can be (Figure M13). In conventional fluorescence microscopy, 
delocalized electrons of fluorophores can be transferred from a ground state (S0) to 
an excited state (S1) and, as they oscillate back into the S0, they emit fluorescence. 
In GSD Super-resolution technique, this oscillation cycle is modified by switching 
the fluorophores to off-states, reducing the amount of simultaneously emitting 
excitable fluorophores that become spatially and temporally distinct from 
neighboring fluorophores. Then, the fluorophores in off-states can return back to S0 
and fluoresce again, while other molecules switch to off-states (Fölling et al., 2008; 
Dixon et al., 2017). 
 
 Figure M13. GSD Super-resolution microscopy based principle. 
 
The burst of fluorophores can be fitted to a Gaussian curve whose centroid 
corresponds to the exact position of each fluorophore and, by collecting all the 
single fluorophore information of several thousands of separated images, a GSD 
Super-resolution image with sub-diffraction-limit resolution is reconstructed 
(Figure M14). The quality of the GSD Super-resolution images obtained depends on 
the numerical aperture (NA) of the lens, the wavelength of light used for excitation 
and, crucially, the fluorophore properties: number of photons per switched event, 
the on-off duty cycle, photostability and number of switching cycles. Using 
fluorophores with high photon yield per switching event and low on-off duty cycle 
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provides both high localization precision and density. Furthermore, the imaging 
buffer conditions and properties can modified the switching properties of 
fluorophores and the quality of the reconstructed image (Dempsey et al., 2011; 
Dixon et al., 2017). 
 
Figure M14. Scheme of ON-OFF switching cycles and GSD Super-resolution image reconstruction. 
 
GSD Super-resolution technique was used to explore the exact localization of single 
molecules, such as purinergic receptors and TRPC channels, on the membrane of 
VSMCs. In addition, the association and clustering properties of these membrane 
proteins was also studied. Using immunocytochemistry fundaments with different 
antibody combinations, it was possible to obtained GSD reconstructed images 
showing the protein distribution of these receptors and channels with high 
resolution. 
7.4.2. GSD Super-resolution System 
The GSD Super-resolution system used in this study consists of several parts: 
inverted microscope, TIRF/GSD module, high power lasers, external light source 
and acquisition software (Figure M15). 
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Figure M15. GSD Super-resolution system. 
 
a) Inverted microscope 
A DMI6000B inverted microscope (Leica Mycrosystems, IL, USA) was used for 
Super-resolution measurements. Images were acquire using 160x HCX PL APO 
(NA=1.47) oil-immersion lens and an Andor iXon3 897 EMCCD Camera coupled to 
the inverted microscope. The inverted microscope with all of the attached 
components were placed on an anti vibration table. 
b) TIRF/GSD module 
A DMi8 S TIRF module (Leica Mycrosystems, IL, USA) coupled to the inverted 
microscope was used to switch from TIRF to GSD conditions. This TIRF/GSD module 
enables to control the TIRF penetration depth and the illumination angle of the 
samples, allowing the acquisition of super-resolution images with high power 
illumination options. 
c) Sample SuMo stage 
A sample Suppressed Motion (SuMo) 11888439 stage (Leica Mycrosystems, IL, 
USA) coupled to the inverted microscope was used to minimize possible drifts, 
ensuring stability during acquisition. 
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d) High power lasers 
The GSD Super-resolution system is equipped with high-power lasers with the 
following wavelengths: 488 nm, 532 nm and 642 nm. The measured intensities at 
the focal plane of each one are 1.4 kW·cm-2, 2.1 kW·cm-2 and 2.1 kW·cm-2, 
respectively. In addition, the system comprises a 405 nm laser to control the single 
molecule switching behaviour (backpumping). 
e) External light source 
An external EL6000 light source (Leica Mycrosystems, IL, USA) connected to the 
inverted microscope via a liquid light guide was used to enhance fluorescence 
imaging. By using an alignment-free, mercury metal halide bulb, it keeps heat away 
from the sample and the microscope. 
f) Acquisition software 
For the image acquisition, LAS X (Leica Mycrosystems, IL, USA) software was used. 
This software allows controlling the focus in all the XYZ directions, switching 
between TIRF and GSD imaging modes, and stablishing the setting conditions for 
acquiring images. In addition, it allows analyzing the high resolution reconstructed 
images. 
7.4.3. GSD Super-resolution procedure 
GSD Super-resolution requires labelling the proteins of interest with fluorophores, 
which can be done with the conventional immunocytochemistry technique. Using 
commercial primary and secondary antibodies, specific mounting media and GSD 
Super-resolution software, the on-off duty cycles of fluorophores can be easily 
controlled to obtain a single molecule reconstructed GSD image. 
a) GSD Super-resolution immunostaining protocol 
Freshly isolated VSMCs were settled on 25x25 mm square coverslips at room 
temperature during 1 h and then cells were fixed with PFA-GA (3% 
paraformaldehyde-0.1% glutaraldehyde in PBS) at room temperature for 10 min. 
After washing three times with PBS, cells were reduced with 0.1% NaBH4 in ddH2O 
at room temperature during 5 min. Then, cells were blocked with SBTx blocking 
solution (20% Sea Block-0.25% Triton-X 100 in PBS) for 1 h at room temperature. 
After removing SBTx solution, samples were incubated with 10 μg·mL-1 of the 
primary antibodies: rabbit anti-P2Y6, goat anti-TRPC3, rabbit anti-TRPC3 and rabbit 
anti-TRPC6, in SBTx solution, at 4°C overnight. After washing three times, cells were 
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incubated with 2 μg·mL-1 of the secondary antibodies Alexa  647 donkey anti-goat 
and Alexa 568 goat-anti rabbit, at room temperature for 1 h protected from light. 
Then, samples were washed three times with PBS and postfixed using 0.25% GA in 
PBS at room temperature during 10 min. Finally, samples were washed three times 
with PBS and kept at 4°C in 3 mM azide and protected from light until image 
acquisition. 
b) GSD Super-resolution sample mounting 
In GSD Super-resolution, fluorophores are required to be fluorescent only a fraction 
of time to be individually localized. For this purpose, the imaging buffer contains 
two components: β-Mercaptoethylamine (MEA, Cysteamine, Sigma Aldrich), to 
induce photoswitching of the fluorophore, and an oxygen-scavenging system 
(Glucose-oxidase+Catalase), to reduce the effects of photobleaching. The 
previously described (Dempsey et al., 2011) imaging buffer used in this study was 
prepared as following (Table M8): 
Composition 
MEA 
(mM) 
Diluting 
buffer B 
(mM) 
GLOX 
(mM) 
Imaging buffer 
10 mM 
(mM) 
MEA 100   GLOX 
Glucose oxidase 
Catalase 
 
0.56 mg mL
-1
 
0.34 μg mL
-1
 
Glucose  10% w/v  
NaCl  10  
Tris 1M pH 8  50 10 MEA 10 
Glucose oxidase   56 mg mL
-1
 Buffer B Vf 
Catalase   3.4 mg mL
-1
   
pH 8 (HCl)     
Table M8. Imaging buffer components for GSD Super-resolution microscopy. Left, separately 
stored aliquots of the components of the imaging buffer. Right, imaging buffer, freshly prepared. 
 
100 mM-MEA aliquots of 1mL were stored frozen at -20°C, and centrifuged-(14000 
rpm, 3 min) GLOX (Glucose-oxidase+Catalase) aliquots were kept at 4°C, both used 
within 1-2 weeks. The imaging buffer has to be freshly prepared and used within 1-
2 h due to the acidification caused by the enzymatic reactions, preventing changes 
in the photophysics properties of the fluorophores. 
To mount the samples, slides of 76x26x1.5 mm with a depression of 15-18 mm 
diameter and 0.6-0.8 mm depth (neoLab®, Germany) were used. Firstly, imaging 
buffer was placed on the depression and then coverslips with cells were carefully 
mounted, avoiding formation of air bubbles. Finally, coverslip was fixed using the 
yellow and blue components of silicone-glue Twinsil® (Picodent, Wipperfürth, 
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Germany), previously mixed in a 1:1 volume quantity. After 5-10 min, the glue was 
hardened and samples were mounted on the inverted microscope. 
c) GSD Super-resolution acquisition protocol 
For the GSD Super-resolution acquiring, images were acquired firstly with 642 laser 
and then with 532 laser, using a penetration depth of 130 nm and a TIRF angle of 
66.32°. For VSMCs cells, the threshold value to eliminate background, nonspecific 
signals, was stablished in 85 events·pixel-1 and the minimum number of events per 
image were fixed at 8. A minimum of 30000 images per laser were acquired to 
obtain the GSD reconstructed image. 
7.4.4. GSD Super-resolution analysis 
Three different analyses were performed from the GSD reconstructed images: 
shortest intermolecular distance analysis and cluster size and density analysis. 
a) Shortest intermolecular distance analysis 
An object-based analysis to measure the shortest distance between purinergic 
receptors and TRPC channels was performed using the JACoP plug-in of the ImageJ 
software (National Institute of Health, NIH). This previously described analysis is 
based on image segmentation by connexity analysis (Henis et al., 2003; Bolte and 
Cordelieres, 2006; Mercado et al., 2014). Briefly, all the adjacent pixels of a 
reference pixel with intensity above a set threshold limit are considered to be part 
of the same structure as the reference pixel. After segmentation, these individual 
particles are represented by centroids, defined as the geometrical centre of each 
particle including its global shape. With JACoP plugin, the shortest distances 
between centroids are analyzed for each laser-activated GSD reconstructed image. 
Analyzing the data using frequency histograms fitted to a Gaussian curve of two or 
three components, these measurements allowed stablishing colocalization 
between particles. 
b) Cluster size and density analysis 
Cluster size (in μm2) and density (in particles·μm2) analysis were performed using 
the ImageJ software for each individual laser-activated GSD reconstructed image. 
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8. CHO cell line culture and maintenance 
Chinese Hamster Ovary (CHO) cell line was used as an in vitro model to explore the 
role of different transfected ion channels present in native cells. This epithelial-like 
cell line was initiated in 1957 (Gamper, Stockand and Shapiro, 2005) and several 
subclones have been developed since then. Their easy culture and maintenance, 
high transfection efficiency and very low expression of endogenous ion channels 
make CHO cells specially valuable for electrophysiological studies. 
CHO cells were maintained in Dulbecco´s modified Eagle´s medium supplemented 
with 10% fetal bovine serum, penicillin-streptomycin (100 U·ml-1 each) and 2 mM L-
glutamine at 37°C in a 5% CO2 humidified atmosphere. CHO cells were grown as a 
monolayer in poly-lysine-coated coverslips prior to transiently transfection using 
TransIT-X2® System (Mirrus, Madison, WI, USA) following the manufacturer´s 
instructions. Cells were trasnfected with: 1 μg of DNA of hTRPC3-YFP (yellow 
fluorescent fusion protein) kindly provided by Dr Klauss Groschner, (University of 
Graz, Austria), 1 μg of a bicistronic plasmid expressing ratTRPC6 and green 
fluorescent protein (GFP) as separate proteins (a gift from DR Jason Yuan, 
University of Arizona, USA), or 0.5 μg of each. Cells were used within 24-72 h 
postransfection for immunocytochemistry, coIP and electrophysiological studies. 
 
9. Electrophysiology: patch-clamp technique 
 
9.1. Patch-clamp fundamentals 
Patch-clamp is a technique used to study ionic currents in individual isolated living 
cells. An electrical potential difference (𝑉𝑚) across the cell membrane is generated 
by the selective ion permeability of the membrane, and it is maintained by the Na+-
K+ pump. The ion channels and transporters of the lipid membrane behave as 
conductors (𝐺𝑚), meaning that they represent the pathways for ionic current (𝐼) to 
flow. These three parameters (Vm, I and Gm) are related by the Ohm´s law: 
∆𝑉𝑚 = 𝐼𝑅𝑚 =
𝐼
𝐺𝑚
 
In resting conditions, the ∆𝑉𝑚 between the inner and outer sides of lipid membrane 
depends on the concentrations of ions to which the membrane is permeable and 
on their permeabilities (𝑝𝑖𝑜𝑛). In most mammalian cells, K
+, Na+ and Cl- make the 
largest contribution to the resting membrane potential (𝑉𝑚), described as the 
steady-state condition with no net flow of electrical current across the membrane. 
Therefore, 𝑉𝑚 follows the Goldman-Hodgkin-Katz (GHK) equation: 
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𝑉𝑚 =
𝑅𝑇
𝐹
ln (
𝑝𝐾[𝐾
+]𝑜 + 𝑝𝑁𝑎[𝑁𝑎
+]𝑜 + 𝑝𝐶𝑙[𝐶𝑙
−]𝑖
𝑝𝐾[𝐾+]𝑖 + 𝑝𝑁𝑎[𝑁𝑎+]𝑖 + 𝑝𝐶𝑙[𝐶𝑙−]𝑜
) 
For performing the patch-clamp recordings, a micropipette (a glass tube filled with 
an electrolyte solution and containing an AgCl recording electrode connected to an 
amplifier) is brought into contact with the cytosol of an isolated cell. Another 
electrode (reference or bath electrode) is placed in a bath surrounding the cell. An 
electrical circuit can be formed between the recording and reference electrode 
with the cell of interest in between, and changes in ion flows across the cell 
membrane can be measured. 
9.2. Patch-clamp set-up 
 
a) Perfusion chamber 
The perfusion chamber consists of a polycarbonate chamber (RC-24E, Warner 
Instruments, Hamden, CT, USA) attached to an aluminum platform (P1, Warner 
Instruments) and a glass coverslip perfectly sealed to the bottom of the chamber. 
The small volume (~200 μL) of the chamber is controlled by an inlet and an outlet 
connected to a perfusion system, allowing quick solution changes. Cells are placed 
on the bottom of the chamber either directly or previously attached to glass 
coverslips. 
b) Perfusion system 
The perfusion system consists of six reservoirs controlled by electrovalves. 
Solutions from reservoirs perfuse by gravity at a rate of 1-2 ml·min-1 through 
silicone tubes and converge in one tube to reach the perfusion chamber. The outlet 
tube connected between the chamber and the vacuum pump system facilitates the 
quick solution changes of the chamber. 
c) Inverted microscope 
IX70 (Olympus, Tokyo, Japan) and Eclipse TE300 (Nikon, Tokyo, Japan) inverted 
microscopes were used for patch-clamp experiments. pE-100 Light Source systems 
(CoolLED, UK) attached to each microscope were used when patching transfected 
CHO cells. Both microscopes were also adapted with a support for the electrode 
holder (2.0 mm 64-840 QSW, Warner Instruments), the perfusion chamber and the 
macro and micromanipulation system. The macro manipulator system is attached 
to the holder through the amplifier headstage (AU CV201, Axon Instruments). 
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d) Micro and macromanipulators 
The macro (PSC-500 Series, Burleigh, Newton, NJ, USA) and micromanipulators 
(423 Series, Newport, Irvine, CA, USA) used for electrophysiological studies allows 
finely controlling the distance between the micropipette and the cell. The macro 
manipulator allows localizing the micropipette and moving it closer to the cell and 
the micromanipulator permits stablishing contact between the pipette tip and the 
cell membrane. Adjustments in the three XYZ spatial axes can be performed. 
e) Vibration isolation table 
The vibration isolation table (63-544 microg, TMC, Peabody, MA, USA) works based 
on air cushions placed on the table legs that support a heavy table top. This table 
top is kept afloat using a gas source from a nitrogen tank. The inverted microscope 
is placed on the table top, isolating it from external vibrations. The vibration 
isolation table is essential for stable recordings to avoid crushing the pipette to the 
bottom of the chamber or detaching the pipette from the cell. Moreover, the 
microscope, the perfusion system and the macro and micromanipulators are 
placed inside a Faraday cage to isolate from external electric fields. 
f) Amplifiers 
The Axopatch-200 and the Multiclamp 700A (Axon Instruments, Inc., Foster City, 
CA, USA) amplifiers used in this study allow amplifying the signal and also to control 
several recording settings: current/voltage clamp switching, offset control, 
capacitance and series resistance compensations, holding potential settings, gain 
and other useful controls. 
g) Digitizers 
Digidata 1322A and 1440A (Axon Instruments) were the devices used to convert de 
analogical recorded data (AD) to digital data (DA) and vice versa. In addition, these 
interfaces enable the communication between the cell signals, the amplifier and 
the computer software, by using AxoScope software. Analogical signals generated 
by cells are converted to digital format by the analog-digital converter of digitizers. 
Similarly, digital signals and protocols generated by the computer are converted to 
analogic by the digital-analog converter of Digidata. 
h) Patch-clamp software 
pClamp 10.2® software (Axon Instruments) was used to communicate the AD/DA 
conversion interface to the computer and to perform the patch-clamp data 
 - 78 - 
 
MATHERIAL AND METHODS 
analysis. This software comprises several subroutines, and we used mainly two of 
them: Clampex® subroutine, to design stimulation protocols and acquire the data, 
and Clampfit® subroutine to analyze the recorded data. 
9.3. Micropipette manufacturing system 
Borosilicate glass capillaries with outer and inner diameters of 2.00 and 1.12 mm, 
respectively, and an inner filament (1B200F-4, World Precision Instruments, Inc., 
UK) were used as for making micropipette electrodes. The inner filament helps with 
the filling of the pipette by increasing capillary properties and avoiding bubble 
formation. Two micropipettes were obtained from each capillary by pulling them, 
and after that, the tips were fire-polished to obtain a smooth surface and increase 
their resistance. 
PP-83 vertical puller (Narishige, Tokyo, Japan) and P-97 automatic puller (Sutter 
Instruments, Novato, CA, USA) were used to stretch borosilicate glass capillaries. 
The vertical puller heats the capillaries using a heating coiled resistance and 
stretches them in two successive steps. With the automatic puller, the capillaries 
are clamped at both ends and a resistance placed between the clamps heats and 
stretches the capillaries following a previously fixed cycle protocol. This protocol 
consists of several heating and successive stretching cycles by setting several 
parameters, such as pulling, velocity, resistance cooling time and air flow pressure. 
By controlling these parameters, electrodes can be obtained with a greater 
reproducibility. 
9.4. Patch-clamp procedure 
Electrophysiological recordings were carried out in CHO transfected cells and in 
native VSMCs from mesenteric arteries. Freshly isolated VSMCs were placed in the 
perfusion chamber and allowed to adhere to the chamber bottom at room 
temperature for 15 min. For CHO cells, the coverslip of transfected cells was 
directly placed in the chamber. Then, the perfusion system, previously purged with 
the bath solutions, was connected to the inlet of the chamber and the vacuum was 
activated. The glass micropipette filled with internal solution (Tables M11 and M12) 
was attached to the AgCl electrode and fixed to the pipette holder. Using the 
macromanipulator, the micropipette electrode was placed above the selected cell 
and, with the micromanipulator, got in contact with the cell to make a high 
resistance (GΩ) seal. We monitored the resistance of the pipette using the 
subroutine Seal Test of the software Clampex®, which continuously records the 
current in response to a pulse of -10 mV (Figure M17). After gigaseal formation, the 
holding potential was made negative, close to resting membrane potential of cells 
  
- 79 - 
 
MATHERIAL AND METHODS 
(-40 mV for VSMCs and -60 mV for CHO cells). At this point we are in the cell-
attached configuration of the patch-clamp technique. Patch-clamp technique can 
be used in several different configurations (Figure M16). In this work we use the 
whole-cell configuration for voltage-clamp measurements and the perforated-
patch configuration for current-clamp studies. 
 
Figure M16.  Different configurations of the patch-clamp technique. 
 
With the voltage-clamp, we control the membrane potential with an electronic 
feedback system that measures the cell membrane potential and compares it with 
the potential established in the experimental protocol. Differences between both 
potentials are immediately corrected with an injection of current, that mirrors 
(with opposite direction) the ionic current that we are registering. To reach the 
whole-cell configuration we start from the point in which we got the gigaseal 
formation (cell-attached configuration). After this, a negative pressure is applied to 
the tube connected to the micropipette electrode, disrupting the seal and allowing 
the access to intracellular solution. This can be detected by the large capacitative 
transient that appears when the gigaseal is broken (Figure M17). The amplitude 
and the time course of these peaks were used to estimate the series resistance or 
access resistance (Ra) and membrane capacitance (Cm) of the cells. A good 
recording typically has a stable seal over 1 GΩ, Ra of less than 20 MΩ (and usually 
much smaller, below 10 MΩ) and constant cell capacitance and resistance during 
all recording. In this configuration we achieve electrical continuity between the 
recording electrode and the inside of the cell. Since the cell volume is negligible 
compared to the volume of the internal solution in our pipette, we considered the 
composition of the medium in the intracellular side of the membrane identical to 
that of our internal solution. 
Cell-attached 
_
_
C
O
Inside-Out 
Outside-Out
_
_
C
O
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_
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Applying suction Gigaseal Capacitative transient 
Figure M17. Current response vs time when forming the GΩ seal and accessing the patched cell. 
 
9.5. Patch-clamp protocols 
The patch-clamp protocols are different depending on whether we use voltage-
clamp measurements (fixing the membrane potential to study ionic currents) or 
current-clamp (fixing the currents to study membrane potential variations). 
9.5.1. Voltage-clamp measurements 
To study changes in currents across the membrane, voltage-clamp (Vclamp) 
technique was used in whole-cell configuration, as previously described. As 
mentioned above, using whole-cell configuration, the pipette solution directly 
contacts cytoplasm and replaces it, so it is important to use pipette solutions 
similar to intracellular one with the appropriate modifications to study the ion 
conductance of interest. 
The voltage-protocols used with Vclamp technique consisted mainly on voltage-
ramps (Figure M18). 1s depolarizing ramps from -150 mV to +80 mV from a holding 
potential of -10 mV were applied every 10 s under control conditions or in the 
presence of agonists or blockers. When this protocol was used with intracellularly 
applied antibodies, the access resistance (Ra) and the membrane capacitance (Cm) 
were continuously monitored and recorded by applying the membrane test 
algorithms of Clampex 10 software throughout the experiment. Only cells with GΩ 
seal and stable Ra and Cm values were considered for analysis. Data were acquired 
at a frequency of 5 kHz and filtered at 2 kHz. 
 
 
Figure M18. Ramps protocol used for Vclamp measurements in whole-cell configuration. 
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9.5.2. Current-clamp measurements 
To study changes in the membrane potential induced by agonists and blockers, 
current-clamp (Iclamp) technique was used in perforated-patch configuration. With 
Iclamp technique, if we do not inject current (I=0) we record the resting membrane 
potential. Unlike in the voltage clamp mode, where the membrane potential is held 
at a level determined by the experimenter, in current-clamp mode the membrane 
potential is free to vary, and the amplifier records the  voltage the cell generates 
either spontaneously or as a result of stimulation. 
 
Figure M19. Stablishment of perforated-patch configuration. The gigaseal is 
formed at t=0 min. The patch initially appears to become leaky and then the 
capacitative transients are developed (modified from Molleman, 2003). 
 
Using amphotericin B, small holes permeable to monovalent ions (but not larger 
molecules and second messengers) are formed on the cell membrane, allowing the 
contact between both sides of membrane while preserving the intracellular milieu. 
Thus, when the GΩ seal is stablished, the presence of amphotericin B (300 μg·mL-1) 
in the pipette solution leads to the perforated-patch configuration within minutes, 
and this can be monitored by the slow increase of the capacitative transients 
together with the decrease of the Ra through the pipette (Figure M19). Recording 
of membrane potential changes in response to different agonists and blockers was 
initiated when the Ra values fall below 20 MΩ. At this point, the amplifier can be 
switched to current-clamp mode (I=0) to record membrane potential. The high Ca2+ 
content of the pipette solution ensures the correct performance of the perforated-
patch technique, as accidental rupture of the patch (changing to whole-cell 
configuration) leads to a sudden Ca2+ load and cell death. These recordings were 
carried out in a gap-free acquisition mode. 
 
Figure 3.11
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9.6. Patch-clamp solutions 
The bath and pipette solutions used to study the contribution of purinergic 
receptors, TRPC channels and chloride channels currents in VSMCs and CHO cells 
are described in the following sections. 
a) Solutions for TRPC current recordings 
External solution. The TRPC external solution was designed to explore unspecific 
cationic currents in VSMCs and includes nicardipine to block VOCCs channels, CsCl2 
to block Kv currents and DIDS and Niflumic acid to block Ca
2+-activated Cl- currents. 
For CHO cells, standard solution 1X was used (Table M9). 
Internal solution. The TRPC internal solution was designed to let 100 nM of free 
Ca2+ and includes CsCl2 to block Kv currents. This solution was prepared adding all 
components but Mg-ATP and setting a pH of 7.0. Next, keeping the solution at 4°C 
on ice, ATP was added and pH was brought to 7.2 using KOH. Aliquots of 1 mL were 
stored at -80°C. Internal solution was filtered before use and always kept on ice. 
When intracellularly antibodies were needed, the antibody (4.5 μg·mL-1) was added 
to the filtered internal solution (Table M10). 
Composition 
TRPC external 
solution 
(mM) 
STD 1X 
solution 
(mM) 
NaCl 141 141 
CaCl2 1.8 1.8 
MgCl2·6H2O 1.2 1.2 
KCl  4.7 
CsCl2 5  
Glucose 10 10 
Hepes 10 10 
Nicardipine 5 μM  
DIDS 100 μM  
Niflumic acid 100 μM  
pH 7.4 (NaOH) 
Table M90. Bath solutions for TRPC recordings. 
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Composition 
TRP internal 
Solution 
(mM) 
Perforated-patch 
internal solution 
(mM) 
CsCl2 10  
Cs-Aspartate 110  
NaCl 10  
CaCl2 3.2 8 
Mg-ATP 2  
KCl  10 
K-Glutamate  95 
Hepes 10 10 
BAPTA 10  
Amphotericin B  300 μg mL
-1
 
pH 7.2 (CsOH) 7.2 (KOH) 
Table M10. Intracellular solutions for TRPC recordings. 
 
b) Solutions for Ca2+-activated Cl- current (IClCa) recordings 
External solution. The IClCa external solution was designed to explore the Ca
2+-
activated Cl- currents in VSMCs. This solution includes CsCl2 and 
tetraethylammonium chloride (TEA) to block K+ currents and nicardipine to block 
VOCCs channels (Table M11). 
Internal solution. The IClCa internal solution was designed to let 500 nM of free Ca
2+ 
and includes CsCl2, Cs-Aspartate and TEA to block K
+ currents. ATP was added to 
ice-cold solutions and then pH was adjusted. Aliquots of 1 mL were stored frozen at 
-80°C and filtered before filling the pipette electrode (Table M11). 
c) Solutions for perforated-patch recordings  
For Iclamp measurements, we used the standard solution 1X in the bath (Table M9) 
and the perforated-patch internal solution (Table M10) in the pipette. This internal 
solution could be stored at 4°C as it does not contain ATP. When filling the pipette 
electrode, the pipette tip was first dipped in filtered perforated-patch internal 
solution (without amphotericin B) and then backfilled with the same solution 
containing amphotericin B. Amphotericin-B solutions were prepared freshly every 2 
hours by adding 4 µl of a stock 50 µg/µl of Amphotericin B in DMSO to 500 µl of 
filtered internal solution. The solution was then sonicated to allow amphotericin to 
come into solution and kept at room temperature protected from light. 
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Composition 
IClCa external 
Solution 
(mM) 
IClCa internal 
Solution 
(mM) 
NaCl 131  
CaCl2 1.8 7.22 
MgCl2·6H2O 1.2  
CsCl2 5 10 
Cs-Aspartate  110 
TEA Cl 10 10 
Mg-ATP  2 
Glucose 10  
Hepes 10 10 
EGTA  10 
Nicardipine 5 μM  
pH 7.4 (NaOH) 7.2 (CsOH) 
Table M11. Electrophysiological solutions for Ca
2+
-activated Cl
-
 
channels. 
 
9.7.  Data processing and analysis 
Electrophysiological data acquisition and part of the analysis were performed with 
the Clampfit subroutine of the pCLAMP software (Axon Instruments) and with 
Origin 7.5 software (OriginLab Corp., Northampton, MA, USA). 
 
10. Statistical analysis 
Statistical analysis was performed using R software (R Foundation for Statistical 
Computing, Austria). Data are expressed as mean values ± standard error of the 
mean (SEM) from several different experiments. 
For pressure measurements, pressure myography, electrophysiology and PLA data, 
statistical comparisons were performed using the Student´s two-tailed t-test for 
paired or unpaired data or ANOVA with Bonferroni tests, depending on 
experimental design. For quantitative PCR data, Student´s t-test was performed in 
the case of normal distribution (i.e. a Saphyro-Wilks test with p>0.05), whilst a 
pairwise Mann-Whitney-Wilcoxon test (i.e. a non-parametric test) was applied to 
determine whether the differences between groups of pooled data were 
statistically significant. All through the Results section, values of p<0.05 are 
represented with one asterisk, while values of p<0.01 and p<0.001 were 
represented with two and three asterisks, respectively. 
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1. Essential Hypertension mouse model. 
The contribution of purinergic receptors, TRPC and Ca2+-activated chloride (CaCCs) 
channels to the increased vascular tone in hypertension was explored using the 
BPN/BPH mice model of essential hypertension. 
 
Figure R1. Systolic, diastolic and mean arterial blood pressures 
and pulse pressure in BPN and BPH mice. Each bar represents 
the mean ± SEM, n=24 and n=16 of BPN and BPH mice, 
respectively. *** P<0.001 compared to BPN. 
 
BPN and BPH arterial blood pressures were measured by Volume Pressure 
Recording method using a tail-cuff system. Systolic, diastolic, mean pressures and 
pulse pressure were obtained from BPN and BPH mice between 10 and 40 weeks of 
age and were consistently higher (~30 mmHg) in BPH compared to BPN mice 
(Figure R1). Within the ranges of age studied, no time-dependent changes in blood 
pressure were observed in either group. 
1.2. Characterization of vascular reactivity to sympathomimetic agonists in 
BPH phenotype. 
BPH VSM cells have a more depolarized resting membrane potential when 
compared with BPN cells. The values obtained in this work, measured in BPN and 
BPH freshly isolated VSMCs under current-clamp (I=0) perforated-patch 
configuration were -48.8 ± 1.1 and -40.7 ± 0.7 mV respectively (n=76 cells from 35 
BPN, and n=97 cells from 38 BPH) , in good agreement with previous data obtained 
in our laboratory (Moreno-Domínguez et al., 2009; Tajada et al., 2012). 
Mesenteric arteries from BPH mice showed also a higher myogenic tone compared 
to BPN vessels (Tajada et al., 2012). The role of different ionic channels underlying 
these differences between BPN and BPH arteries has been thoroughly 
characterized in our laboratoty (all references from the lab). However, vascular 
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tone is physiologically regulated by many modulators that activate Gq-coupled 
receptors, and the possible differences between BPN and BPH mice have not been 
studied yet. The sympathetic nervous system (SNS) is a main regulator of vessel 
tone by releasing Noradrenaline (NA) that stimulates VSMCs contraction activating 
the α1-adrenergic receptors present in these cells. Nevertheless, activation of these 
receptors does not entirely mimic the physiological activation of sympathetic 
neuronal contraction due to the release of other neurotransmitters such as ATP 
(Hirst and Edwards, 1989; Mulvany and Aalkjaer, 1990; Wier and Morgan, 2004). In 
order to explore the differences between BPN and BPH responses to NA, the effect 
of Phenylephrine (PHE), a specific α1-adrenergic receptor agonist, on vessels tone 
was investigated by pressure myography using segments of 2nd and 3rd order 
mesenteric arteries pressurized to 70 mmHg (Figure R2). 
 
Figure R2. Vasoconstriction response elicited by PHE. 
Dose-response curves of PHE were obtained in BPN (blue) 
and BPH (red) mesenteric arteries. Data represents mean 
± SEM, n=5-12 BPN mice and n=3 of BPH mice. **p<0.01 
when applying ANOVA and Bonferroni tests. 
 
Concentration-response curves of the PHE-elicited vasoconstrictor effects were 
obtained in BPN and BPH mice (Figure R2) and fitted to a Hill function curve as 
follows: 
𝐸 = 𝐸𝑚𝑎𝑥 ∙
[𝑃𝐻𝐸]𝑛
𝐸50
𝑛 + [𝑃𝐻𝐸]𝑛
 
Where, 𝐸𝑚𝑎𝑥 represents the maximum vasodilator effect, 𝐸50 represents the [PHE] 
that gives the 50% of the maximum effect and 𝑛 represents the Hill coefficient. BPH 
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arteries are more reactive to PHE, evidenced by a higher Emax (40.3% vs. 31.2%) and 
a lower E50 (2.51 μM vs. 6.64 μM). In both cases, the Hill coefficient (0.99 and 0.90) 
and the correlation R2 coefficient (0.99 and 0.99), the last related to the fitting 
method, were close to 1.  
These results demonstrate that BPH arteries exhibit a greater reactivity to an α1-
adrenergic agonist, pointing to differences in the signaling pathway between BPN 
and BPH mice not explored yet. For that reason, we decided to explore ion 
channels participating in the α1-adrenergic signaling pathway-induced contraction 
which could contribute to the more depolarized Vm and the greater reactivity in 
BPH cells, such as the transient receptor potential classic (TRPC1-7) family of 
channels. 
 
2. Role of TRPC channels in essential hypertension. 
 
2.1. mRNA expression profile of TRPC channels 
In order to study the contribution of the non-specific cationic TRPC channels to the 
BPH phenotype, their mRNA expression profile was explored by qPCR. Resistance 
vessels, such as mesenteric arteries, and femoral and aorta tissues from BPN and 
BPH mice were used. The genes explored included members of the TRPC family 
(TRPC1-7) and several control genes, such as calponin as a control of VSMC, 
endothelial nitric oxide synthase (eNOS) as a control of endothelial contamination, 
and ribosomal protein 18S (RP18S) as an endogenous control for the qPCR 
technique. We explored both the relative abundance (expressed as 2−∆𝐶𝑡) and the 
differences in expression observed in BPH mice compared to BPN (expressed as 
log 2−∆∆𝐶𝑡). 
All members of the family, with the exception of TRPC5 and TRPC7, were expressed 
in the three vascular beds, although channel expression was larger in resistance 
(mesenteric) than conduit (femoral and aorta) arteries (See figure R3 and note the 
different scale for the femoral an aorta data). While TRPC1 expression was 
dominant in conduit arteries, expression of TRPC1, 3, 4 and 6 was very similar in 
mesenteric arteries. When differences in expression between BPN and BPH were 
studied (Figure R3, right panel), the only channel overexpressed in BPH cells was 
TRPC3. Differences in expression are represented as log 2−∆∆𝐶𝑡, so that 0 values 
indicate no change in mRNA expression, positive values mean higher expression in 
BPH and negative values mean the opposite. 
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Figure R3. Changes in the mRNA expression profile of TRPC family of channels in BPN and 
BPH arteries. Left panels show the relative abundance of TRPC family channels in VSMC 
of mesenteric, femoral and aorta arteries expressed as 2-
ΔCt
, where ΔCt=Ctchannel – Ct18S. 
Right panels show differences in the TRPC channels expression in BPH arteries using BPN 
as calibrator calculated as 2
-ΔΔCt
, where ΔCt=ΔCtBPH – ΔCtBPN. Positive values mean 
increased expression whilst negative values mean decreased expression. Each bar is 
mean±SEM, n=10. **P<0.01. 
 
Since TRPC channels expression is higher in resistance vessels (which functionally 
contribute more to set blood pressure), and TRPC3 is overexpressed in those 
vessels in BPH mice when compared with BPN, we decided to explore the possible 
contribution of TRPC3 channels to the hypertensive phenotype in mesenteric 
arteries. We used a pharmacological approach, testing several pyrazole compounds 
(Pyr3, Pyr6 and Pyr10) that have been described as putative blockers of the TRPC 
channels (Kiyonaka et al., 2009; Schleifer et al., 2012), to explore the contribution 
of TRPC3 channels to vascular tone using pressure myography and 
electrophysiology. While Pyr3 and Pyr10 have been proposed as selective blockers 
of DAG-activated TRPC3 channels, Pyr6 seems to exhibit greater potency inhibiting 
Orai-mediated Ca2+ entry (Schleifer et al., 2012). 
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2.2. TRPC3 contribution to vascular tone. 
Endothelium-denuded arteries were pressurized to 70 mmHg and precontracted 
with PHE (5-10 μM) in order to activate TRPC channels and assess the vasodilatory 
response elicited by the pyrazole compounds. Pyr applications at different 
concentrations were performed in the continuous presence of PHE, and at the end 
of the experiment nifedipine (10 μM) was applied to determine the maximum 
passive vessel diameter (Figure R4 A). 
 
Figure R4. Effects of Pyr compounds on the vascular tone in BPN and BPH mesenteric arteries. A, 
representative examples of the vasodilator effect of Pyr3 in BPN (left) and BPH (right) mesenteric 
arteries. Arteries were pressurized to 70 mmHg and precontracted with PHE (5 μM) before Pyr 
applications at the indicated concentrations (μM). At the end of the experiment, Nif (10 μM) was 
added to obtain the maximum passive diameter. B, concentration-response vasodilator effect of 
Pyr10, Pyr3 and Pyr6 in BPN (blue) and BPH (red) PHE-precontracted mesenteric arteries. Data were 
normalized to the maximal diameter values obtained with Nif and expressed as percentage of 
relaxation (see Methods). Each point is mean ± SEM, n=5-9 arteries in each group. *p<0.05, **p<0.01 
Concentration-response curves were obtained for each Pyr compound in BPN and 
BPH arteries, and data were fitted to a Hill function (Figure R4 B). Pyr3 and Pyr10 
elicited a concentration-dependent vasodilator response which was more effective 
in BPN mesenteric arteries. In fact, the Hill fitted curves for Pyr3 and Pyr10 in BPN 
arteries were best fitted with two different components (Table R1), being the high-
affinity one responsible for ~ 30% of the total response. This high-affinity 
component was not present in BPH. We hypothesized that this component 
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represents the specific blockade of TRPC3 channels described in the literature, 
while the low-affinity corresponds to some unspecific effect. In contrast to the 
effects seen with Pyr3 and Pyr10, Pyr6 vasodilation was less potent and no 
significant differences between BPN and BPH at lower concentrations were found. 
 
 
 
 
If we assume that the main target of Pyr3 and Pyr10 are TRPC3 channels, the larger 
vasodilator effects of these drugs at concentrations ≤10 μM in BPN arteries would 
suggest an increased functional role of TRPC3 channels in these arteries. These 
results were certainly not anticipated by the mRNA expression studies, although 
several facts could explain the apparent discrepancy. First, it is possible that mRNA 
changes in expression do not correlate with changes in protein. Second, the 
differences in the Pyr3/10 effects could reflect differences not only in the number 
of channels present in the membrane but also in the subunit composition of the 
TRPC tetramers. Since TRPC6 and TRPC1 expression was smaller in BPH mesenteric 
arteries (see figure R3), and it is well known that TRPC3 and TRPC6 form 
heteromultimers in physiological conditions (Hofmann et al., 2002; Earley and 
Brayden, 2015), we decided to explore the second possibility using 
electrophysiological and immunocytochemical approaches, previously validated in 
heterologous expression system. 
2.3. Characterization of the Pyr10 sensitivity of TRPC3 and TRPC6 channels in 
a heterologous expression system. 
The dependence of the effect of Pyr10 on the composition of the TRPC tetramers 
was explored by characterizing the effect of Pyr10 on the non-selective cationic 
currents recorded in the CHO cell line overexpressing TRPC3, TRPC6 or both 
(TRPC3/6). Depolarizing ramps from -150 mV to +80 mV were used in transfected 
and mock transfected CHO cells in resting conditions and in the presence of Pyr10 
(10 μM). In addition, as TRPC3 and TRPC6 mediated currents can be activated by 
several GPCR as well as by pressure-induced membrane stretch (Gonzales et al., 
2014; Wilson and Dryer, 2014), we tested the effect of Pyr10 on currents activated 
by a hypotonic stimulus (70% STD 1X solution, HS, see Methods). 
 BPN BPH 
Kd1 (µM) Kd2 (µM) R
2
 Kd (µM) R
2
 
Pyr3 0.013
 
8.3 0.99 20 0.99 
Pyr10 0.067
 
5.97 0.99 10 0.99 
Pyr6 - 8.16 0.95 20 0.98 
Table R1. Kd values (μM) for each Pyr compound. Kd1 values refer to the 
high affinity component of the Hill fitted curve. 
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Figure R5. Functional contribution of TRPC3 and TRPC6 channels to basal and stretch-activated, non-
selective cation currents in CHO cells. A, representative traces of currents recorded in unstimulated 
CHO cells transfected with TRPC3, TRPC6 or TRPC3/6 channels. The effect of the Pyr10 (10 μM) 
application (Pyr10, green) and the subtracted Pyr10-sensitive current (C-Pyr10, red) are also shown. B, 
bar plots showing averaged currents amplitudes (pA/pF) measured at -150 mV (lower bars) and +80 
mV (upper bars) in each condition and also in mock cells. Data are mean ± SEM, n=7-23 cells in each 
condition. C, representative time course experiment showing the effect of Pyr10 on the stretch-
activated currents recorded at -150 mV and +80 mV in a TRPC3/6 transfected CHO cell. D, summary of 
the Pyr10 effect on stretch-activated currents recorded at -150 mV (lower bars) and +80 mV (upper 
bars) for each condition. Data are mean ± SEM, n=13-22 cells in each condition. 
Cationic currents of variable amplitudes were recorded in mock transfected CHO 
cells and in cells transfected with TRPC3, TRPC6 or TRPC3/6 channels. In all cases, 
basal currents were significantly larger in transfected cells (Figure R5 B). Figure R5 
A shows representative current traces of cells transfected with TRPC3, TRPC6 or 
both, in control conditions and in the presence of Pyr10 (10 μM). The figure also 
shows the Pyr10-sensitive currents (red), obtained by subtracting the current 
obtained in the presence of Pyr from the current obtained in the absence of the 
blocker (C-Pyr10). Control currents were higher in TRPC3 than in TRPC6 transfected 
cells and showed an intermediate behavior in TRPC3/6 transfected cells. Regarding 
the effect of Pyr10, data showed that only cells expressing TRPC6 channels (alone 
or with TRPC3) were sensitive to Pyr10 (figure R5 B). Since TRPC3 and TRPC6 are 
activated when cells are stretched, we also tested the effect of Pyr10 on stretch-
activated CHO cells. Typical traces obtained in whole-cell experiments recording 
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the current peak density at -150 mV and +80 mV, before and after Pyr10 
application, are shown in figure R5 C. As expected, HS application elicited a 
reversible increase in the recorded currents similar in the three conditions studied 
(TRPC3-, TRPC6- and TRPC3/6-transfected cells), significantly larger than the 
obtained in untransfected cells. Interestingly, as in the case of basal currents, the 
blocking effect of Pyr10 (10 μM) on HS-activated currents was obtained only when 
TRPC6 channels were present (figure R5 D). 
Taken together, these data strongly suggested that Pyr10 is actually a TRPC6 
channel blocker, in clear disagreement with previous data in the literature where 
Pyr10 has been described as specific for TRPC3 channels (Schleifer et al., 2012). In 
our hands, Pyr10 is indeed a TRPC6 blocker, and since this blockade occurred either 
in TRPC6 or TRPC3/6 transfected cells, it could be hypothesized that Pyr10 behaves 
as a TRPC current blocker of TRPC6 homotetramers and also of TRPC6 
heteromultimers with other TRPC channels, such as the TRPC3. 
In order to confirm the presence of those heteromultimers in the CHO cells 
transfected with TRPC6 and TRPC3 channels, we performed co-
immunoprecipitation assays using GFP-Trap® beads that bind to the TRPC3-YFP 
fusion protein. The antibodies against TRPC3 and TRPC6 channels used for the 
immunoblotting step were first tested with immunocytochemistry in TRPC3- or 
TRPC6-transfected CHO cells. Figure R6 shows the specificity of both antibodies as 
well as the membrane expression of both TRPC channels. 
 
Figure R6. Immunostaining evidence of the location and association of TRPC3 and TRPC6 channels 
in CHO cells. Representative confocal images of immunolabelling using anti-TRPC3 and anti-TRPC6 
antibodies (middle images) in TRPC3-YFP (left) and TRPC6-GFP (right) transfected (upper images) 
CHO cells. Immunostaining was predominant at the cell membrane and correlated with YFP (fusion 
protein)-labelling for TRPC3 (lower images). No cross-reactivity was observed in either case. 
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Figure R7 shows a typical co-immunoprecipitation experiment in which TRPC3 
channels could be detected in the pull-downs obtained from both TRPC3 and 
TRPC3/6 transfected cells, strongly suggesting that TRPC3 and TRPC6 associate to 
form heteromultimers. As expected, TRPC6 could only be detected in the pull-
downs obtained from the TRPC3/C6 transfected cells. 
 
Figure R7. TRPC3-YFP and TRPC3-YFP/TRPC6 transfected cells were co-
immunoprecipitated using GFP-Trap beads and immunoblotted with 
anti-GFP (as load control), anti-TRPC3 and anti-TRPC6. Data are 
representative of two independent experiments. 
 
These experiments demonstrate that Pyr10 is a tool for studying TRPC6 channels, 
either as homo or heteromultimers. To our knowledge, there is not a similar 
pharmacological tool to explore specifically TRPC3 channel function. However, 
since anti-TRPC3 antibodies have shown a good specificity when tested in 
immunocytochemical and western-blot experiments, we decided to explore if they 
could affect functionally TRPC3 channels when applied intracellularly in a patch-
clamp pipette. Therefore, whole-cell patch-clamp experiments were performed in 
transfected and mock CHO cells adding to the pipette solution anti-TRPC3 or anti-
GFP/RFP (as negative control, see Methods). 
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Figure R8. Use of antibodies to determine functional contribution of TRPC3 and TRPC6 channels in 
CHO cells. A, blocking effect of the intracellularly applied antibodies on whole-cell currents in 
TRPC3-transfected (right) and mock CHO (left) cells. Bars are average basal current densities at -
150 mV (lower bars) and +80 mV (upper bars) after 5-10 min of recording in control pipette 
solution or in presence of the indicated antibodies. Data are mean ± SEM, n=9-14 cells from at 
least four different experiments. The inset plots show representative current traces obtained at the 
indicated times in a mock (left) or in a TRPC3-transfected (right) cell with anti-TRPC3 in the pipette 
solution. B, same protocol of intracellularly applied antibodies used on stretch-activated currents 
with HS solution in TRPC3- and TRPC3/6-transfected cells. Bars are mean ± SEM, n=8-10 cells. 
 
No changes in basal current amplitudes were observed in transfected and mock 
cells when using control antibodies up to 10 min of recording, while a significantly 
reduction in transfected cells was observed when dialyzing with anti-TRPC3 (Figure 
R8 A). Similar results were obtained when the effect of antibodies was tested on 
HS-activated currents (Figure R8 B). The effect of anti-TRPC3 antibodies was also 
tested in cells transfected with TRPC3/6 (Fig R8 B). In this case, the effect was also 
evident, suggesting that the antibody was also effective on heteromultimeric 
channels. 
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2.4. Characterization of TRPC3/6 heteromultimers in VSMCs from BPN and 
BPH mice. 
We have shown that Pyr10 and anti-TRPC3 antibodies were good tools for 
exploring TRPC6 and TRPC3 mediated currents, respectively, although they could 
not provide information about possible changes in heteromultimeric composition 
when both channels are present. This is the case of native VSMCs from mesenteric 
arteries. However, the larger expression of TRPC3 and lower expression of TRPC6 
mRNA in BPH cells could translate into a different composition of TRPC3/6 
heteromultimers in these cells, and this could have functional consequences in the 
control of vascular tone. To test this hypothesis, Proximity Ligation Assays (PLA, see 
Methods) were carried out in freshly isolated VSMCs from BPN and BPH mesenteric 
arteries using combinations of anti-TRPC3 and anti-TRPC6 antibodies raised in 
different species. Since PLA gives positive signals with proteins that are closer than 
40 nm, it can detect the presence of heteromultimers in the membrane, although 
the existence of clusters of channels can not be excluded (see the Discussion 
section). Nevertheless, and for the sake of simplicity, the possible associations that 
could be found in a single tetramer, and how they would be detected with the 
three tested combinations of antibodies (C3/C3, C6/C6 and C3/C6), are depicted in 
the figure R9. Briefly, the combination C3/C6 labels only the heteromultimers, 
whilst the combinations C3/C3 and C6/C6 detect not only homomultimers but also 
heteromutimers with more than one subunit of the corresponding channel. 
 
Figure R9. Scheme of the C3-C3, C6-C6 and C3-C6 possible 
associations that can be recognized using PLA. 
 
Figure R10 A shows representative confocal images of the punctae distribution 
obtained in BPN and BPH native cells for the three tested combinations of 
antibodies. Labelling the cells with two different anti-TRPC3 antibodies (C3-C3 
combination) or combining anti-TRPC3 and anti-TRPC6 antibodies (C3-C6 
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combination) produced a significantly higher number of puncta per cell in BPH than 
in BPN cells. In contrast, the labelling with two different TRPC6 antibodies (C6-C6 
combination) was significantly smaller. Average values of the punctae density 
normalized to the cell size for all the described combinations are depicted in figure 
R10 B. Since C3/C3 and C6/C6 labelling are mutually exclusive, and the combination 
of both would label all possible associations of TRPC3 and TRPC6 channels, the 
percentage of heteromultimers with more than a TRPC3 (C3>1) or TRPC6 (C6>1) in 
BPN and BPH cell can be estimated from the C3/C3 and C6/C6 data (Figure R10 C). 
 
Figure R10. Differences in TRPC assembly in BPN and BPH mesenteric VSMCs. A, representative 
confocal images of the punctae distribution in BPN (upper) and BPH (lower) native VSMC cells. B, bar 
plot showing the average of density punctae of each condition represented in (A). Data are mean ± 
SEM, n=36-64 cells in each condition from four different experiments. *p<0.05, **p>0.01 compared to 
BPN. C, interpretation of the summary data, considering 100% as the sum of C3-C3 or C6-C6 and 
assuming C3-C6 is included in both. 
Although these experiments do not provide accurate information about the total 
expression of TRPC3 or TRPC6 channels in the cells, they allow us to conclude that 
heteromultimers are more abundant in BPH cells, and that the TRPC3/TRPC6 ratio 
in those multimers is higher than in BPN cells. 
2.5. Characterization of the functional contribution of TRPC3 and TRPC6 
multimeric associations in native VSMC cells from BPN and BPH mice. 
All data presented so far suggest a higher TRPC3 contribution, either as homo or 
heteromultimers, to the BPH phenotype. To test this hypothesis from a functional 
point of view, we characterized the TRP mediated currents in freshly isolated native 
VSMCs with the whole-cell configuration of the patch-clamp technique using Pyr 
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compounds (to block TRPC6 channels) or intracellular anti-TRPC3 antibodies (to 
block TRPC3 channels). Cationic currents were elicited with a ramp voltage protocol 
(see Methods) either on non-stimulated VSMCs (basal currents) or after the 
application of different agonists activating GPCRs (Receptor Operated Currents, 
ROCs). 
2.5.1. Characterization of basal TRPC currents. 
Ionic currents were recorded in the presence of TRP bath solution (see Methods). 
Basal current amplitudes at -150 mV were significantly larger in BPH than in BPN 
cells, even when current amplitudes were corrected for cell size (-8.1 ± 0.5 pA/pF in 
BPH vs. -6.4 ± 0.7 pA/pF in BPN, figure R11 B), since BPH cells were significantly 
larger than BPN (16.9 ± 0.6 pF, n=61 cells from 25 BPH; vs. 13.9 ± 0.5 pF, n=36 cells 
from 16 BPN). On the contrary, the effect of Pyr3 and Pyr10 on current amplitude 
was smaller in BPH cells. Figure R11 A shows representative records obtained in 
cells from both mice, and Figure R11 C represents the Pyr3 ad Pyr10 sensitive 
currents expressed as percentage of total current, measured at -150 mV. 
 
Figure R11. Pyr sensitivity of TRPC-mediated basal currents in native VSMCs. A, 
representative current-voltage traces of a BPN and a BPH native cells in TRP solution 
(C), in presence of Pyr10 (10 μM) and after washout of the blocker (R). B, bar plot 
showing averaged current amplitudes at -150 mV for BPN and BPH cells. Data are 
mean ± SEM, n=40-60 cells from 16-25 mice in each condition. *p<0.05. C, bar plot 
showing the average fraction of Pyr3- and Pyr10- sensitive current at -150 mV. Data 
are mean ± SEM, n=10-23 cells from 7-13 mice in each condition.**p<0.01; 
***p<0.001. 
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For these recordings, the composition of intra and extracellular solutions was 
designed to minimize or block any other currents (see Methods). Also, particular 
care was taken to study inly cells with high resistance seals and very good access, 
so that the contribution of other unspecific, leak conductances is negligible. With 
these assumptions, the larger TRP currents recorded in BPH cells could certainly 
contribute to the more depolarized Vm characteristic of that phenotype, and the 
Pyr effects suggested a smaller contribution of TRPC6 channels to the cationic 
currents in BPH cells, in clear agreement with the results obtained in the PLA 
experiments and with the smaller expression of TRPC6 mRNA in VSMCs from 
mesenteric arteries. Those experiments also suggested a higher contribution of 
TRPC3 channels in BPH cells. To confirm this last point, the effect of intracellularly 
applied anti-TRPC3 antibody on whole-cell currents was analyzed in native BPN and 
BPH cells. A ramp protocol from -150 mV to +80 mV was applied in cells where the 
antibody anti-TRPC3 (or an antibody control, anti-RFP) was included in the pipette 
solution. Ramps were applied every 10 s, and the time course of the current 
amplitudes at -150 mV and +80 mV was studied, being t=0 the beginning of the 
whole-cell recording (figure R12 A). In the presence of anti-TRPC3 antibody in the 
pipette, basal current amplitude of BPH cells decreased by 25% and by 39% after 5 
and 10 min of recording, respectively. No changes were observed when applying 
anti-RFP or no antibody. The effects of the anti-TRPC3 antibody were very small in 
BPN cells, being only significant in BPH cells (figure R12 B). 
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Figure R12. Effect of anti-TRPC3 antibody on TRPC3-mediated currents in BPN and BPH cells. A, 
representative traces of the current amplitudes at the indicated voltages in a BPH cell recorded with 
anti-RFP (left) or with anti-TRPC3 (right) antibodies in the pipette solution. Current-voltage ramp 
traces 1, 2 and 3 corresponding to 0, 5 and 5 min of recording are depicted. B, average current 
amplitudes represented as the fraction of the initial current with both, anti-TRPC3 or control 
antibodies, are shown for BPN and BPH cells. Each bar is mean ± SEM, n=7-14 cells in each group. For 
the control group, untreated cells and anti-RFP treated cells were pooled together. *p<0.05. 
These results strongly suggest that TRPC3 contribution to the cationic currents in 
native VSMCs is higher in BPH when compared to BPN mice. 
2.5.2. Characterization of Receptor activated TRPC currents.  
We have demonstrated so far differences in the contribution of TRPC3/6 channels 
to basal currents in BPN and BPH VSMCs. Next, we explored these differences 
when these currents were activated with different agonists, such as ATP (30 μM), 
UTP (50 μM), Phenylephrine (10 μM) or the DAG-analogue OAG (100 μM). These 
agonists were applied to activate ROCs, and the effect of Pyr3/10 (10 μM) was 
investigated to explore the contribution of TRPC6 channels to the currents (Figure 
R13). 
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Figure R13. Effect of Pyr blockers on agonist-activated currents in native VSMCs. A, summary data of 
30 μM-ATP-, 50 μM-UTP-, 100 μM-OAG- and 10 μM-PHE-activated currents alone or in the presence of 
10 μM-Pyr3/10 recorded with a ramps protocol from -150 mV to +80 mV. Each bar is the mean ± SEM, 
n=17-36 cells for agonist-induced currents and n=6-14 cells for Pyr3/10 blockade. **p<0.01 compared 
with UTP-activated currents in BPN cells. B, representative current amplitude traces recorded in the 
presence of 30 μM ATP alone or with 10 μM Pyr3 at the indicated voltages in a BPN (left) and a BPH 
(right) cell. Inset plots showing current-voltage traces in control (1) conditions, in the presence of ATP 
(2) or ATP+Pyr3 (3). C, bar plot showing the fraction of ATP-activated current that can be blocked by 
Pyr3 or Pyr10 in BPN and BPH cells. *p<0.05 compared to BPN. 
ROCs amplitude showed no significant differences between BPN and BPH cells for 
all the studied agonists, except for UTP, which elicited significantly smaller currents 
in BPH cells. However, a remarkable difference was obtained when comparing the 
blocking effect of Pyr compounds. Although Pyr3/10 almost fully abolished ROCs in 
BPN cells, a significant fraction of the activated currents was insensitive to these 
drugs in BPH cells. Figure R13 B shows representative traces obtained in BPN and 
BPH cells when ATP was used to elicit ROCs. 
Taken together, expression and functional studies performed so far strongly 
suggest a significant change in the contribution of TRPC3 and TRPC6 channels to 
the VSMCs electric phenotype in BPH mice. TRPC3/6 mediated currents are larger 
in BPH cells, and so is the ratio of TRPC3/TRPC6. This “shift” towards a more 
dominant role of TRPC3 channels could contribute in part to the increased vascular 
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tone present in the BPH phenotype. However, these differences between BPN and 
BPH cells do not explain all the differences observed when ROCs were studied, 
especially when UTP was used as agonist. 
Since electromechanical coupling is very relevant for controlling vascular tone 
(Herring and Paterson, 2018) and TRPC3/C6 are just one element in the activation 
cascade from the receptor to contraction, we decided to explore in detail the 
purinergic signaling cascade both in BPN and BPH mesenteric arteries in order to 
better contextualize the observed changes in TRPC3/6 channel. 
 
 
3. Differences in the purinergic signaling cascade between 
BPN and BPH VSMCs. 
 
3.1. Functional contribution of P2XR and P2YR receptors to vascular tone. 
Purinergic signaling is particularly relevant in the physiology of vascular smooth 
muscle cells, since it is involved in the sympathetic control of the vessel tone. NA 
and ATP co-released by sympathetic nerves mediates vasoconstriction in a biphasic 
way. First, there is a transient response mediated mainly by the P2X purinergic 
receptors which is followed by a sustained response mediated by the α1-
adrenoreceptors (von Kügelgen and Starke, 1968; Sneddon and Burnstock, 1985). 
However, the contribution of the purinergic and adrenergic components to the 
overall vasoconstrictor response to nerve stimulation is not homogeneous in the 
different vascular beds. In large arteries, the response is essentially adrenergic, 
while in smaller arteries the response is mediated predominantly through P2X 
receptors (Gitterman and Evans, 2001). In addition to these responses mediated by 
the neurogenic release of ATP, it is well known that other nucleotides, like UTP, 
mediate vasoconstrictor responses through the activation of P2Y receptors, and 
these receptors have been described to play a relevant role in the myogenic 
response of small vessels (Kauffenstein et al., 2016). 
To investigate the possible differences in the purinergic signaling pathways 
between BPN and BPH VSMCs, vascular responses to different agonists and 
blockers of those pathways were first explored by pressure myography. Mesenteric 
arteries (2nd or 3rd order) were pressurized to 70 mmHg and concentration-
response curves of ATP and UTP were obtained to discriminate between P2X- and 
P2Y-mediated responses, respectively. 
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Figure R14. Differences in the vasoconstrictor response to ATP and UTP in BPN and BPH mesenteric 
arteries. A, B, representative examples showing the ATP- and UTP-mediated effects on the vascular 
tone of BPN (A) and BPH (B) mesenteric arteries. The inset plots show the ATP- and UTP-mediated 
effects on 10 μM αβ-MeATP- activated arteries. 
 
Figure R14 shows typical experiments carried out in BPN (left) and BPH (right) 
arteries. In both cases, UTP and ATP were applied sequentially in several steps with 
increasing concentrations, from 1 to 50 µM. Whilst ATP responses were transient, 
and very similar in BPN and BPH cells (10 μM ATP: 18.3 ± 2.1 % vs. 16.7 ± 2.7 % of 
vasoconstriction, p=0.68, n=7-16 arteries from 8 BPN and 5 BPH mice, respectively), 
vasoconstrictor effects of UTP were sustained and significantly larger in BPH 
mesenteric arteries (Figures R15 and R16 A). At the end of each sequence, the 
higher concentration of the agonist was tested in the presence of αβ-MeATP (10 
μM), an agonist of P2X1 that elicits a fast and transient response due to receptor 
desensitization. These responses are shown in the lower part of the figure at a 
magnified time scale. Concentration-response curves obtained for ATP and UTP in 
several arteries were averaged, and data were plotted and fitted to a Hill function 
curve as follows: 
𝐸 = 𝐸𝑚𝑎𝑥 ∙
[𝑁𝑇𝑃]𝑛
𝐸50
𝑛 + [𝑁𝑇𝑃]𝑛
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Where, 𝐸𝑚𝑎𝑥 represents the maximum effect, [NTP] represents the concentration 
of the tested nucleotide triphosphate, 𝐸50 represents the concentration of the 
agonist that gives the 50% of the maximum effect and 𝑛 represents the Hill 
coefficient. The best fitting parameters are shown in the following table (Table R2): 
 
Figure R15. Dose-response vasoconstrictor effect of ATP (left) and UTP 
(right) in BPN (blue) and BPH (red) mesenteric arteries. Data were 
normalized to maximal diameter values obtained with Nif (10 μM) and are 
expressed as percentage of vasoconstriction (see Methods). Each point is 
mean ± SEM, n=5-16 arteries in each group. p<0.001 in UTP curves when 
applying ANOVA and Bonferroni test. 
 
 
 
BPN BPH 
Emax  
(%) 
𝐸50 
(µM) 
n R
2 
Emax 
(%) 
𝐸50 
(µM) 
n R
2
 
ATP 33.2±7.5
 
6.8±3.8 1.2±0.4 0.99 27.2±11.8 6.4±8.5 0.9±0.4 0.98 
UTP -
 ~115* - 0.84 40.2±8.6 2.9±1.8 1±0.4 0.99 
Table R2. Main kinetics parameters obtained after fitting ATP and UTP dose-response curves to a Hill 
function. *Since proper fitting to the Hill function was not possible in BPN cells, the apparent 𝐸50 was 
stimated carrying out a fitting procedure assuming Emax and n values identical to those obtained in 
BPH. 
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In the presence of αβ-MeATP, a maximal dose of ATP did not elicit any response, 
suggesting that ATP vasoconstriction is essentially mediated by P2X1 purinergic 
receptors. Moreover, whilst the effects of ATP are very similar in BPN and BPH 
arteries, BPN cells are almost insensitive to UTP stimulation (as the concentration-
response curve in these arteries is shifted to the right almost two orders of 
magnitude). This larger response to UTP in BPH mice was clearly not anticipated 
from the results obtained when the effect of UTP on TRPC currents was studied 
(Figure R13). 
Since the constrictor responses to UTP are in all likelihood mediated by the P2Y1-7 
family of purinergic receptors, the striking difference in the response between BPN 
and BPH arteries suggests a more relevant contribution of P2Y purinergic receptors 
to the vascular tone in BPH mice. To determine the members of the P2Y family of 
purinergic receptors involved, we tested the effects of the agonists and blockers 
described in Table R3: 
 
 
Average results are shown in figure R16. The vasoconstrictor effects of UTP (mainly 
through P2Y2/P2Y4) and UDP (mainly through P2Y6) were much larger in BPH than 
in BPN arteries. However, due to the fast break down of UTP to UDP, the UTP-
mediated effects obtained could represent, at least in part, UDP-mediated effects. 
Therefore, the more stable synthetic UTP-analog UTPγS and the specific P2Y6 
synthetic agonist PSB0474 were tested at 10 μM. Both elicited larger 
vasoconstrictions in BPH. In addition, the effect of the specific P2Y6 blocker MRS 
2578 (10 μM) was tested on the responses induced by UDP or PSB0474, and in both 
 P2X1 P2Y1 P2Y2 P2Y4 P2Y6 
ATP   =UTP =UTP  
UTP   =ATP =ATP  
UDP     >UTP 
αβ-MeATP      
MRS 2578      
PSB0474      
UTPγS      
Table R3. Specific physiological (top) and synthetic (bottom) agonists 
(green) and blockers (red) previously described in the literature used to 
explore purinergic receptors involved in UTP-mediated signaling 
cascade in BPN and BPH arteries (from Lewis and Evans, 2000; Malmsjö 
et al., 2000; Sugihara et al., 2011). 
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cases a partial blockade was obtained. Taken together, these data suggest that 
UTP-elicited vasoconstrictor effects are mainly mediated by P2Y6 receptors, with a 
smaller contribution of P2Y2 and/or P2Y4 receptors. 
 
Figure R16. Involvement of P2Y6 purinergic receptors in UTP-mediated responses in 
BPH. A, bar plot showing differences in the vasoconstriction responses mediated by the 
indicated P2Y agonists (10 μM) in BPH and BPN mesenteric arteries. Each bar is mean ± 
SEM, n=2-16 arteries in each group. **p<0.01; ***p<0.001, compared to BPN. B, bar 
plot showing blocking effect of MRS 2578 (10 μM) on BPH arteries precontracted with 
UDP and PSB (10 μM). Each bar is mean ± SEM, n=2 arteries. 
 
To further investigate the different contribution of the purinergic receptors to the 
hypertensive phenotype, their mRNA expression pattern was explored by qPCR 
(Figure R17). qPCR data showed mRNA expression of P2X1 and P2X4 and P2Y1, P2Y2, 
P2Y4 and P2Y6 purinergic receptors. Even though P2X mRNA levels were much 
larger than P2Y (note the different scale for each family), mRNA expression was 
identical in BPN and BPH arteries when comparing the mRNA expression pattern. 
However, significantly higher expressions of P2Y2 and P2Y6 and lower expression of 
P2Y1 receptors were observed in BPH VSMCs. These data agreed with the 
hypothesis of a higher expression of P2Y receptors contributing to the larger UTP-
mediated effects in the BPH phenotype. 
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Figure R17. mRNA expression profile  of P2X and P2Y purinergic receptors in BPN 
and BPH mesenteric arteries. Left, relative abundance of purinergic receptors in BPN 
mesenteric arteries normalized to the amount of RP18S. Data are expressed as 
2−∆𝐶𝑡, where ∆𝐶𝑡 = 𝐶𝑡𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟 − 𝐶𝑡18𝑆. Right, changes in P2X and P2Y receptors 
expression in BPH compared to BPN. Differences are expressed as 𝑙𝑜𝑔 (2−∆∆𝐶𝑡), 
where  ∆∆𝐶𝑡 = ∆𝐶𝑡𝐵𝑃𝐻 − ∆𝐶𝑡𝐵𝑃𝑁, meaning that positive, negative and 0 values 
indicate increased, decreased and no change mRNA expression, respectively. Each 
bar is the mean ± SEM, n=4 mice in each group. *P<0.05; ***P<0.001. 
Nevertheless, the good correlation of changes in P2Y receptor expression and UTP 
responses between BPN and BPH cell is clearly at odds with the effect of UTP on 
TRP currents. Therefore, we decided to explore the UTP signaling pathway in more 
detail, to better understand the differences between BPN and BPH phenotypes and 
in order to clarify the role of TRP in this signaling pathway. 
3.2. Characterization of the P2Y signaling pathway in the BPH phenotype. 
P2Y receptors are members of the GPCR receptors superfamily, coupled to PLC 
activation through Gq proteins. DAG and IP3 produced by the PLC-mediated PIP2 
breakdown induces TRPC3/6 activation and Ca2+ release from intracellular stores, 
respectively, leading altogether to an intracellular [Ca2+] increase. This increased 
[Ca2+]i triggers activation of Ca
2+-activated Cl- channels (CaCCs) and membrane 
depolarization (Figure I4). While the described differences in P2Y2/6 expression are 
consistent with the greater contractile response to UTP in BPH arteries, our 
electrophysiological studies showing a larger activation of TRPC currents in BPN do 
not fit in this scheme. There are two questions that we need to answer to solve this 
apparent paradox, and we explored two other levels of the signaling pathway to try 
to answer them. 
Q1. Why do we see less UTP-mediated TRPC currents in BPH cells if we have 
more receptors and more channels? 
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We explored the coupling between P2Y6 receptors and TRPC3/6 channels. 
Differences in their location and association could shed light on question 1, as 
we could have a less efficient signaling in spite of having more proteins. These 
data are shown in section 3.2.1. 
Q2. How can we have a larger contractile response to UTP while activating 
smaller TRPC currents? 
 
We studied the expression and contribution of other channels, (CaCCs 
channels) to UTP-mediated responses. A different contribution of both 
channels (TRPC and CaCCs) in BPN and BPH cells to UTP responses could 
explain the changes in contraction. We explore this hypothesis on section 3.2.2. 
3.2.1. P2Y6 and TRPC3/6 coupling. 
We speculate that the smaller efficacy of UTP activating TRP currents, despite 
having more receptors and more channels in BPH cells, could be due to differences 
in the physical association (v.g. in membrane microdomains) between P2Y 
receptors and TRPC channels. To explore this hypothesis, Ground State Depletion 
(GSD) Super-resolution and PLA studies were performed in BPN and BPH VSMCs. 
A B 
  
Figure R18. Spatial organization of TRPC3 channels and P2Y6 receptors in BPN and BPH VSMC cells. A, 
representative TIRF (top) and GSD (bottom) super-resolution microscopy images showing the spatial 
organization of TRPC3 and P2Y6 in a BPH cell. The magnification of the areas shown in yellow boxes is 
also depicted. B, histograms showing the areas of TRPC3 and P2Y6 clusters in BPN and BPH cells. 
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GSD Super-resolution data (Figure R18) revealed that TRPC3 channels and P2Y6 
receptors were broadly distributed in clusters with a large variety of sizes both in 
BPN (TRPC3, 2036.67 ± 23.60 nm; P2Y6, 1788.29 ± 22.11 nm) and BPH (TRPC3, 
1717.31 ± 9.39 nm; P2Y6, 1632.61 ± 12.38 nm) VSMC cells. Sites of close proximity 
between TRPC3 channels and P2Y6 receptors could be observed (Figure R19) and 
were analyzed by fitting the lowest intermolecular distance between both proteins 
to a Gaussian function of two components with centers at ~53.9 and ~109.2 nm in 
BPN, and ~44.8 and ~81.3 nm in BPH. There is a small population of TRPC3 
channels and P2Y6 receptors that seem to be further apart in BPN cells.  The closer 
proximity between TRPC3 channels and P2Y6 receptors observed in BPH is 
compatible with an enhanced coupling between both signaling pathways.   
Nevertheless, since the lowest distances are not very different, and most of them 
seemed to be close enough to be detected by PLA, an additional test of protein 
association was performed using PLA assay by labelling TRPC3/6 channels and P2Y6 
receptors in BPN and BPH cells (Figure R20). 
A 
 
B 
 
Figure R19. Expanded merged GSD images showing sites of close interaction between TRPC3 and P2Y6. 
A, images of the associated object-based colocalization (bottom) between TRPC3 (red centroids) and 
P2Y6 (green regions). Colocalization centroids (blue) are also depicted. B, plot showing the lowest 
intermolecular distances between TRPC3 and P2Y6 centroids in BPN (n=3713 particles from 3 cells) and 
BPH (n=8299 from 8 cells). Data were fit to a Gauss function of two components. 
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PLA data revealed close proximities between P2Y6 receptors and TRPC3 or TRPC6 
channels in BPN and BPH cells. The C3-Y6 condition showed higher punctae than 
the C6-Y6 condition in both preparations. In addition, there are significantly higher 
punctae for C3-Y6 condition in BPN. Since the PLA technique is more sensitive than 
the GSD super-resolution to disclose distances below 40 nm, these results are 
compatible with a higher coupling between P2Y receptors and TRPC3/C6 channels 
in BPN cells, despite the smaller expression of those proteins, and could explain in 
part the larger activation of TRP currents by UTP recorded in BPN cells. 
A B 
  
Figure R20. Differences in the association pattern between TRPC3/6 channels and P2Y6 receptors in 
VSMCs. Representative confocal images (A) of the summarized (B) C3-Y6 and C6-Y6 associations 
obtained in BPN and BPH cells. Each bar is mean ± SEM, n=40-60 cells in each group. ***p<0.001, 
compared to BPN. ###p<0.001, compared to C3-Y6. 
 
However, the fact that UTP elicited very small depolarizations and smaller 
vasoconstrictions in BPN compared to BPH, despite the larger activation of TRP 
currents, suggests additional components in the UTP-activated P2Y6 signaling 
pathway responsible for the larger depolarization and the bigger response to UTP 
in BPH arteries. One of such components could be the CaCCs. 
3.2.2. Ca2+-activated Cl- channels involvement in the UTP-activated P2Y6 
signaling pathway. 
Several members of the membrane CaCCs channels have been found in VSMCs (see 
Introduction for references). To evaluate their contribution to the UTP response, 
we measured the UTP activated currents in two different recording conditions 
(Figure R21). One of them was designed to maximize the TRP component, blocking 
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CaCCs with Niflumic acid (100 µM), DIDS (100 µM) and 10 mM EGTA. These 
currents are labelled in the figure R21 as ITRP. The other was designed to record any 
current activated by the agonist, adding no blockers and keeping the intracellular 
calcium buffered at ~500 nM. These currents likely represent the activation of both 
TRP and CaCCs channels and are labelled in the figure R21 as ITRP/CaCC. Examples of 
typical experiments of each condition are shown in Figure R21A. Results 
demonstrate that although ITRP currents are smaller in BPH, as previously shown 
(Figure R13), ITRP/CaCC are significantly larger in BPH cells, strongly suggesting that 
differences in CaCC channels between BPN and BPH could contribute to explaining 
the differences in the UTP response. 
 
Figure R21. Differences in the UTP effects on whole-cell currents in BPN and BPH VSMCs. A, 
representative traces of UTP-elicited effects on the peak current recorded at -150 mV and +80 mV in 
each condition in BPH cells. B, summary of the UTP-sensitive current recorded at -150 mV in BPN and 
BPH cells. Each bar is mean ± SEM, n=96 and n=73 cells from BPN and BPH, respectively. **p<0.01. 
 
In this context, we explored the mRNA expression pattern of several members of 
the known families of CaCCs channels in mesenteric arteries from BPN and BPH 
mice. We explored also the expression of some proteins that contribute to the [Cl-]i 
control, such as the Na+, K+, Cl- cotransporter NKCC1 and the voltage-activated Cl
- 
channel ClCN3 (Figure R22). qPCR data showed higher mRNA expression of ClCa1 
and ANO1 channels in BPH compared to BPN mesenteric arteries, while no changes 
of ClCa2, ClCN3 and the NKCC1 cotransporter were observed. These data are in good 
agreement with the larger activation of CaCC currents in BPH cells and point out to 
ANO1 as a good molecular correlate of that difference between BPN and BPH cells. 
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Figure R22. Differences in the mRNA expression profile of several Ca
2+
-activated Cl
-
 channels and Na
+
, 
K
+
, Cl
-
 cotransporters in BPN and BPH mesenteric VSMCs. Left, relative abundance of the indicated 
channels and cotransporters in BPN VSMCs from mesenteric arteries normalized to the amount of 
RP18S. Data are expressed as 2−∆𝐶𝑡, where ∆𝐶𝑡 = 𝐶𝑡𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟 − 𝐶𝑡18𝑆 . Right, changes in mRNA 
expression in BPH compared to BPN. Differences are expressed as 𝑙𝑜𝑔 (2−∆∆𝐶𝑡), where  ∆∆𝐶𝑡 =
∆𝐶𝑡𝐵𝑃𝐻 − ∆𝐶𝑡𝐵𝑃𝑁, meaning that positive, negative and 0 values indicate increased, decreased and 
no change mRNA expression, respectively. Each bar is the mean ± SEM, n=4 mice in each group. 
**P<0.01; ***P<0.001. 
 
These data suggest that an increased contribution of CaCCs activation in BPH cells 
could explain the enhanced UTP-induced contraction in the hypertensive arteries. If 
this were the case, we would expect to see differences between BPN and BPH cells 
in the depolarization induced by UTP and in the sensitivity of that response to the 
effect of TRP or CaCC blockers. To test this hypothesis, we measured the effect of 
UTP and different blockers on membrane potential with the perforated-patch 
configuration of the current-clamp technique. Average results are shown in Figure 
R23 A, whilst Figure R23 B shows two typical records obtained in a BPN and a BPH 
cell. The effect of high extracellular K+ (60 mM) was used to determine cell 
integrity. Under these conditions the reversal potential for K+ will be around -20 mV 
(for an estimated [K+]i of 130 mM). We can see that there are other cationic 
conductances that contribute to set resting Vm in VSMCs since the values recorded 
were always more positive than the calculated EK.  Although the two cells in the 
example seem to be different, there were not statistical differences between BPN 
and BPH cells in the Vm value reached with 60 mM K+ stimulation (-11,14 ± 0,75 mV 
in BPH vs -10,93 ± 1,4 in BPN, p=0,9, n= 21-40 cells).  
UTP produced a significantly larger depolarization in BPH cells, in line with the 
differences in the response to UTP between BPN and BPH arteries. In fact, the 
depolarization obtained in BPN cells was almost undetectable in many cells. Also, 
as expected for channels that are open at resting membrane potential, the 
blockade of TRPs and CaCCs produced a significant hyperpolarization both in BPN 
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and BPH cells. The hyperpolarization induced by Pyr3 was significantly larger in BPH 
cells, in agreement with a larger expression of TRP channels in those cells. The 
effect of Niflumic Acid was not different, but the effect of the specific inhibitor of 
ANO1, also called T16Ainh, was significantly larger in BPH, in good agreement with 
the expression data. 
A B 
 
 
Figure R23. Differences on the effects of UTP and the blockers of TRPC3/6 and CaCCs 
channels on resting membrane potential in BPN and BPH cells. A, bar plot showing the 
UTP (50 μM)-induced depolarizations and Pyr3 (10 μM)-, Niflumic (100 μM)- and ANO1 
inhibitor (10 μM)-induced hyperpolarizations in BPH compared to BPN cells. Each bar is 
the mean ± SEM, n=5-54 cells in each group. *P<0.05; ***P<0.001. B, Representative 
traces of the effect of UTP and Niflumic on Vm in a BPN and a BPH cell from A. 
Depolarizations induced by KCl (60 mM) as a control of cell stability are also depicted. 
 
If we compare the effect of TRP or CaCC blockade on membrane potential, there 
are no apparent differences, suggesting that both channel families are contributing 
to set the membrane potential. In fact, the larger effects of Pyr3 in BPH cells 
suggest that TRP could contribute to the characteristic depolarized basal state of 
BPH VSMCs. However, when the effect of TRP or CaCC blockers are tested on UTP-
induced depolarization in BPH cells, the different contribution of those channels to 
the response is striking (Figure R24). All inhibitors affected the depolarization 
induced by UTP, suggesting that all channels contribute to that response, but the 
magnitude of the effect was very different. Pyr3 showed a very small effect, whilst 
Niflumic Acid and/or the specific blocker of ANO1 completely abolished (or even 
reverted) the effect of UTP. These results pointed clearly to CaCCs as important 
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players in the response to UTP and suggested that the differences in the expression 
of these channels are at the core of the differences in the purinergic pathway 
between BPN and BPH mice. 
 
Figure R24. Differences in the contribution of TRPC3/6 and CACCs channels to the UTP-induced 
depolarization in BPN and BPH cells. A, representative traces of the blocking effects elicited by Pyr3 
(10 μM), Niflumic Acid (100 μM) and ANO1 inhibitor (10 μM) on UTP-induced depolarizations. As a 
control of the cell stability KCl (60 mM)-induced depolarizations are also depicted. B, bar plots 
showing the summarized blocking effects expressed as absolute values (top) and percentage 
(bottom) on UTP-induced depolarizations in BPN and BPH cells. Each bar is the mean ± SEM, n=5-10 
cells in each group. 
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In the present study, using the BPN/BPH model of essential hypertension, we have 
explored the contribution of TRPC channels to the hypertensive phenotype. 
Furthermore, since TRPC channels are prototypic examples of Receptor Operated 
Channels (ROCs), we have investigated the differences between normal and 
hypertensive mice in the vascular responses to the α-adrenergic and the purinergic 
signaling pathways, the two GPCR pathways mainly associated with the 
sympathetic stimulation of resistance arteries. Using different approaches, we have 
explored differences in the expression profile of members of the purinergic P2X 
and P2Y families of receptors and we have functionally characterized their relative 
contribution to the hypertensive phenotype. Focusing on the UTP-mediated 
activation of purinergic signaling pathway, we have also explored downstream 
members, such as TRPC and CaCCs channels that, by their direct or second 
messenger-mediated coupling to purinergic signaling, could be enhancing the 
integrated response of vasculature. Thus, although we have separately explored 
the different contribution of these families of receptors and ion channels to the 
BPH vs BPN phenotype, the obtained results must be interpreted in the context of 
the integrated responses of arterial vessels to understand the complexity of the 
hypertensive phenotypic change. 
 
1. TRPC Channels in the BPN/BPH model 
TRPCs channels have been widely described as ROCs that contribute to modulate 
the membrane potential and the contractility of vasculature (Earley and Brayden, 
2015). In this Thesis we have explored the mRNA expression profile of TRPC 
channels in several vascular beds of BPN and BPH mice. All channels, but TRPC5 
and TRPC7, are expressed in VSMCs from both mice strains. Overall, mRNA 
expression is more than 20 times larger in resistance (mesenteric) than in conduit 
(femoral and aorta) arteries, and whilst TRPC1 is the more highly expressed 
channel in conduit arteries, TRPC1/3/4/6 mRNAs are more abundant in the 
mesenteric bed. When the expression levels are compared between BPN and BPH 
mesenteric VSMCs, it is evident that TRPC3 are the only channels that are 
overexpressed in the hypertensive cells (Figure R3). On the contrary, TRPC1 and 
TRPC6 are downregulated (although only data for TRPC1 is statistically significant). 
TRPC1 channels are mainly involved as SOCs (Nesin and Tsiokas, 2014; Ambudkar, 
de Souza and Ong, 2017), so we decided to focus on TRPC3 and TRPC6 channels as 
the main candidates to carry out ROCs in mesenteric VSMCs. Since these channels 
have been described to form functional multimeric channels in several tissues 
(Hofmann et al., 2002; Earley and Brayden, 2015), we also hypothesized that in 
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addition to their different expression levels, changes in the composition of homo- 
or heterotetramers of these two channels could contribute to the genesis of the 
hypertensive phenotype. In any case, these differences should determine different, 
and experimentally discernible, biophysical, pharmacological and functional 
properties of TRPC channels in BPN and BPH VSMCs. 
Pyr-compounds are the only available blockers described in the literature as 
putative blockers of TRPC3 channels (Kiyonaka et al., 2009; Schleifer et al., 2012). 
We tested the effect of three of these compounds (Pyr10, Pyr3 and Pyr6) on the 
vascular tone induced in mesenteric arteries by the stimulation with the α1 agonist 
Phenylephrine (Figure R4). Pyr10 and Pyr3 exhibited a powerful vasodilatory effect 
both in BPN and BPH arteries. Nevertheless, the effect is clearly different at 
concentrations below 10 µM, where vasodilation is larger in BPN than in BPH 
arteries. 
However, since the specificity for TRPC channel blockers has not been thoroughly 
tested in the literature, we have tried out several methodological approaches to 
investigate the functional contribution of TRPC channels in a heterologous 
expression system (CHO cells) overexpressing TRPC3, TRPC6 or both. In this way we 
have determined that pyrazole compounds (Pyr3 and Pyr10) are effective blockers 
of TRPC mediated currents when CHO cells are transfected with TRPC6 channels, 
either alone or with TRPC3 (Figure R5). As TRPC3 and TRPC6 associate forming 
heteromultimers (Figure R7), the simplest interpretation of the effect of pyrazole 
compounds is to assume that the presence of TRPC6 subunits in the channel 
tetramer is a requirement for the inhibitory effect of these compounds. If this 
interpretation is correct, pyrazole compounds are effective blockers of TRPC6 
channels, and could be used in native cells to estimate the contribution of these 
channels to the effects mediated by TRPC channels. This interpretation is also 
consistent with the smaller vasodilatory effect of these compounds in BPH arteries, 
where, according to mRNA data, we have increased TRPC3 and decreased TRPC6 
expression. 
These results clearly contradict the previously reported selective blocking effect on 
TRPC3 channels of Pyr10 and Pyr3. Although these reported effects on native 
TRPC3 channels (Kiyonaka et al., 2009; Schleifer et al., 2012) are compatible with 
the presence of TRPC3/6 heterotetramers in those preparations, we do not have a 
clear explanation for the discrepancy. Nevertheless, several differences in the 
experimental methodology can be highlighted. We have characterized the effects 
of Pyr on TRPC3, TRPC6 or TRPC3/6 overexpressed in CHO cells by exploring both 
basal and stretch-activated whole-cell currents with the patch-clamp technique, 
while previous reports have used TRPC3-transfected HEK293 (and/or HEK293T) 
cells and have estimated channel activity indirectly from changes in [Ca2+]i upon 
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stimulation of endogenous muscarinic receptors with carbachol (Schleifer et al., 
2012). Noteworthy, it has been described that HEK cells endogenously express 
TRPC3 and TRPC6 channels (Bugaj et al., 2005). In addition, we have analyzed the 
acute effects of Pyr compounds when applied in the external solutions both in 
basal conditions and in the presence of the stimulus, while previous reports 
explored the Pyr-elicited effects, mainly Pyr3, upon chronic pre-treatment before 
stimulation. Thus, it is quite possible that differences associated to the endogenous 
expression of TRPC3 and TRPC6 channels in different cell lines and/or differences 
associated to the response of the blockers related to the specific activation 
pathway could explain the observed discrepancies. 
Since Pyr compounds turned out to be experimental tools to check the functional 
contribution of TRPC6 channels, we explored the possibility of using antibodies 
against TRPC3 channels to study the functional contribution of those channels. 
Although the only available antibodies recognize intracellular epitopes of the 
channel and their use must be limited to patch-clamp experiments where the 
intracellular medium is accessible, this experimental approach has proven to be 
instrumental to block TRPC3 mediated currents when these channels were 
overexpressed in CHO cells (Figure R8). 
Non-selective cationic currents recorded in VSMCs isolated from BPN or BPH 
mesenteric arteries are significantly different in magnitude and in their sensitivity 
to Pyr compounds and anti-TRPC3 antibodies. The larger currents recorded in BPH 
cells in the absence of receptor activation (basal activity, Figure R11B), the smaller 
sensitivity to Pyr compounds (Figurer R11C) and the larger effect of anti-TRPC3 
antibodies (Figure R12B) strongly correlate with the larger expression of TRPC3 in 
BPH VSMCs. Certainly, these differences can contribute to explain the more 
depolarized resting Vm of VSMCs cells from BPH, the increased vascular reactivity 
observed in BPH mesenteric arteries (Moreno-Domínguez et al., 2009) and the 
larger effect of Pyr compounds observed in mesenteric arteries form BPN mice. 
The results obtained with this electrophysiological approach in native cells are 
supported by data obtained with the Proximity Ligation Assay (PLA) technique. PLA 
data demonstrate a larger proportion of TRPC3-containing channels (and the 
consequent smaller proportion of TRPC6 subunits) in BPH cells (Figure R10). These 
findings are consistent with a larger number of TRPC3 homotetramers and/or 
heteromultimeric TRCP3/6 complexes in VSMCs from BPH mice. Early evidences 
previously reported that TRPC heteromultimerization, such as the case of TRPC6/7, 
showed distinct functional properties than the homomultimeric association 
(Hofmann et al., 2002; Maruyama et al., 2006). Thus, a better understanding of the 
mechanisms by which TRPC subunits combine to form functional ion channels 
complexes is essential to evaluate their contribution to endogenous cation 
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currents. In many cases, the use of KO animal models helps to understand the role 
of a particular channel, but this is not the case of TRPC3 or TRPC6 channels. Several 
studies using single, double TRPC3/6 and up to quadruple KO of TRPCs channels 
concluded that TRPC functions are a result of the combined activity of multiple 
TRPC proteins and that the interfering with one single TRPC channel does not imply 
an alteration in the functional responses, thus indicating possible redundancies in 
the function of TRPC channels (Sexton et al., 2016). However, in good agreement 
with the results obtained in this Thesis, a study using TRPC6 KO mice showed 
changes in the vascular phenotype consisting of increased vascular reactivity and 
blood pressure, which was a result of a compensatory upregulation of TRPC3 
channels. From these data, we could conclude that TRPC3 and TRPC6 channels are 
not freely interchangeable and that they have distinct and non-redundant roles in 
the vasculature (Dietrich et al., 2005). 
 
2. GPCR signaling Pathways in the BPN/BPH model: The 
sympathetic drive 
Noradrenaline (NA) and ATP are co-released by sympathetic neurons in the vicinity 
of VSMCs contributing to the physiological setting of vascular tone. NA induces 
contraction by activating α1 receptors whilst ATP activates a complex set of 
purinergic receptors (ionotropic and metabotropic). Pressure myography data 
show differences in agonists-induced vascular responses between BPN and BPH 
mice when the α1 agonist PHE is used (Figure R2), but not when the agonist is ATP 
(Figure R15, left panel). These results are compatible with the reported 
sympathetic hyper sensitivity of BPH mice (Davern et al., 2009, 2010) and point to 
the α1 receptor signaling pathway as the more probable culprit of the differences. 
We have tested the functional impact of TRPC currents on these responses 
investigating ROCs elicited by PHE, ATP and OAG in BPN and BPH VSMCs (Figure 
R13). ROCs are not significantly different in magnitude although the sensitivity to 
Pyr compounds strongly suggests that the TRPC channels mediating the response 
are mainly TRPC3 in BPH and TRPC6 in BPN, as expected from the expression data. 
Nevertheless, the different role of TRPC3 and TRPC6 channels contributing to Vm 
depolarization when PHE (or NA) are the agonists has not been characterized in 
detail and needs to be further explored. 
ATP-induced ROCs are much bigger than ROCs elicited by PHE or OAG (Figure R13). 
This difference can be easily explained if we consider that ATP is activating also P2X 
ionotropic receptors. In fact, when the effect of ATP is characterized using 
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myography, almost 100% of the contractile response can be attributed to the P2X 
receptors, since ATP does not elicit a contractile response when P2X receptors have 
been desensitized with αβ-MeATP (Figure R14). These results are in good 
agreement with the large expression of P2X receptors, compared with P2Y (see 
below), but are difficult to reconcile with the large effect of Pyr compounds on ATP 
induced currents, both in BPN and BPH cells (Figure R13C). Although the simplest 
explanation for these results is to assume some unspecific effect of Pyr compounds 
on P2X currents, we have not fully characterized the biophysical properties of ATP 
currents to thoroughly test this possibility. 
 
3. GPCR signaling Pathways in the BPN/BPH model: The UTP 
divergence 
The more striking result that we obtained comparing ROCs currents in BPN and BPH 
VSMCs was the effect of UTP (Figure R13A), since non-specific cationic currents 
elicited by this agonist are twice as big in BPN mice. Surprisingly, larger currents do 
not correlate with bigger responses in terms of vessel contraction, and in fact, BPN 
mesenteric arteries are almost insensitive to UTP stimulation, with apparent EC50 
over 100 µM (Figure R14 and R15), whilst BPH arteries respond to much lower UTP 
concentrations (EC50~3µM). Nevertheless, in agreement with the results obtained 
with other agonists, the effect of Pyr10 suggests that these UTP activated currents 
are mainly mediated by TRPC6 channels in BPN and by TRPC3 channels in BPH 
mice. Physiologically, UTP is released from platelets and endothelial damaged cells, 
and these remarkable differences in the response of mesenteric arteries can be 
relevant defining the vascular phenotype of the hypertensive animals. 
Several studies in the literature demonstrate some discrepancies in the 
contribution of TRPC3 channels to the UTP-activated responses. UTP-induced 
depolarizations and contraction were found to be mediated by TRPC3 channels in 
cerebral arteries of adult rats (Reading et al., 2005), as well as in rat 
cardiomyocytes where TRPC3/7 channels were found to be involved in ATP/UTP-
mediated responses (Alvarez et al., 2008). In contrast, dual signaling pathways 
through P2X1-like receptors, and in a less degree through P2Y receptors, but not via 
TRPC3 channels, appear to be the main molecular mechanisms by which 
extracellular UTP constricted rat aorta, mesenteric and cerebral arteries (Sugihara 
et al., 2011). In this latter study, UTP-elicited inward currents could not be blocked 
by Pyr3 nor intracellularly applied anti-TRPC3 antibodies, although it could be due 
to the weak TRPC3 expression they found in rat vasculature.  
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None of these reported differences in the contribution of TRPC channels to the UTP 
signaling pathway in different species and vascular beds give us any clue to explain 
our discrepant results in the BPN/BPH model of essential hypertension. 
Nevertheless, we have explored several hypotheses to explain the lack of 
correlation between the size of the non-specific cationic currents elicited by UTP 
and the obtained amount of vessel contraction: (1) A different functional 
expression of purinergic receptors, (2) a different interaction of UTP receptors and 
TRPC channels and (3) a significant role of other channels different from TRPC 
modulating membrane potential. 
3.1. Expression of purinergic receptors in the BPN/BPH model. 
In agreement with data available in the literature regarding other mouse strains, 
mRNA expression studies performed in mesenteric arteries from BPN mice showed 
the presence of P2X1, P2X4, P2Y1, P2Y2, P2Y4 and P2Y6 purinergic receptors (Figure 
17R). P2X mRNA levels are over ~200 times bigger than P2Y mRNA, and P2X1 and 
P2Y6 are the mRNAs more abundant in each family. Interestingly, whilst there are 
no differences in the expression levels of P2X receptors between BPN and BPH 
arteries, there is an increased expression of P2Y2 and P2Y6 and a decreased 
expression of P2Y1 purinergic receptors in the BPH mice (Figure R17).  
The functional contribution of P2Y receptors to the contractile response elicited by 
UTP was explored in BPH mesenteric arteries with pressure myography using 
several selective agonists and blockers of different purinergic receptors. UTP (a 
non-selective agonist of P2Y receptors) at 10 µM elicited a response close to 
maximal in BPH arteries (~30%, Figure R15 and R16). UDP and UTPS, at the same 
concentration as UTP, elicited responses that represented a ~70% and ~28% of the 
UTP response, respectively. If we take into account that UDP is a selective agonist 
of P2Y6 and UTPS of P2Y2/4 receptors, it seems reasonable to assume that those 
percentages could approximately reflect the contribution of those receptors to the 
overall P2Y response. However, the response obtained with 10 µM PSB0474 
represents only a ~50% of the UTP response, although at that concentration 
PSB0474 is supposed to be highly selective to P2Y6. Additionally, partial blockade of 
UDP and PSB0474 mediated responses were obtained using the specific blocker of 
P2Y6 receptors MRS2578 (Figure R16B). Taking together, these data suggested a 
strong contribution of P2Y6 purinergic receptors to the UTP and UDP mediated 
vasoconstrictor responses in BPH mice and point to the differences in the 
expression of this receptor as a partial explanation of the differences observed 
between BPN and BPH regarding the UTP responses. Nevertheless, part of the 
response to UTP is also mediated by P2Y2/4. Certainly, the proper quantitative 
characterization of the relative contribution of each P2Y receptor would have 
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required a more detailed characterization of the concentration-response curves 
and the relative efficacies of each agonist. 
All data commented above demonstrate that P2Y receptors are functionally 
relevant in BPH, and almost irrelevant in BPN arteries (Figures R15 and R16), 
although UTP is clearly more effective activating ROCs through TRPC channels in 
BPN mice (Figure R13). These results clearly pose two interesting questions. First, 
how more P2Y receptors in BPH cells elicited less activation of TRPC currents. And 
second, how UTP can induce bigger contractile responses activating less TRPC 
currents.  To answer the first question we explored the possibility of a different 
coupling between P2Y6 receptors and TRPC channels due to a different spatial 
distribution. To answer the second, we investigated if, in addition to TRPC 
channels, there were other channels recruited by P2Y6 activation that could be 
contributing to UTP effects on membrane potential and vascular tone, specially in 
BPH cells. 
3.2 Membrane location of UTP receptors and TRPC channels. 
One possible explanation of the lack of correlation between the amount of P2Y 
receptors and TRPC currents could be a weaker coupling between receptors and 
channels due to different membrane localization (more distant) of the proteins. 
GSD Super-resolution imaging has revealed that both, TRPC3 and P2Y6 receptors 
are expressed in BPN and BPH cells forming clusters of similar sizes (Figure R18). 
The distribution of minimal intermolecular distances between receptors and 
channels seems to be very similar in BPN and BPH mice (40-50 nm), although there 
is a small fraction of P2Y6- and TRPC3-containing clusters which were more distant 
in BPN (~100 nm) than in BPH (~80 nm) VSMCs cells (Figure R19). The proximity of 
the receptor and channel clusters is confirmed by PLA studies, although this 
technique demonstrate a higher punctae distribution for both P2Y6/TRPC3 and 
P2Y6/TRPC6 associations in BPN compared to BPH cells (Figure R20), even when 
pre-incubating samples with UTP to activate purinergic signaling pathway (data not 
shown). The PLA technique gives positive results when proteins are closer than 40 
nm, a figure very close to the limit of GSD resolution. Therefore, the results 
obtained with both techniques seemed to point to a closer location of P2Y6 and 
TRPC3/6 proteins in BPN cells. We can speculate that proximity correlates with 
coupling, since DAG diffusion could be more efficient for activating TRPC channels if 
receptors are closer to channels, although further studies are required to confirm if 
the differences observed between BPN and BPH are functionally relevant. 
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 3.3 Contribution of CaCCs channels to the UTP signaling pathway in the BPH 
phenotype 
Although TRPC channels are activated by agonist and are responsible for a 
significant amount of the ROCs, it is well known that in vascular smooth muscle the 
activation of GPCR coupled to Gq proteins increases [Ca2+]i, and then many calcium 
dependent proteins, such as Ca2+ activated chloride channels (CaCCs). Since the 
ionic composition of the recording solutions used in the experiments discussed 
above were designed to block CaCCs, we performed another batch of experiments 
studying UTP activated currents in the absence of blockers of chloride channels and 
with high Ca2+ in the pipette, to facilitate the activation of CaCCs. With these 
recording conditions, UTP activated currents should be the sum of the activation of 
both, TRPC channels and CaCCs, and the comparison with currents recorded 
without CaCCs theoretically would allow us to define the role of CaCCs. These 
experiments are shown in Figure R21, and the results turned out to be not as easy 
to interpret as initially supposed: 
 UTP activated currents recorded in BPN VSMCs when TRPC and CaCCs 
are available (ITRP/CaCC) are not significantly different from those 
recorded when CaCCs are blocked (ITRP). Contrary to that, in BPH 
VSMCs, ITRP/CaCC are almost twice as big as ITRP. 
 
 ITRP/CaCC are significantly larger in BPH cells. 
The simplest interpretation of differences between ITRP and ITRP/CaCC in each group of 
animals is to consider that CaCCs are not functionally present in BPN VSMCs (since 
ITRP ~ ITRP/CaCC), whilst they represent half of the total current recorded in BPH 
VSMCs. However, this explanation is unlikely, since ITRP/CaCC currents are sensitive to 
CaCC blockers both in BPN (Figure D1) and BPH VSMCs. Another possibility could be 
related with a possible modulation of TRPC currents by intracellular calcium. There 
are several reports documenting the sensitivity of non-specific cationic currents 
and those mediated by some known channels like TRPC3 to extracellular and 
intracellular calcium (see Lichtenegger and Groschner, 2014 for a review). The 
modulation by intracellular calcium is more controversial, but there is some 
evidence showing that TRPC3 currents are bigger when calcium entry is moderately 
buffered with EGTA and much smaller when forming heterotetramers with TRPC1 
(Lintschinger et al., 2000). To our knowledge, a detailed characterization of the 
intracellular calcium dependence of TRPC3/C6 has not been carried out, but in the 
light of the results depicted in figure R21, it is reasonable to postulate that TRPC 
currents are smaller in the presence of intracellular calcium. 
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Figure D1. Effects of CaCCs blockers (10 μM) on UTP (50 μM)-activated currents in a BPN 
VSMC cell. 
 
In any case, the lack of correlation between the size of UTP activated currents and 
the UTP effect on vessel contractility disappears when TRPC and CaCC mediated 
currents are recorded together (ITRP/CaCC), since they are significantly larger in BPH: 
Larger currents would produce bigger depolarizations, more activation of voltage-
dependent calcium channels and more contraction (Figures R14 and R15). In fact, 
that is the case, since UTP elicited robust and weak depolarizations in BPH and BPN 
VSMCs, respectively (Figure R23A). However, it is surprising that UTP almost has no 
effect on BPN VSMCs membrane potential because the size of UTP activated 
currents (ITRP or ITRP/CaCC) is far from being negligible. The result is even more 
unexpected if we take into account that TRPC channels and CaCCs contribute in 
basal conditions to membrane potential, as demonstrated by the fact that Pyr 
compounds or CaCC blockers (Niflumic Acid or ANO1 inhibitor) hyperpolarize both 
BPN and BPH VSMCs. Is interesting to note that although the effect of blocking 
basal currents on membrane potential is significantly larger in BPH cells than in BPN 
cells when Pyr-compounds or ANO-1 inhibitors are used, and although the effect of 
both inhibitors is quantitatively very similar in BPH cells (Figure R23), the inhibition 
of CaCCs is much more effective blocking the depolarization induced by UTP in BPH 
cells (Figure R24). 
These results strongly suggest that CaCCs are the main mediators of the 
depolarization elicited by UTP and point to differences in the expression of CaCCs 
between BPN and BPH mice. This difference exists at the mRNA level (Figure R22) 
since mesenteric arteries from BPH mice have a significantly larger expression of 
the CaCC channel ANO-1 (TMEM16A) and its associated subunit ClCa1 (Sala-
Rabanal et al., 2015). Nevertheless, we do not have a satisfactory explanation for 
the lack of correlation between the activation of TRPC3/6 currents by UTP and the 
level of changes obtained in membrane potential. It has been described that TRPC3 
and TRPC6 channels associate with large conductance Ca2+-activated K+ channels 
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(BKCa) in cultured podocytes (Kim, Alvarez-Baron and Dryer, 2009) and that TRPC1 
channels associated with the same channels in vascular smooth muscle cells (Kwan 
et al., 2009): Ca2+ entry trough TRPC channels would activate BKCa channels and the 
hyperpolarizing effect of such activation would brake the depolarizing effect of 
TRPC activation. Certainly, this type of interaction could explain at least in part the 
lack of correlation between TRPC currents and membrane potential, especially if 
the association between TRPC and BKCa channels is dependent on the activation of 
a signaling pathway. Obviously, the association of TRPC3/6 channels and BK 
channels must be demonstrated in the BPN/BPH model, and this is a venue 
certainly worth studying in the future if we consider the already described 
differences between BPN and BPH mice regarding BKCa function (Tajada et al., 
2013). 
Besides differences in tissues and species specificities, CaCCs channels are activated 
in smooth muscle both, by Ca2+ released from the SR and by Ca2+ entry via VOCCs, 
SOCs and ROCs (Leblanc et al., 2015). In addition, it has been shown (Nelson et al., 
1995; Jaggar et al., 1998; Yip et al., 2018) that the release of Ca2+ from intracellular 
stores can activate Spontaneous Transient Currents mediated by K+ (Outward, 
STOC) and Cl- (Inward, STICS) channels. In this context, it is quite possible that the 
hyperpolarizations beyond resting Vm obtained with ANO1 inhibitor or Niflumic 
Acid during UTP stimulation (figure R24) could be due to the Ca2+-triggered 
activation of IK(Ca), since it has been previously reported that Niflumic Acid-
mediated blockade of ICaCC) enhanced the evoked Ca
2+ release from intracellular 
stores without altering its spontaneous release, thus enhancing Ca2+-activated IK(Ca) 
and hyperpolarization (Hogg, Wang and Large, 1994). It is tempting to speculate 
that whilst the relative amount of STOCs and STICs could regulate resting 
membrane potential, the activation of GPCR could activate ROCs (TRPC3/6) and 
Ca2+ release from the SR, activating CaCCs, depolarizing the plasma membrane and 
activating VOCCs, depending on the intensity of the response of the relative 
activation of CaCCs and BK channels. This Thesis, and previous work of our lab 
(Moreno-Domínguez et al., 2009; Tajada et al., 2012, 2013), demonstrate that all 
these channels are differently expressed in BPN and BPH mice, contributing to set 
the hypertensive phenotype, although we still do not have a clear picture of the 
fine tuning of the spatiotemporal relationships of all of them upon the stimulation 
of all the relevant receptors. Since in a nonlinear system such as VSMCs, subtle 
differences in one parameter could produce big changes in the final output 
depending on the state of other parameters in the system, a proper understanding 
of the final integrated response requires a good understanding of all relevant 
changes in the system.  
In conclusion, it seems that in BPH mesenteric arteries UTP activates a P2Y6-
dependent signaling pathway leading to the associated Ca2+ release from 
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intracellular stores, which in turn may activate the opening of membrane CaCCs 
channels, mainly ANO1 channels, leading to Cl- efflux and subsequent membrane 
depolarization. Since these channels do not inactivate (Large and Wang, 1996), the 
continuous evoked depolarization contribute to the opening of VOCCs channels, 
leading to Ca2+ influx and [Ca2+]i increase, thus enhancing vasoconstriction.  
Several reports have described in detail the kinetics of ANO1-triggered inward 
currents using pharmacological approaches, with Niflumic Acid and ANO1 inhibitor 
(Hogg, Wang and Large, 1994; Large and Wang, 1996; Davis et al., 2013; Bradley et 
al., 2014; Leblanc et al., 2015), and KO and siRNA-silencing mechanisms (Bulley et 
al., 2012; Dam et al., 2014; Heinze et al., 2014). In all these studies, low unitary 
conductance (1.2-3.5 pS) of CaCCs channels were confirmed in several smooth 
muscle and non-smooth muscle tissues. However, differences in the mean open 
time were reported, with smaller values obtained in excised patches compared to 
intact cells. In addition, they also reported an increased probability of open 
channels upon depolarization, but not an increase in the single-channel 
conductance (Large and Wang, 1996), that seemed to be voltage-dependent with 
membrane depolarization increasing the efficacy of Ca2+ in activating the channels 
(Leblanc et al., 2015). 
Previous studies have also reported the vasodilator effects of Niflumic Acid and 
ANO1 inhibitor on agonist precontracted arteries (Large and Wang, 1996; Remillard 
and Leblanc, 2000; Davis et al., 2013). However, almost all of them explored the 
contribution of ANO1 channels on the Norepinephrine-, Angiotensin II and 
vasopressin-elicited vasoconstrictions. In fact, the role of chloride channels in 
Noradrenaline induced responses is well documented, and several studies 
demonstrated that a reduction in [Cl-]o by partial substitution for aspartate or SCN
- 
inhibited NA-induced oscillations in vascular tone (vasomotion) in rat mesenteric 
arteries (Boedtkjer et al., 2008). Nevertheless, few reports exist investigating the 
role of these channels on the UTP-triggered purinergic signaling on vascular 
contractility (Mitchell et al., 2012). Most of the available studies on UTP-triggered 
activation of ANO1 channels focused their efforts on epithelial secretion 
mechanisms (Rock et al., 2009; Dutta et al., 2011). We have not yet characterized 
the effect of CaCCs inhibitors in the response of UTP in BPH arteries, but we have 
tested their effect on the response to PHE in BPN, as shown in Figure D2. In 
agreement with the data obtained in other preparations, the contractile response 
elicited by the activation of α1-adrenergic receptors is very sensitive to CaCCs 
blockers. 
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Figure D2. Effects of CaCCs (10 μM) blockers on PHE (10 μM)-
induced vasoconstriction in a BPN mesenteric artery. 
 
We did not perform a full characterization of the sensitivity of the contractile 
response in BPN and BPH arteries to these inhibitors, but we hypothesize that the 
higher responsiveness to PHE typical of BPH (Figure R2) could be also due to a 
higher role of CaCCs in the α1-adrenergic signaling pathway in BPH mice. In fact, we 
hypothesize that some of the differences in the kinetic and the intensity of the 
responses to the activation of different Gq-coupled receptors are related to a 
different contribution of ROCs mediated by TRPC channels and depolarizing 
currents mediated by CaCCs, especially ANO1. This hypothesis needs to be 
confirmed with further experiments, quantitatively characterizing the role of 
TRPC3/6 and ANO1 in the response elicited by different relevant agonists. 
Although qPCR results showed a higher mRNA expression of ANO1 channels in BPH 
cells, and current-clamp experiments demonstrated a higher contribution of those 
channels to set the resting Vm in basal conditions and upon stimulation with UTP 
(Figures R22 and R23), we did not carry out in this Thesis a full characterization of 
the sensitivity to ANO1 inhibitors of UTP-elicited inward currents. These studies 
need to be done, but they must be properly designed in order to take into account 
the complex kinetic behavior of these channels. It is known that changes in [Cl-]o 
modulate the gating kinetics and the permeation properties of the channel both in 
resting (Contreras-Vite et al., 2016) and in UTP-activated conditions (Muraki, 
Imaizumi and Watanabe, 1998). A decrease in [Cl-]o lead to a decrease in the Cl
- 
conductance of the channels and [Cl-]o has a dual effect on the kinetics of 
activation, being monoexponential at low concentrations and biexponential at 
large concentrations (Large and Wang, 1996; Muraki, Imaizumi and Watanabe, 
1998; Contreras-Vite et al., 2016).  
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In addition to this role of [Cl-]o modulating the channel conductance and the kinetic 
properties of ANO1, [Cl-]i in VSMCs is also of paramount importance, since the Cl
- 
equilibrium potential is very close to Vm and changes in [Cl-]i would determine the 
net effect of the opening of chloride channels on resting Vm. Intracellular Cl- is not 
at equilibrium in VSMCs as its concentration depends on the activity of several 
transporters such as NKCC1 (see the Introduction section). Changes in the activity 
of this cotransporter can influence [Cl-]i, Cl
- driving force and then the subsequent 
effect on Vm of ANO1 activity. 
Previous studies on hypertensive animal models have reported a higher mRNA and 
protein expression of NKCC1 cotransporter associated to an increased functional 
activity and a larger contribution to myogenic tone and agonists-induced 
vasoconstriction (Meyer et al., 2002; Lee et al., 2010; Ye et al., 2012; Orlov et al., 
2015). In addition, the blockade or even the lack of this cotransporter led to 
decreases in the agonists-induced vasoconstriction and in the mean blood 
pressure, as shown in  studies using bumetanide and in studies in NKCC1-/- KO 
models (Meyer et al., 2002; Koltsova, Kotelevtsev, et al., 2009; Lee et al., 2010; Ye 
et al., 2012). We did not find any difference in the mRNA expression of NKCC1 
between BPH and BPN mice (Figure R22), although preliminary functional studies 
revealed a relevant role of NKCC1 modulating PHE-induced constrictions of BPN 
mesenteric arteries (Figure D3). We are in the process of characterizing the effect 
of blocking NKCC1 in BPN and BPH mice, aiming to understand the relationship 
between [Cl-]i, CaCC activity and the hypertensive phenotype in response to 
different agonists. 
 
Figure D3. Vasodilator effect of the NKCC1 blocker bumetanide on 
PHE-induced vasoconstriction in a BPH mesenteric artery. 
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Taken together, our results suggest a clear involvement of TRPC3/C6 and CaCCs 
(mainly ANO1) in setting the more depolarized resting Vm of BPH VSMC cells. In 
addition, the role of both channels in the contractile responses induced by GPCR 
agonists seems to be agonist dependent and quite different in BPN and BPH mice. 
UTP activation of the P2Y6-dependent purinergic signaling pathway increases 
membrane DAG (opening TRPC3/C6 channels) and [Ca2+]i (opening ANO1). The 
activation of both conductances depolarizes the membrane potential, activates 
VOCCs, further increases [Ca2+]i and induces the final contractile response. 
However, this response is only relevant in BPH arteries, since UTP is almost unable 
to elicit a response in BPN animals. Although ANO1 channels are good candidates 
to explain part of the differences between BPN and BPH responses to UTP, it is 
quite remarkable how subtle changes in the expression of all the players involved 
in the response to the same agonist produce such a big difference in the final 
output. A full understanding of the subtle differences that lead to the hypertensive 
phenotype of BPH mice requires a detailed characterization of the quantitative 
contribution of all the ionic channels involved in the control of membrane potential 
during the activation of different GPCRs by different agonists, especially if we 
consider that other G proteins, in addition to Gq are also relevant. This 
characterization is certainly part of a future project that will deepen our 
understanding of the differences between BPN and BPH mice, giving new 
quantitative insights that will have the huge advantage of allow a full integrative 
analysis of the results, since all subtle differences can be contextualized in the 
same model of hypertension. 
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1. BPH mice show a moderate essential hypertensive phenotype, which associates 
with an increased vascular tone and sympathetic activity. BPH mesenteric 
arteries exhibit larger responses to the α1-adrenergic agonist PHE than BPN 
arteries, whilst there are no differences in the effect of ATP. 
2. Differences in the expression of TRPC3 and TRPC6 channels, which are the 
molecular correlate of the ROCs currents, can explain the differences in the α1-
adrenergic responses. The mRNA expression profile of TRPC channels 
demonstrate a larger expression of TRPC3 and a lower expression of TRPC6 
channels in VSMCs from mesenteric BPH arteries. 
3. Pyr compounds (10 and 3) and anti-TRPC antibodies are good tools to 
investigate the functional role of TRPC channels in native systems. Control 
experiments carried out in a heterologous expression system (CHO cells) have 
validated the use of Pyr compounds as blockers of TRC6 channels, and anti-
TRPC3 antibodies as blockers of TRPC3 channels.      
4. The effect of Pyr compounds on PHE induced vasoconstriction is larger in BPN 
arteries, in good agreement with the higher expression of TRPC6 in those cells.  
5. Basal TRPC currents in BPH VSMCs are larger, more sensitive to intracellular 
anti-TRPC3 antibody and less sensitive to Pyr3/10 blockers than in BPN cells. 
Altogether, these results suggest a higher contribution of TRPC3 channels to 
basal currents in BPH VSMCs.  
6. PLA and immunocytochemical experiments demonstrate a different profile of 
TRPC3/C6 association in BPH VSMCs. BPH cells have a higher expression of 
TRPC3 channels in the membrane, either as homo or as heterotetramers with 
TRPC6, whilst TRPC6 homomultimers predominate in BPN VSMCs.  
7. PHE, ATP and OAG-activated currents are similar in BPN and BPH VSMCs, while 
UTP activated ROCs are smaller in BPH VSMCs. The closer proximity between 
TRPC3/6 channels and P2Y6 UTP receptors in BPN VSMCs suggested by PLA and 
Super-resolution imaging techniques could explain these differences. However, 
ROCs elicited with all the stimuli are less sensitive to Pyr compounds in BPH 
cells, which agree with the higher expression of TRPC3 channels in these cells. 
8. Pressure myography studies show that ATP induced vasoconstriction is mainly 
mediated through P2X1 receptors activation and is unchanged in BPH arteries. 
In contrast, UTP effect is much larger in BPH vessels. The increased expression 
and functional contribution of P2Y6 receptors in BPH mesenteric VSMCs can 
account for this effect of UTP.   
9. In current-clamp experiments, UTP induced depolarization of VSMCs cells is 
significantly larger in BPH cells. This effect is insensitive to Pyr10 but can be 
inhibited by CaCCs blockers such as Niflumic acid and ANO1-inhibitor. There is 
also a larger contribution of CaCCs to UTP activated currents in BPH cells, and a 
 - 136 - 
 
CONCLUSIONS 
larger mRNA expression of ANO1 and its regulatory subunit ClCa1. These results 
strongly suggest that UTP-induced depolarization is mediated by the activation 
of ANO1 channels. 
10. GPCR signaling pathways in BPN/PBH mice are mediated by the integrated 
coupling between GPCRs and TRPC3/6 and ANO1 channels, although the 
relative importance of those channels seems to be receptor dependent.  
Although both TRPC and ANO1 channels contribute to set the resting Vm of 
VSMCs, ANO1 channels are the essential mediators of the UTP-induced 
depolarizations. In this context, differences in the functional expression and/or 
the coupling between GPCRs and TRPC and CaCCs channels could contribute to 
the increased reactivity of BPH arteries, pointing out to all these proteins as 
new potential therapeutic targets for the treatment of essential hypertension
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RESUMEN FINAL 
1. Introducción 
La hipertensión arterial (HTA) es una enfermedad crónica que se caracteriza por un 
aumento sostenido de la presión sanguínea arterial, siendo un factor de riesgo 
determinante de diversas patologías cardiovasculares, neurológicas y renales. El 
90% de los casos de HTA se diagnostican como hipertensión esencial, de origen 
genético y sujeto a factores ambientales y estilos de vida como sedentarismo, 
tabaquismo, ingesta de alcohol, dieta y obesidad (Aaronson, Ward and Wiener, 
2004). El 10% restante de los casos de HTA se diagnostican como hipertensión 
secundaria, cuyo origen deriva de problemas de causa patológica conocida, 
incluyendo hiperaldosteronismo, patologías renovasculares, feocromocitoma o  
toxemia preeclámptica, entre otros (Herring and Paterson, 2018). 
Fisiológicamente, la presión arterial está finamente regulada por el sistema 
cardiovascular mediante el control del gasto cardíaco (CO) y las resistencias 
periféricas totales (TPR). Inicialmente, la HTA esencial se asocia a un aumento del 
CO con valores normales o ligeramente elevados en las TPR; sin embargo, con el 
transcurso del tiempo, el CO revierte a sus valores fisiológicos mientras que los 
valores que definen las TPR se mantienen crónicamente elevados. El estado y la 
actividad contráctil de las células que componen la capa de músculo liso vascular 
(VSMCs), concretamente en arterias y arteriolas, son los principales determinantes 
de las TPR. Normalmente, los vasos sanguíneos se encuentran en un estado de 
contracción parcial denominado tono vascular que determina el diámetro del vaso 
en condiciones basales. En respuesta a estímulos, el cambio en el estado contráctil 
de las VSMCs determina la contracción y dilatación de los vasos, regulando de esta 
forma de manera muy eficiente el flujo sanguíneo en los distintos lechos 
vasculares. Este tono vascular basal depende directamente del potencial de 
membrana (Vm) de las células VSMCs, finamente regulado por los canales de K+ y 
los canales de Ca2+ dependientes de voltaje (VOCCs), de manera que la 
despolarización de las VSMCs da lugar a contracción vascular, mientras que los 
estímulos hiperpolarizantes producen vasodilatación. En trabajos previos de 
nuestro grupo, se ha identificado la contribución de diferentes canales de K+ y 
canales VOCCs al desarrollo de la hipertensión en el modelo murino de 
hipertensión esencial BPH/BPN. Sin embrago, existen otros muchos canales y 
receptores de membrana cuya contribución en la patogénesis de la hipertensión 
esencial aún se desconoce. 
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2. Objetivos 
El objetivo principal de esta Tesis consiste en caracterizar la contribución funcional 
de los canales activados por receptor (ROCs) y de los receptores acoplados a 
proteínas G (GPCR) en la patogénesis de la hipertensión arterial esencial en el 
modelo murino de hipertensión BPH/BPN. Concretamente, el estudio se ha 
centrado en caracterizar las diferencias en la contribución de los canales TRPC al 
fenotipo hipertenso en condiciones basales, así como tras estimulación de la 
cascada de señalización purinérgica. 
 
3. Material y Métodos 
Para la realización de esta Tesis, se ha utilizado principalmente el modelo de ratón  
BPH/BPN. Se trata de  un modelo genético de HTA esencial, obtenido a partir del 
cruce de distintas cepas de ratón seleccionadas fenotípicamente. De este modo se 
han obtenido ratones con fenotipo hipertensivo moderado (BPH) y sus respectivos 
controles (BPN), compartiendo un fondo genético similar. Todos los protocolos 
aplicados a los animales utilizados en esta Tesis han sido aprobados por el Comité 
de Ética en Experimentación Animal de la Universidad de Valladolid, acorde con la 
Guía de Principios de la Comunidad Europea relativa a la protección de animales 
utilizados para experimentación y otros fines científicos (Directiva 2010/63/UE). 
Además, se ha utilizado la línea celular CHO como sistema heterólogo de expresión 
génica de distintos vectores que codifican para canales TRPC, lo que nos ha 
permitido caracterizar de forma aislada la expresión y el patrón de asociación  de 
dichos canales, así como sus propiedades electrofisiológicas. 
Mediante estudios de expresión génica (PCR cuantitativa) y estudios de expresión y 
asociación de proteínas (inmunocitoquímica, co-IP, PLA, GSD Super-resolution…) 
hemos caracterizado las diferencias, a nivel molecular, de los canales iónicos y 
receptores de membrana entre los fenotipos BPH y BPN. La caracterización 
funcional se ha llevado a cabo mediante estudios de electrofisiología en células 
aisladas y estudios de miografía de presión en arterias mesentéricas. Con la técnica 
de patch-clamp hemos caracterizado las corrientes iónicas a través de los canales 
de membrana, así como la contribución de dichos canales al Vm, y con los estudios 
de miografía de presión hemos caracterizado la contribución de dichos canales y 
receptores de membrana a las diferencias en la contractilidad vascular entre BPH y 
BPN. 
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4. Resultados 
Los resultados obtenidos en la caracterización del modelo de hipertensión BPH 
mostraron un incremento moderado en los valores de presión arterial, valores de 
potencial de membrana de las VSMCs en reposo más despolarizados y una mayor 
respuesta contráctil al agonista α1-adrenérgico Phenilephrine (PHE) respecto los 
ratones control BPN, sugiriendo que el incremento de la actividad simpática 
contribuye al aumento del tono vascular en nuestro modelo.  
Los resultados de expresión génica obtenidos en células VSMCs procedentes de 
arterias mesentéricas de ratones BPH mostraron un aumento de la expresión de los 
canales TRPC3 y una disminución de los canales TRPC6 respecto el fenotipo BPN. 
Además, mediante los estudios realizados en células CHO, validados 
posteriormente en células VSMCs, caracterizamos la actividad electrofisiológica de 
los canales TRPC3/C6, así como las diferencias en el patrón de expresión y 
formación de heteromultímeros TRPC3/C6. Para esta caracterización funcional  
hemos utilizado el  bloqueo mediante anticuerpos específicos anti-TRPC3 aplicados 
intracelularmente para determinar la contribución de los canales TRPC3, y el 
bloqueo farmacológico con los compuestos Pyr3/10 para estudiar la contribución 
de los canales TRPC6. Nuestros resultados son consistentes con un aumento de la 
contribución funcional de los canales TRPC3 en células BPH, tanto en condiciones 
basales como en respuesta a la estimulación por distintos agonistas. Las corrientes 
basales fueron mayores en células BPH y sólo ellas  fueron sensibles al bloqueo con 
anticuerpos anti-TRPC3. Por otro lado, las corrientes inducidas por agonistas se 
bloquearon en su totalidad por Py3/10 en células BPN, y sólo parcialmente en 
células BPH, sugiriendo una mayor expresión de canales TRPC6 en normotensos.   
Así mismo, los resultados obtenidos mediante miografía de presión mostraron un 
mayor efecto vasodilatador de los compuestos Pyr3/10 en arterias mesentéricas de 
ratones BPN pre-contraídas con el agonista PHE. Finalmente, los estudios de PLA 
apoyaron estos datos funcionales, revelando  una mayor expresión de canales 
TRPC3 en BPH, tanto como homomultímeros TRPC3 como heteromultímeros 
TRPC3/C6, frente a una mayor expresión de homomultímeros TRPC6 en BPN, datos 
que también concuerdan con los resultados obtenidos en el patrón de expresión de 
mRNA. En conjunto, los resultados obtenidos en el estudio de la caracterización de 
los canales TRPC como ROCs en nuestro modelo BPH/BPN nos sugieren una mayor 
contribución de los canales TRPC3 al fenotipo hipertenso.  
Por otro lado, cuando comparamos la amplitud de las corrientes ROC mediadas por 
TRPC en respuesta a distintos agonistas en células BPN y BPH, sólo encontramos 
diferencias en el caso de UTP. Las corrientes TRPC inducidas por el agonista UTP 
fueron significativamente mayores en células BPN. Sin embargo, los estudios de 
caracterización funcional de la señalización purinérgica mostraron un mayor efecto 
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vasoconstrictor de UTP mediado principalmente por receptores P2Y6 en el fenotipo 
BPH, y un aumento en la expresión de mRNA de P2Y6 en BPH; .  
Una posible explicación a esta observación (hay más canales TRPC3 y más 
receptores P2Y6 en las células BPH y, sin embargo, las corrientes TRPC activadas por 
UTP son menores) podría ser una diferencia en el acoplamiento entre los 
receptores y los canales. Los estudios de PLA y Super-resolución (GSD) mostraron 
una mayor proximidad entre canales TRPC3 y receptores purinérgicos P2Y6 en 
células BPN, lo que podría explicar en parte el aumento de corrientes ROC 
activadas por UTP obtenido en BPN.  
Finalmente, el aumento de la respuesta vasoconstrictora en las arterias BPH, a 
pesar de tener una menor corriente TRPC inducida por UTP, podría explicarse por la 
contribución a esta respuesta vasoconstrictora de otros canales además de los 
TRPCs. Observamos que la aplicación de UTP en BPH produce una despolarización 
del potencial de membrana mucho mayor que en BPN, y en ambos casos, se inhibe 
de forma parcial por Pyr10 y casi totalmente en presencia de bloqueantes de los 
canales de Cl- activados por Ca (CaCCs) como Ácido Niflúmico o el inhibidor de los 
canales Anoctamina 1 (ANO1-Inhibitor). 
 Así mismo, los estudios electrofisiológicos de las corrientes totales activadas por 
UTP mostraron una mayor contribución de los canales CaCCs en el fenotipo BPH, 
acorde con el mayor patrón de expresión de mRNA del canal ANO1 y su subunidad 
reguladora ClCa1. Estos resultados indican que los canales CaCCs contribuyen de 
manera importante a la respuesta mediada por UTP, y sugieren que las diferencias 
en la expresión de estos canales pueden explicar las diferencias en la señalización 
purinérgica entre las células de BPN y BPH.  
 
5. Discusión y Conclusiones 
El modelo BPH es un modelo de hipertensión esencial moderada asociado a un 
aumento del tono vascular y a un incremento de la actividad simpática. Puesto que 
los canales TRPCs son el prototipo de los canales activados por receptor (ROCs), 
hemos investigado las diferencias  en las repuestas vasculares a agonistas α1- 
adrenérgicos y purinérgicos, ya que son las dos vías de señalización más 
importantes asociadas a la estimulación simpática en arterias de resistencia.  Los 
patrones de expresión de mRNA y asociación proteica de los canales TRPC 
mostraron un aumento en la expresión de TRPC3, asociado como homomultímeros 
o heteromultímeros con TRPC6, en BPH; mientras que la asociación de 
homomultímeros TRPC6 fue predominante en BPN. Además, el aumento de 
expresión de TRPC3 se correlaciona con la mayor actividad basal del canal en 
células BPH. 
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Por otro lado, lo estudios control llevados a cabo en células CHO demostraron que 
tanto los compuestos Pyr3/10 como los anticuerpos anti-TRPC3 son buenas 
herramientas farmacológicas para el estudio del papel funcional de los canales 
TRPC en sistemas nativos. De esta manera, mientras que los anticuerpos anti-
TRPC3 fueron capaces de bloquear selectivamente las corrientes basales a través 
de TRPC3, los compuestos Pyr3/10 bloquearon la actividad del canal TRPC6. Estos 
resultados fueron posteriormente validados en células nativas, de manera que se 
obtuvo un mayor efecto bloqueante con los anticuerpos anti-TRPC3 y una menor 
sensibilidad al bloqueo mediado por los compuestos Pyr3/10 en BPH; mientras que 
los efectos de Pyr3/10 fueron mayores en BPN. Por tanto, estos datos nos sugieren 
una mayor contribución de los canales TRPC3 al fenotipo hipertenso. 
La caracterización funcional de la respuesta activada por UTP en el modelo BPH nos 
sugiere que está principalmente mediada por los receptores purinérgicos P2Y6. 
Además, existe una gran contribución de los canales CaCCs, concretamente del 
canal ANO1, a la despolarización inducida por UTP en BPH, lo que concuerda con la 
mayor expresión de mRNA de ANO1 y su subunidad reguladora ClCa1. 
En conjunto, nuestros resultados sugieren que los cambios en la expresión  tanto 
delos canales TRPC como de los canales CaCCs contribuyen a fijar un potencial de 
membrana más despolarizado en las células BPH, y por tanto una mayor 
vasoconstricción basal.  Además, la contribución de estos dos tipos de canales a las 
respuestas inducidas por agonistas de receptores acoplados a proteínas G (GPCR) 
es diferente en BPH y BPN y además es dependiente del tipo de agonista. Así, la 
activación por UTP de los receptores P2Y6 da lugar a un amento de DAG, que activa 
canales TRPC3/6, y a un aumento de calcio intracelular, que activa los canales 
ANO1. La activación de ambos canales da lugar a una despolarización que 
desencadena la respuesta contráctil. Sin embargo, esta respuesta es mucho mayor 
en las arterias BPH  debido, en gran parte, al aumento de la contribución funcional 
de los canales CaCCs en células BPH. En este contexto, cambios pequeños en la 
expresión y/o el acoplamiento de los distintos elementos de la vía de señalización 
(GPCR, TRPC y CaCCs) pueden dar lugar a diferencias importantes en la respuesta 
final, sugiriendo que estas proteínas pueden representar nuevas dianas 
terapéuticas para la prevención y el tratamiento de la hipertensión esencial. 
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Differences in TRPC3 and TRPC6 channels assembly in
mesenteric vascular smooth muscle cells in essential
hypertension
Ine´s A´lvarez-Miguel, Pilar Cidad, M. Teresa Pe´rez-Garcı´a∗ and Jose´ Ramo´n Lo´pez-Lo´pez∗
Departamento de Bioquı´mica y Biolog´ıa Molecular y Fisiolog´ıa e Instituto de Biolog´ıa y Gene´tica Molecular (IBGM), Universidad de Valladolid y
Consejo Superior de Investigaciones Cient´ıficas (CSIC), Valladolid, Spain
Key points
 Canonical transient receptor potential (TRPC)3 and TRPC6 channels of vascular smooth
muscle cells (VSMCs) mediate stretch- or agonist-induced cationic fluxes, contributing to
membrane potential and vascular tone.
 Native TRPC3/C6 channels can form homo- or heterotetrameric complexes, which can hinder
individual TRPC channel properties. The possibility that the differences in their association
pattern may change their contribution to vascular tone in hypertension is unexplored.
 Functional characterization of heterologously expressed channels showed that TRPC6-
containing complexes exhibited Pyr3/Pyr10-sensitive currents, whereas TRPC3-mediated
currents were blocked by anti-TRPC3 antibodies.
 VSMCs from hypertensive (blood pressure high; BPH)mice have larger cationic basal currents
insensitive to Pyr10 and sensitive to anti-TRPC3 antibodies. Consistently, myography studies
showed a larger Pyr3/10-induced vasodilatation in BPN (blood pressure normal) mesenteric
arteries.
 We conclude that the increased TRPC3 channel expression in BPH VSMCs leads to changes in
TRPC3/C6 heteromultimeric assembly, with a higher TRPC3 channel contribution favouring
depolarization of hypertensive VSMCs.
Abstract Increased vascular tone in essential hypertension involves a sustained rise in total
peripheral resistance. A model has been proposed in which the combination of membrane
depolarization and higher L-type Ca2+ channel activity generates augmented Ca2+ influx
into vascular smooth muscle cells (VSMCs), contraction and vasoconstriction. The search
for culprit ion channels responsible for membrane depolarization has provided several
candidates, including members of the canonical transient receptor potential (TRPC) family.
TRPC3 and TRPC6 are diacylglycerol-activated, non-selective cationic channels contributing
to stretch- or agonist-induced depolarization. Conflicting information exists regarding changes
in TRPC3/TRPC6 functional expression in hypertension. However, although TRPC3-TRPC6
channels can heteromultimerize, the possibility that differences in their association pattern
may change their functional contribution to vascular tone is largely unexplored. We probe
this hypothesis using a model of essential hypertension (BPH mice; blood pressure high) and
its normotensive control (BPNmice; bloodpressurenormal). First, non-selective cationic currents
through homo- and heterotetramers recorded from transfected Chinese hamster ovary cells
indicated that TRPC currents were sensitive to the selective antagonist Pyr10 only when TRPC6
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was present, whereas intracellular anti-TRPC3 antibody selectively blocked TRPC3-mediated
currents. In mesenteric VSMCs, basal and agonist-induced currents were more sensitive to Pyr3
and Pyr10 in BPN cells. Consistently, myography studies showed a larger Pyr3/10-induced vaso-
dilatation in BPN mesenteric arteries. mRNA and protein expression data supported changes in
TRPC3 andTRPC6 proportions and assembly, with a higher TRPC3 channel contribution in BPH
VSMCs that could favour cell depolarization. These differences in functional and pharmacological
properties of TRPC3 and TRPC6 channels, depending on their assembly, could represent novel
therapeutical opportunities.
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Introduction
Smooth muscle cells of blood vessels (vascular smooth
muscle cells; VSMCs) act as critical determinants of blood
pressure by modulating the vessel diameter and hence
blood flow. Most importantly, vascular disease resulting
in high blood pressure is among the most common causes
of death and disability in the western world.
Ion channels initiate and regulate contraction and
VSMC tone, modulating intracellular [Ca2+] levels.
The identification of ion channel genes expressed in
VSMCs has significantly improved our knowledge of
the signalling pathways leading to VSMC contraction, as
well as their possible contribution to pathophysiological
conditions. Although L-type, voltage-dependent Ca2+
channel (LTCC) is the primary pathway for Ca2+ influx
in VSMC, non-selective cation channels have also been
identified as importantplayers in the regulationof vascular
tone, either modulatingmembrane potential or providing
a Ca2+ entry pathway independent of the activation of
LTCCs (Albert & Large, 2006).
The molecular correlates of the non-selective cation
channels expressed in VSMCs are members of the trans-
ient receptor potential (TRP) family. TRP channels are
activated by vasoconstrictors, by membrane stretch and
by Ca2+ store depletion (Dietrich et al. 2006; Nilius &
Honore´, 2012), and the canonical TRP (TRPC) family
has been proposed as the molecular constituent of
receptor- and stretch-operated channels (ROCs andSOCs,
respectively) that link the diacylglycerol (DAG) signalling
cascade pathway to the activation of LTCCs. The seven
TRPC family members can be classified into subfamilies
on the basis of their amino acid similarity. Among
them, the TRPC3/6/7 subfamily has been proposed as
the DAG-activated ROCs (Hofmann et al., 1999, 2002),
although TRPC7 channels have not been found in the
vasculature (Earley & Brayden, 2015).
Despite years of study characterizing the biophysical
properties and the functional roles of TRPC3 and TRPC6
channels, surprisingly little is known regarding their
contribution to vasoconstriction and vasorelaxation in
arteries. Several reasons contribute to the paucity of
these studies, including their lack of distinct biophysical
properties and the shortage of selective pharmacological
blockers. Moreover, the use of small interfering RNA
approaches to study these channels in cultured VSMCs
has provided information that is not easy to interpret in
terms of the contribution of the channels to the regulation
of VSMCs contractility because cultured VSMCs undergo
phenotypic modulation and show lost contractile
properties (Owens et al. 2004). In recent years, knockout
(KO) animals and more selective pharmacological agents
have provided better approaches for studying the
contribution of these channels to vascular tone. However,
no conclusive results could be obtained from TRPC3
and TRPC6 KO animals. Neither agonist-induced, nor
pressure-evoked contraction was reduced in arteries from
TRPC6-KOmicebecauseupregulationofTRPC3channels
provided a compensatory vasoconstrictor mechanism in
these animals (Dietrich et al. 2005). Although these
channels have been described in VSMCs from many
arteries, as for TRPC3-KO, the TRPC3-deficient mice
phenotype shows an impaired vasodilatation related to
the lack of endothelial TRPC3 channels (Senadheera et al.
2012; Yeon et al. 2014). In any case, the combination
of several of these approaches enables the distinction
of the contributions of these two channels to vascular
tone in different vascular beds. TRPC6 channels are
linked to pressure-induced (myogenic) vasoconstriction
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and can also be activated by a variety of G-protein
coupled receptors (GPCR) ligands (Mederos y Schnitzler
et al. 2008; Gonzales et al. 2014; Earley & Brayden,
2015). However, the mechanisms linking stretch or
mechanical stimuli to TRPC6 channels activation remain
controversial. Although some studies suggest that TRPC6
channels could be intrinsically mechanosensitive (Wilson
& Dryer, 2014), other laboratories conclude that TRPC6
channel gating in response to stretch is an indirect
effect resulting from the mechanical activation of GPCR
(Sharif-Naeini et al. 2008; Gonzales et al. 2014). An
interesting proposal that can solve this controversy
sugggests that both mechanisms could be acting in a
synergistic way, so that simultaneous receptor-mediated
and mechanical stimulation could amplify calcium
influx through TRPC6 channels (Inoue et al. 2009).
TRPC6 channel exhibits mechanosensitivity only after its
receptor-mediated activation via PLC/diacylglycerol and
PLA2/ 20-HETE pathways.
TRPC3 channels contribute to basal tone and to
agonist-induced vasoconstriction but do not appear to
have a role in the myogenic response (Reading et al.
2005; Dietrich et al. 2006). However, these studies
also show some discrepancies regarding the expression
and the functional contribution of these channels
in different preparations and leave several relevant
questions unanswered. In particular, the characterization
of the unique contributions of these two channels in
pathophysiological contexts with an altered vascular tone
has not been defined. An increased expression of TRPC3
channels in conduit arteries from hypertensive animals
has been reported (Liu et al. 2009; Noorani et al. 2011),
although their expression and functional contribution in
VSMCs from resistance arteries remain a matter of debate
(Reading et al. 2005; Adebiyi et al. 2012; Senadheera et al.
2012). Also, the upregulation of TRPC6 channels (with
normal TRPC3 channel expression) has been described in
mesenteric arteries in other hypertension models (Linde
et al. 2012).
Aside from the differentmodels and vascular beds used,
these discrepancies can be related to the fact that the
contribution of TRPC3 and TRPC6 channels in native
VSMCs is dependent on their association as homo- or
heterotetrameric complexes. Because TRPC3 and TRPC6
expression overlaps in most VSMC tissues and their
physical interaction has been demonstrated (Hofmann
et al. 2002; Beech et al. 2004; Shin et al. 2011), TRPC3/6
heterotetramers may be the molecular correlate of the
native receptor-operated non-selective cationic influx in
VSMCs. For this reason, the characterization of end-
ogenous TRPC channels in native cell is challenged
by the possibility of heteromultimeric associations that
can hinder the contribution of an individual TRPC
channel (Maruyama et al. 2006). In this regard, the
possibility that differences in their association patternmay
change their functional contribution to vascular tone is
unexplored.
In the present study, we probe this hypothesis using
a model of essential hypertension (BPH mice; blood
pressure high) and its normotensive control (BPN mice;
blood pressure normal) (Schlager & Sides, 1997). We
observed changes in the expression of TRPC3 mRNA
in mesenteric VSMCs from BPH animals, and we
aimed to define its possible contribution to the hyper-
tensive phenotype by determining the functional and
pharmacological profile of TRPC3 andTRPC6 homo- and
heterotetramers, combining studies in native VSMCs, in
heterologous expression systems, and in whole arteries.
The data obtained indicate that changes in TRPC3
channels expression determine differences in TRPC3 and
TRPC6 proportions and assembly, leading to a higher
TRPC3 channel contribution in BPH VSMCs that could
favour cell depolarization in the hypertensive phenotype.
Methods
Ethical approval
All animal protocols were approved by the Institutional
Care and Use Committee of the University of Valladolid,
and are in accordance with the European Community
guiding principles with respect to the care and use of
animals (Directive 2010/63/UE).
Mice protocols
Colonies of BPH and BPN mice (Jackson Laboratories,
Bar Harbor, ME, USA) were housed in the animal
facility of the School of Medicine of Valladolid, under
temperature-controlledconditions (21 °C) and with
unlimited access to water and food. Blood pressure was
measured in awake mice with a tail-cuff pressure meter
(LSI Letica Scientific Instruments, Barcelona, Spain) as
described previously (Tajada et al. 2012). BPN and BPH
mice used in the present study were paired in terms of age,
ranging from 16 to 58 weeks (average 36.2± 2.4 weeks for
BPN and 34.6± 1.7 weeks for BPH). However, the weight
of BPN animals was significantly larger that BPH mice of
matching ages (29.33 ± 0.23 g for BPN vs. 24.37 ± 0.24 g
for BPH, n = 69–80, P < 0.001), as described previously
(Moreno-Domı´nguez et al. 2009). Mice were deeply
anaesthetized by isoflurane inhalation (5% at 2.5 l min−1
O2) and killed by decapitation. Mesenteric arteries were
obtained as described previously (Moreno-Domı´nguez
et al. 2009). Briefly, arteries were carefully dissected and
cleaned of connective and endothelial tissues in cold
(4 °C) oxygenated (95% O2–5% CO2) smooth muscle
dissociation solution (SMDS)–10μMCa2+ (120mMNaCl,
4.2mMKCl, 25mMNaCHO3, 0.6mMKH2PO4, 1.2MgCl2
and 11 mM glucose, pH 7.4). Subsequently, arteries were
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either frozen at−80 °C for further RNA extraction or used
directly for myography measurements or to obtain freshly
dispersed VSMCs.
Chinese hamster ovary (CHO) cells culture and
transfection
CHO cells were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% foetal bovine
serum, penicillin-streptomycin (100 U ml−1 each) and
2 mM L-glutamine at 37 °C in a 5% CO2 humidified
atmosphere. CHO cells were grown as a monolayer
in poly-L-lysine-coated coverslips prior to transiently
transfection by using TransIT-X2 R© System (Mirus,
Madison,WI,USA) in accordancewith themanufacturer’s
instructions. Cells were transfected with 1 μg of DNA of
hTRPC3-YFP (kindly provided by Dr Klaus Groschner,
University of Graz, Austria), 1 μg of ratTRPC6-green
fluorescent protein (GFP) (a gift from Dr Jason Yuan,
U of Arizona) or 0.5 μg of each. Cells were used 24–72 h
after transfection.
RNA extraction
RNA extraction was carried out from 30–40 mesenteric
arteries from five or six BPN and BPH mice (Cidad
et al. 2010). After cleaning of connective, adipose and
endothelial tissues, total RNA from arteries was iso-
lated with a MELTTM Total RNA Isolation System Kit
(Ambion, Inc., Thermo Fisher Scientific, Waltham, MA
USA) in accordance with the manufacturer’s instructions.
After DNAse I (Ambion, Inc.; Thermo Fisher Scientific)
treatment, 500–750 ng of RNA was used for the reverse
transcription reaction (2.5 U μl−1 MuLvRT, 1 U μl−1
RNase inhibitor, 2.5 μM random hexamers, 1 × PCR
buffer, 5 mM MgCl2 and 4 mM mixed dNTPs; Applied
Biosystems, Thermo Fisher Scientific) at 42 °C for
60 min to obtain cDNA. Real-time PCR was carried out
using TaqMan Low-Density Arrays (Applied Biosystems;
Thermo Fisher Scientific) and an ABI Prism 7900HT
sequence detection system (Applied Biosystems) at the
Genomic Service of the CNIC (Madrid, Spain). Data
were analysed with the threshold cycle (Ct) relative
quantification method (Ct) (Livak & Schmittgen,
2001). We analysed two different housekeeping genes:
ribosomal protein 18 s (RP18s) and Gapdh. RP18s is
included in the arrays such that is also an internal control
of the reaction. By contrast, Gapdh serves as an external
control because its expression is determined from the
same samples in an independent reaction. Because the
data obtained with the two housekeeping genes showed
no significant differences in expression between BPN
and BPH samples, expression data were normalized by
the level of ribosomal RNA 18S transcript. The relative
abundance of the genes was calculated from 2(–Ct), where
Ct=CtChannel-Ct18S. Differences between BPN and BPH
samples were calculated from 2(–Ct), where Ct =
CtBPH – CtBPN. In this way, the levels of mRNA in
BPH samples are expressed as changes relative to BPN:
2(–Ct) = 1 will indicate the absence of changes between
both preparations; increased expression is denoted by a
2(−Ct) > 1; and decreases are indicated by 2(–Ct) < 1.
Amore intuitive expression can be obtainedwhen changes
are expressed as log 2(–Ct) (Fig. 1): positive values
indictate a higher expression in BPH mice, whereas
negative values indicate a lower expression compared to
BPN mice.
Myography measurements
Segments of third-ordermesenteric arteriesweremounted
in a pressure myograph system (Danish Myo Technology,
Aarhus, Denmark). The arteries were cannulated between
two borosilicate glass pipettes and fixed with nylon
filaments at both ends. Then, the artery segment was
air bubbled to remove endothelial tissue and filled with
physiological saline solution (120 mM NaCl, 2.5 mM
CaCl2, 1.17 mM MgSO4, 5 mM KCl, 1.18 mM Na2HPO4,
25 mM NaHCO3, 1 mM EDTA, 10 mM glucose, pH 7.4
adjusted with 5% CO2–95% air), which was maintained
throughout the duration of the experiment. The arteries
were pressurized to 70 mmHg in physiological saline
solution and incubated at 37 °C for at least 20 min
to equilibrate before starting the measurements. The
viability of mesenteric arteries was evaluated by their
ability to constrict in response to phenylephrine, and
the endothelium denudation was confirmed in control
experiments by the absence of dilatation in response
to 10 μM ACh. Data regarding the external diameter
were collected with a CCD camera placed in an inverted
microscope (Danish Myo Technology) and were analysed
using MyoView software (Danish Myo Technology). The
vasodilatory effect of the Pyr compounds was tested in
phenylephrine (5–10 μM) precontracted arteries. At the
end of each experiment, vessels were superfused with a
solution containing 10 μM nifedipine to determine the
maximal vessel diameter upon relaxation. Dose–response
curves of chemical agentswere calculatedwith the formula
100 × (D – DPhe)/(DNif – DPhe) and fitted by either one or
two Hill functions.
VSMC isolation
Fresh VSMC cells were obtained after two sequential
enzymatic incubations at 37 °C of second- and
third-order mesenteric arteries in accordance with pre-
viously described methods (Moreno-Domı´nguez et al.
2009; Tajada et al. 2012). The first digestion was carried
out in SMDS-Ca2+-free solution containing 0.8 mg ml−1
papain (Worthington Biochemical Corp., Lakewood, NJ,
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USA), 1 mg ml−1 BSA (Sigma-Aldrich, St Louis, MO,
USA) and 1 mg ml−1 dithiothreitol (Sigma-Aldrich)
and the second one was performed in SMDS-10 μM
Ca2+ supplemented with 0.6 mg ml−1 collagenase F
(Sigma-Aldrich) and 1 mg ml−1 BSA. Subsequently, the
tissues were washed three or four times in SMDS-10 μM
Ca2+ and were mechanically dissociated with a wide-bore
glass pipette to obtain freshly isolated VSMC cells. Single
cells weremaintained at 4 °C until patch clamp recordings
or protein expression assays.
Protein expression assays
Protein expression inVSMCandCHOcells was studied by
immunocytochemistry and immunoprecipitation assays,
as well as by a proximity ligation assay (PLA). For the
immunocytochemistry assay, transfectedCHOcells plated
on poly-lysine coated coverslips were fixed with 4 %
paraformaldehyde in PBS for 15 min, permeabilized in
PBTx (PBS, 0.1% Triton X-100) and blocked with PBTx
with 1% of BSA for 10 min. Then, cells were incubated
first with the primary antibody: rabbit anti-TRPC3
(4.5 μg ml−1; ACC-016; Alomone Labs, Jerusalem,
Israel) or rabbit anti-TRPC6 (4.5 μg ml−1; ACC-017;
Alomone) and then with the secondary antibody: Alexa
594 goat anti-rabbit (dilution 1:1000; Molecular Probes,
Carlsbad, CA, USA), both in blocking solution. The nuclei
were labelled with Hoechst 33342 (dilution 1:2000; Life
Technologies, Grand Island, NY, USA) and coverslips
weremountedwithVectashield (Vector Laboratories, Inc.,
Burlingame, CA, USA).
For the immunoprecipitation assay, cell lysate from
transfected CHO cells was collected in modified radio-
immunoprecipitation assay buffer (MRB) (150 mM
NaCl, 50 mM Tris, pH 8, 1% NP-40 and 0.2%
sodium deoxycholate, pH 7.4 adjusted with NaOH) with
Proteases Inhibitor Cocktail (Roche, Basel, Switzerland).
Then, the cell lysate was incubated at 4 °C with
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Figure 1. mRNA profile of TRPC channels in BPN and
BPH VSMCs
Left: relative abundance of TRPC family channels in VSMC
from BPN mesenteric, femoral and aorta arteries normalized
by the amount of RP18S. Data are expressed as 2−Ct, where
Ct = Ctchannel – Ct18S. Right: showing, for each vascular
bed, the changes in TRPC channels expression in BPH arteries
using BPN arteries as the calibrator. Differences are expressed
as log (2−Ct) where Ct = CtBPH – CtBPN. With the
log scale, a value of 0 represents no change, increases in
expression are depicted as positive changes, and decreased
expression appears as a negative value. For reference, the
values of a two-fold increase or a two-fold decrease are
indicated by the dotted lines. Each bar is the mean ± SEM,
n = 6–10 values from at least three independent experiments.
All through the figures ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001.
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gentle shaking for 2–3 h with the GFP-Trap A beads
in accordance with the manufacturer´s instructions
(Chromotek, Planegg-Martinsried, Germany) and, after
washing three times with MRB buffer and with high
NaCl-MRB buffer (750 mM), samples were maintained at
−20 °C until analysis by western blotting. For immuno-
blot analysis, protein samples were diluted in XTReducing
Agent and XT Sample Buffer (Bio-Rad, Hercules, CA,
USA) and incubated at 95 °C for 5 min. They were then
separated by SDS-PAGE on 10% polyacrylamide gels and
transferredontonitrocellulosemembrane,whichwas then
blocked with 5 % non-fat dry milk in 0.1 % Tween 20 in
Tris-buffered saline for 1 h. Membranes were incubated
with the primary antibodies in blocking solution:
rabbit anti-TRPC3 (4.5 μg ml−1; Alomone) or rabbit
anti-TRPC6 (4.5 μg ml−1; Alomone), at 4 °C overnight.
Next, membranes were incubated with the secondary
antibody: horseradish peroxidase-conjugated anti-rabbit
IgG (dilution 1:20000; Dako, Glostrup, Denmark) for
1 h. Protein signals were detected using a VersaDoc
4000 Image System (Bio-Rad) with chemiluminescence
reagents (SuperSignal West Femto Maximum Sensitivity
Substrate; Pierce, Rockford, IL, USA).
Protein association in native VSMC cells was explored
with PLA technology using the Duolink R© In Situ kit
(Sigma-Aldrich) in accordance with the manufacturer´s
instructions. Briefly, freshly isolated native cells were
incubated in 12 mm diameter dishes at 37 °C in
a 5% CO2 humidified atmosphere for 1 h prior to
be fixed with 4 % paraformaldehyde in PBS. After
washing, cells were permeabilized with 0.2% Triton
x-100 in PBS and blocked with the kit´s blocking
solution at 37 °C for 1 h. Then, cells were incubated
with different combinations of first intracellular anti-
bodies: rabbit anti-TRPC3 (1 μg ml−1; Alomone),
goat anti-TRPC3 (1 μg ml−1; NBP1-70352; Novus
Biologicals, Littleton, CO, USA), rabbit anti-TRPC6
(1 μg ml−1; Alomone) and goat-anti-TRPC6 (1 μg ml−1;
NBP1-00142; Novus Biologicals) at room temperature
overnight. Cells were then labelled with Doulink R© In
Situ PLA probes: anti-goat PLUS and anti-rabbit MINUS
for 1 h at 37 °C and, subsequently, ligation and
amplification reactions were carried out in accordance
with the manufacturer ´s instructions. Samples were
mounted with Vectashield with DAPI to stain the
nuclei and maintained at 4°C until visualization at
the appropriate wavelengths using an SP5 confocal
microscope (Leica Microsystems, Wetzlar, Germany).
Control experiments employed only one primary
antibody.
Electrophysiological recordings
Electrophysiological measurements were carried out
at room temperature (20–25°C) using a whole-cell
configuration of the patch clamp technique. CHO
transfected cells were perfused with a bath solution
(Standarde solution) containing (in mM) 141 NaCl, 1.8
CaCl2, 1.2 MgCl2, 4.7 KCl, 10 glucose an d10 Hepes, pH
7.4 (NaOH). For recordings of freshly isolated VSMCs, we
usedaTRPexternal solution containing (inmM)141NaCl,
1.8 CaCl2, 1.2 MgCl2, 5 CsCl, 10 glucose, 10 Hepes, 0.005
nicardipine, 0.1 DIDS and 0.1 niflumic acid (pH 7.4 with
NaOH). Borosilicate glass patch pipettes of 3–10 M of
resistance were filled with an internal solution (TRP inter-
nal solution) containing (mM) 10 CsCl, 110 Cs aspartate,
10 NaCl, 3.2 CaCl2, 10 Hepes, 10 BAPTA, 2 MgATP, pH
7.2 (with CsOH) and with an estimated free [Ca2+] of
100 nM. When indicated, rabbit anti-TRPC3 or TRPC6
or rat anti-red fluorescent protein (RFP) (Chromotek)
antibodies were included at a final concentration of
4 μg ml−1. Current–voltage relationships were obtained
with 1 s ramp protocols from −150 mV to +80 mV
from a holding potential of −10 mV, under control
conditions or in the presence of the different activators
or blockers. A 70% Standarde solution was applied as
hypotonic stimulus (HS). For the experiments with intra-
cellularly applied antibodies, the access resistance (Ra)
and the membrane capacitance (Cap) were continuously
monitored and recorded by applying the membrane test
algorithms of Clampex 10 software (Axon Instruments,
Foster City, CA, USA) throughout the experiment. Only
cells with G seal values and stable Ra and Cap
values were considered for analysis. Data were acquired
using an Axopatch 200A patch clamp amplifier (Axon
Instruments), at a frequency of 5 kHz and filtered at
2 kHz. Recordings were digitized with a Digidata 1200
interface using Clampex 10 software. Electrophysiological
data analyses were carried out using Clampfit 10 software
(MolecularDevices, Sunnyvale, CA,USA) andwithOrigin
7 software (OriginLab Corporation, Northampton, MA,
USA).
Statistical analysis
Statistical analyses were performed with R software (R
Foundation for Statistical Computing, Vienna, Austria).
Pooled data are expressed as the mean ± SEM.
For the electrophysiology, myography and PLA,
statistical comparisons between groups of data were
carried out using a two-tailed Student’s t test for
unpaired data. P < 0.05 was considered statistically
different.
In the case of the quantitative PCRdata, a Student’s t test
for independent samples was used in the case of normal
distributions (i.e. a Saphyro-Wilks test with P > 0.05). If
thiswasnot the case, a pairwiseMann–Whitney–Wilcoxon
test (i.e. a non-parametric test) was applied to determine
whether the differences between groups of data were
statistically significant.
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Results
We analysed the expression profile of TRPC channels in
mesenteric, femoral and aorta VSMCs from BPN and
BPH mice. The genes explored included all members
of the TRPC family, as well as several control genes,
such as calponin as a control for VSMCs, endothelial
nitric oxide synthase as a control for endothelial cell
contamination and ribosomal protein 18S (RP18S) as
an endogenous control for the quantitative PCR. We
explored both the relative abundance of the channel genes
expressed in the normotensive VSMCs and the changes
observed in BPH animals. The data are summarized
in Fig. 1. We found mRNA expression of all TRPC
channels but TRPC5 and TRPC7 (Fig. 1, left). Changes in
expression upon hypertension (Fig. 1, right) are expressed
as log2(–Ct) so that positive values represent increased
levels of expression compared with BPN, whereas negative
values represent decreased expression (see Methods). In
all cases, TRPC mRNA channel expression was higher in
resistance (mesenteric) than in conduit (femoral or aorta)
arteries, and significant differences in TRPC1 and TRPC3
expression were found in hypertensive mice. Expression
of TRPC1 was decreased in mesenteric and aorta from
BPH, whereas TRPC3 levels were higher in mesenteric
and smaller in femoral.
Because TRPC expression was higher in resistance
arteries, which functionally contribute more to blood
pressure, and the increased TRPC3 expression was
unique to mesenteric VSMCs from hypertensive mice, we
decided to investigate the possible contribution of TRPC3
channels to the hypertensive phenotype using several
pyrazole compounds (i.e. Pyr3, Pyr6 andPyr10).Although
Pyr3 and Pyr10 have been proposed as selective blockers
of the DAG-activated TRPC channels, and particularly
TRPC3, Pyr6 appears to exhibit a greater potency as
inhibitor of Orai-mediated Ca2+ entry (Schleifer et al.
2012).
First, we tested the effect of these compounds on
vessel tone performing pressure myography experiments
in endothelium-denuded mesenteric arteries from BPN
and BPH mice (Fig. 2). Pressurized arteries were
pre-contracted with phenylephrine, and the application
of 10 μM nifedipine (an LTCC blocker) at the
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Figure 2. Effects of Pyr compounds on the vascular tone in BPN and BPH mesenteric arteries
A, representative examples of the effect of Pyr3 application at the indicated concentrations (in μM) on the external
diameter of a BPN (left) and a BPH artery (right). In both cases, the arteries were pressurized to 70 mmHg and
pre-contracted with bath application of 5 μM phenylephrine (Phe). Increased concentrations of Pyr3 were applied
in the continuous presence of Phe. At the end of the experiment 10 μM nifedipine (Nif) was applied to determine
the maximal diameter. B, dose–response effect of Pyr10, Pyr3 and Pyr6 in BPN (filled squares) and BPH (open circles)
arteries. Data are normalized to the maximal diameter values obtained in the presence of nifedipine and expressed
as percentage of relaxation (mean± SEM; 5–9 arteries in each group). Data are fitted to Hill functions with apparent
Kd values between 6 and 20 μM. For Pyr3 and Pyr10, the fitting of BPN data includes an additional high-affinity
component representing 25% of the response and with apparent Kd values of 10 and 60 nM, respectively.
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end of each experiment was used to determine the
maximum diameter. Bath application of Pyr3 elicited
a dose-dependent vasodilator response in mesenteric
arteries (Fig. 2A) and smaller concentrations were needed
to see a response in BPN. The same differences were
observed with Pyr10. The whole dose–response curves are
depicted in Fig. 2B. In both cases, BPN arteries have an
apparent high-affinity component, which is responsible
for 30% of the total response that was not present in
BPH vessels. By contrast, the vasodilator effect of Pyr6
was less potent and there were no differences between
BPN and BPH arteries (Fig. 2B). These data indicate
that both Pyr3 and Pyr10 at concentrations 10 μM
have a larger vasodilator effect in BPN arteries. It is
reasonable to speculate that the high-affinity component
represents the literature described specific blockage of
TRPC3 channels, whereas the low affinity component,
which is responsible for the full vasodilatation, is a result of
some unspecific blockage. Therefore, these results would
suggest that TRPC3 channels have a larger functional role
in BPN arteries.
The effects of TRPC3 blockers were clearly not anti-
cipated by themRNA expression studies depicted in Fig. 1.
Several hypotheses, including the absence of correlation
between mRNA and protein changes, or differences in the
blocking effect of Pyr3/10 compounds depending on the
subunit compositionof theTRPC tetramers, could explain
this discrepancy. We decided to explore this possibility by
characterizing the effect of Pyr10 on the non-selective
cationic currents recorded in CHO cells expressing
TRPC3, TRPC6 or TRPC3/6 channels. Currents of
variable amplitude could be elicited in all experimental
groups, as well as in mock-transfected CHO cells, in
response to depolarizing ramps from −150 to +80 mV.
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Figure 3. Functional contribution of TRPC3 and TRPC6 channels to basal and stretch-activated,
non-selective cationic currents in CHO cells
A, representative examples of the traces recorded in the whole-cell configuration from unstimulated CHO cells
transfected with TRPC3, TRPC6 and TRPC3/6 channels using ramp protocols from −150 mV to +80 mV. The
effect of the application of Pyr10 (10 μM) in each case and the subtracted (C-Pyr), Pyr-10 sensitive current are also
represented in the plots. B, lower bars plot shows average current densities (pA/pF) measured at −150 mV and
+80 mV for each condition, as well as for untransfected CHO cells. Data are the mean ± SEM of seven to 23 cells
in each condition. C, example of the experimental protocol used to explore the effect of Pyr10 on stretch-activated
currents in a CHO cell transfected with TRPC3/6. The plot shows the time course of the current density recorded at
−150 mV and +80 mV together with the time of application of the different stimuli. D, summary of Pyr10 effects
on stretch-activated currents under all of the conditions explored. Bar plot shows average current densities elicited
by application of a hypotonic solution (HS, 70% Standarde solution) and the inhibitory effect of Pyr10 (10 μM).
Data are the mean ± SEM; 13–22 cells in each group.
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Figure 3A shows the average current density obtained
at −150 and +80 mV in all the experimental groups,
together with representative examples of the currents
obtained in TRPC3-, TRPC6- and TRPC3/6-transfected
cells before and during the application of 10 μM Pyr10.
The subtracted, Pyr10-sensitive currents are also shown.
TRPC3-transfected cells hadbigger currents thanTRPC6-,
and TRPC3/TRPC6-transfected cells showed an inter-
mediate behaviour. Regarding the effect of Pyr10, the
data showed that only currents fromCHO cells expressing
TRPC6 channels (alone or together with TRPC3) were
sensitive to Pyr10. Average current densities at +80 and
−150 mV, under control conditions or in the presence of
Pyr10 (10 μM), are shown in Fig. 3B.
Because TRPC3 and TRPC6 mediated currents can be
activated by several GPCR as well as by pressure-induced
membrane stretch (Gonzales et al. 2014; Wilson &
Dryer, 2014), we aimed to test the effect of Pyr10
on currents activated by some of these stimuli. To
simulate a membrane stretch, we used a hypotonic
stimulus (70% Standarde solution, HS) to activate the
channels in CHO transfected cells. A typical experiment
is depicted in Fig. 3C and the summary data obtained
are shown in Fig. 3D. Application of HS elicited a
reversible increase in the TRPC-mediated currents that
was similar in the three conditions studied (TRPC3-,
TRPC6- and TRPC3/6-transfected cells) and significantly
much larger than that in mock-transfected CHO cells.
These HS-induced currents, as found with basal currents,
could be significantly inhibited by 10μMPyr10 only when
TRPC6 channels were expressed.
These data suggest that Pyr10 blocks TRPC6 channels,
and not TRPC3 (as reported previously), either as
homo- or heteromultimers with other TRPC channels.
The presence of heteromultimers between TRPC3 and
TRPC6 channels in TRPC3/6-transfected cells was tested
by co-immunoprecipitation experiments. Figure 4A
shows immunocytochemical staining of TRPC3- and
TRPC6- transfected cells with specific antibodies against
TRPC3 and TRPC6 channels. The specificity of
both antibodies, as well as the proper trafficking of
the expressed proteins, is evident. Figure 4B shows
a typical co-immunoprecipitation experiment, where
TRPC6 or TRPC3 immunolabelling could be detected
after immunoprecipitation of TRPC3/6-transfected cells
using GFP-Trap beads to bind TRPC3-YFP fusion
protein. Altogether, these sets of experiments indicate
that Pyr10-sensitivity could be used as a tool to test
the functional contribution of either TRPC6 or TRPC6
heteromultimers to ROC in native cells.
Becausewe lack apharmacological tool todetermine the
presence and contribution of TRPC3 channels, we aimed
to explore the blocking effect of intracellularly applied
antibodies (Fig. 4C). Control experiments were carried
out in non-transfected CHO cells using anti-TRPC3
or an indifferent antibody (against RFP; anti-RFP). No
changes in the current amplitude could be observed in
any case up to 10 min when recording on the whole-cell
configuration of the patch clamp technique. Current
amplitude of recordings fromTRPC3-transfected cellswas
also stable up to 10 min when no antibody or anti-RFP
antibody was added in the pipette solution, although a
significant reduction was observed when dialysing the
cell with anti-TRPC3. We confirmed that this blocking
effect of anti-TRPC3 (or anti-TRPC6) was specific by
exploring the antibodies effects on the HS-activated
current (Fig. 4D). In TRPC3/C6-transfected cells, both
antibodies led to a significant reduction of the current
density, whereas only anti-TRPC3 (but not anti-RFP)
inhibited HS activated currents in TRPC3-transfected
cells.
All of the results presented so far provide support for
the hypotheses that differences in Pyr10 sensitivity of BPN
and BPH arteries could be a result of changes in the
composition of the TRPC heteromultimers. Therefore, we
aimed to obtain some insights on the subunit composition
of the native TRPC channels in BPN and BPHVSMCs.We
used the PLA assay technique to identify close associations
between two TRPC3 subunits, two TRPC6 or one TRPC3
and one TRPC6 subunits. Figure 5A shows representative
images obtained with this technique for each of the
three combinations explored and in the two different
cells studied (BPN and BPH VSMCs). Labelling with
two different TRPC3 antibodies (C3-C3 combination), or
dual labelling for TRPC3 and TRPC6 (C3-C6), produced
significantly higher numbers of puncta per cell and total
labelled area in BPH than in BPN cells. By contrast,
labelling with two TRPC6 antibodies was significantly
smaller in BPH cells. Average values of all the described
combinations are depicted in the bar graph on the
right of Fig. 5A. The possible associations detected for
each combination (considering just one tetramer) are
depicted in the scheme of Fig. 5B. The charts shown
on the right group the data corresponding to the C3-C3
or C6-C6 combinations, representing the percentage of
heteromultimers withmore than a TRPC3 or TRPC6 sub-
unit, respectively. Althoughmore complex interpretations
are possible, these data suggest that, in the hypertensive
phenotype, there is a change in the composition of the
TRPC3/6 tetramers, with a greater contribution of TRPC3
channels in the BPH cells.
We explored the functional correlate of these differences
by analysing basal and receptor-activated cationic currents
in freshly isolated VSMCs from BPN and BPH mice.
Current amplitude at −150 mV was significantly larger
in BPH cells (Fig. 6B). This difference remains when
expressed it as current density (−8.1 ± 0.5 pA/pF in
BPH vs. −6.4 ± 0.7 pA/pF in BPN) despite the larger
size of BPH cells (16.9 ± 0.6 pF in BPH vs. 13.9 ± 0.5 pF
in BPN) (Moreno-Domı´nguez et al. 2009). In addition
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to differences in current size, there also were differences
in Pyr10 and Pyr3 sensitivity, with the BPH cells being
less sensitive to the drugs (Fig. 6A and B). These data
suggest a decreased contribution of TRPC6 channels to
the non-selective cationic conductance of BPHmesenteric
VSMCs. Both results (i.e. the larger currents and the
decrease of TRPC6 contribution) are compatible with a
larger expression of TRPC3 channels in BPH cells. To
confirm this, we explored the effect of intracellularly
applied anti-TRPC3 antibodies on BPN and BPH cationic
currents (Fig. 6C). Examples are shown of the time course
of the current amplitudes at +80 and −150 mV in
BPH cells in the presence of anti-RFP antibody (control;
Fig. 6C, left) or anti-TRPC3 antibody in the pipette
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Figure 4. Use of antibodies to determine functional contribution, location and association of TRPC3 and
TRPC6 channels in CHO cells
A, representative confocal images of immunolabelling with anti-TRPC3 and anti-TRPC6 of CHO cells transfected
with TRPC3 (left) or TRPC6 (right). Immunostaining was predominant at the cell membrane and shows a good
correlation with GFP-labelling for TRPC3 (a fusion protein). No cross-reactivity was observed in either case. B,
TRPC3-GFP or TRPC3-GFP/TRPC6 cotransfected cells were immunoprecipitated with anti-GFP-trap and immuno-
blotted with GFP antibody (as a load control) or with anti-TRPC3 or anti-TRPC6 antibody. Labelling with anti-TRPC6
was detected on the cotransfected cells, demonstrating heteromultimeric association. Data are representative of
two independent experiments. C, blocking effect of intracellularly applied antibodies on the cationic currents
observed in transfected CHO cells. Average basal current density at −150 mV (open bars) and +80 mV (dashed
bars) was obtained from whole-cell ramps applied every 5 s to control untransfected CHO cells and to cells trans-
fected with TRPC3. The plots show the current density after 5–10 min of recording in control pipette solution or
in the presence of the indicated antibodies. Each bar is the mean ± SEM of nine to 14 cells from at least four
different experiments. The inset shows the current traces obtained at the indicated times in an untransfected CHO
cell (left) or in a TRPC3-transfected CHO cell (right) with anti-TRPC3 antibody in the pipette solution. ∗p < 0.05;
∗∗p < 0.01 compared to CHO/TRPC3 control cells. D, the same protocol was used to explore the blocking effect of
anti-TRPC3 or anti-TRPC6 on stretch-activated currents elicited from TRPC3 and TRPC3/C6 transfected cells upon
exposure to the hypotonic solution (HS). The effects were calculated by subtracting basal, unstimulated currents
and after 5–10 min of recording in control conditions or in the presence of the indicated antibodies. Data are the
mean ± SEM, n = 8–10 cells.
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solution (Fig. 6C, right), up to 10–12 min of recording.
We monitored the stability of the recording conditions by
checking cell capacitance and access resistance (data not
shown) andholding current at−10mV.The initial current
amplitude was reduced by 25% after 5 min and by 39%
after 10 min of recording when anti-TRPC3 was intra-
cellularly applied, whereas no significant changes could be
observed in control cells, either with an anti-RFP antibody
or in the absence of antibodies. Average data obtained in
VSMCs from BPN and BPH mice are depicted in Fig. 6D.
The effect of anti-TRPC3 antibodies was only significant
in BPH cells, again suggesting a greater contribution of
TRPC3-containing channels to cationic currents in BPH
VSMCs.
Finally, we also explored the amplitude of native
currents in BPN and BPHVSMCs activated by several well
defined agonists such as ATP (30 μM), UTP (50 μM) and
phenylephrine (Phe 10μM), aswell as theDAG-permeable
analogue OAG (100 μM) and also the blocking effects of
Pry3 and/or Pyr10 (10μM). Figure 7A shows the summary
data. With the exception of UTP responses, which were
significantly smaller in BPH VSMCs, the amplitude of
the cationic currents elicited by all the other stimuli
was not different between BPN and BPH cells. However,
both preparations showed a remarkable difference when
comparing the blocking effect of Pyr3/Pyr10 compounds.
Although, in BPN cells, these drugs fully abolished the
current activated by all the agonist studied, there is a
fraction of this current that is not sensitive to Pyr3
(black bars) and/or Pyr10 (grey bars) in BPH cells. For
example, in the case of ATP stimulation, although Pyr3/10
block almost completely the ATP-activated current in
BPNVSMCs, thePyr3/10-sensitive current representsonly
60% of this current in BPH VSMCs (Fig. 7A, right).
Representative examples of the time course of the current
amplitude at −100 mV and +40 mV in response to ATP
alone or in combination with Pyr3 are shown in Fig. 7B
(for a BPN cell) and Fig. 7C (a BPH cell).
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Figure 5. Differences in TRPC assembly in BPN and BPH mesenteric VSMCs
A, representative confocal images of the puncta density distribution using the PLA assay in BPN (upper) and BPH
(lower) native VSMC cells. The bars plot shows the averaged density of puncta obtained in the three conditions
represented in (A) for BPN and BPH cells. Data are the mean ± SEM; 36–64 cells in each group from four
independent experiments. ∗p < 0.05, ∗∗p < 0.01 compared to the same condition in BPN. B, scheme of the
possible associations between C3-C3, C6-C6 and/or C3-C6 subunits that can be recognized with each combination
of antibodies used for the PLA assay. Following this scheme, the chart illustrates an interpretation of the data,
considering 100% as the sum of the intensity of C3-C3 and C6-C6 groups and assuming that the C3-C6 group
will be included in both. Accordingly, the C3-C3 group will contain associations with more than one C3 subunit
(C3 > 1) and C6-C6 those with more than one C6 subunit (C6 > 1).
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Discussion
In the present study, we have explored the hypothesis
that TRPC3 and TRPC6 channels expressed in VSMCs
may have a differential contribution to the regulation of
vascular tone, which could be relevant for the changes
in vascular reactivity associated with essential hyper-
tension. This possibility was supported by the initial
observation indicating a highermRNAexpression of those
channels in resistance arteries (mesenteric vs. femoral or
aorta). Furthermore, the changes in themRNA expression
levels of these channels when comparing VSMCs from
BPN and BPH vessels are clearly different in resistance
and conduit arteries (Fig. 1). Although the importance
of either TRPC6 or TRPC3 channels in the vascular
system has been demonstrated clearly over recent years
(Earley & Brayden, 2015), the novelty of the present
study relies on exploring the hypothesis that changes
in these two channels upon hypertension determine a
different composition of homo- and heterotetramers with
discernible biophysical, pharmacological and functional
properties.
Combining several methodological approaches and
using both heterologously expressed channels and
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Figure 6. Characterization of basal cationic currents in BPH and BPN mesenteric VSMCs and effects of
anti-TRPC3 antibody
A, basal cationic currents were obtained by voltage ramps in the presence of TRP external solution. The figure
shows representative examples of current–voltage traces obtained in a BPN and a BPH mesenteric VSMC in control
conditions (C), in the presence of 10 μM Pyr10 and after washout of the blocker (R). B, upper bar plot showing
the current amplitude at −150 mV for both BPN and BPH cells (mean ± SEM, 40–60 cells in each group). The
lower plot shows the average fraction of the Pyr3- or Pyr10-sensitive current at −150 mV in BPN (grey bars) or
BPH cells (white bars). Each bar is the mean ± SEM of 10 cells (for Pyr3) and 23 cells (for Pyr10). C, representative
examples of the time course of the currents elicited by voltage ramps in a BPH cell recorded with anti-RFP (left)
or with anti-TRPC3 antibody (4 μg ml−1) in the pipette solution (right). The plots show the current amplitude at
−150 mV, +80 mV and at the holding potential (−10 mV, grey line). The time course of the cell capacitance and
the access resistance were obtained simultaneously (not shown). Examples of the actual traces obtained with the
ramp protocol at the time points of 0, 5 and 10 min (points 1, 2 and 3 in the graphs) are also depicted (bottom).
D, average current amplitude at 5 and 10 min is represented as a fraction of the initial current amplitude both in
control cells (solid bars) and in anti-TRPC3 treated cells (striped bars), for BPH (left plot) and BPN mesenteric VSMCs
(right plot). Each bar is the mean ± SEM of seven to 14 cells in each group. For the control group, untreated cells
and cells with anti-RFP antibody in the pipette solution were pooled together.
C© 2016 The Authors. The Journal of Physiology C© 2016 The Physiological Society
J Physiol 595.5 TRPC remodelling in essential hypertension 1509
native cells, we conclude that TRPC3 and TRPC6
in BPH and BPN VSMCs show a different pattern
of association (Fig. 8). VSMCs from BPH cells have
a larger fraction of TRPC3-containing homo- and
heterotetrameric channels with an increased basal activity,
which can contribute to the more depolarized resting
membrane potential observed in BPH VSMCs and to
the increased vascular reactivity of BPH mesenteric
arteries (Moreno-Domı´nguez et al. 2009). The larger
basal cationic currents at negative potentials observed in
BPH VSMCs were more sensitive to blockade with intra-
cellularly applied anti-TRPC3 antibodies. The selectivity
of this immunological blockade was confirmed in the
heterologous system. In addition, BPHbasal currents were
less sensitive to Pyr10, which, in our hands, behaved as a
selective blocker of TRPC6-containing channels.
In this regard, our work redefines the meaning of
the pharmacological tools available for the study of
TRPC3/6 channels. We found that the novel pyrazole
compounds recently described as selective blockers of
TRPC3 (mainly Pyr10 and also Pyr3) showed an increased
selectivity for TRPC6-containing channels over TRPC3
homotetramers, in contrast to what has been described
previously (Kiyonaka et al. 2009; Schleifer et al. 2012).
Although the reported effect of these compounds on
native TRPC3 channels (Kiyonaka et al. 2009; Koenig et al.
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Figure 7. Effect of Pyr blockers on agonist-activated cationic currents in native VSMCs
A, summary data showing the current density at −150 mV of the current activated in the presence of ATP (30 μM),
UTP (50 μM), OAG (100 μM) and phenylephrine (Phe, 30 μM) alone or in the presence of Pyr3 (10 μM) or Pyr
10 (10 μM) as indicated. Data were obtained from voltage ramps after subtracting basal, unstimulated currents.
Data were obtained from BPN and BPH isolated mesenteric VSMCs. Blockers were applied in the presence of the
agonists, and their effects were calculated after subtracting basal current as well. Agonist-induced currents are the
average from 17–36 cells in each group, whereas the effect of the blockers was tested in 6–14 cells in each group.
∗∗p < 0.01 compared with UTP-activated currents in BPN cells. The inset shows the fraction of the ATP-activated
current that can be blocked by Pyr3 or Pyr10 in BPN (black bars) and BPH cells (white bars). ∗p < 0.05 compared
to UTP effect in BPN. B and C, representative examples of a BPN and a BPH cells that were stimulated with 30 μM
ATP alone or with 10 μM Pyr3 as indicated in the graphs. The time course of the current amplitude at −100 mV
(open circles) and +40 mV (filled circles) was obtained from voltage ramps applied every 5 s. Traces in control
conditions (1) in the presence of ATP (2) or of ATP + Pyr3 (3) are shown in the inset. BPN cell was also challenged
with 30 μM Phe as indicated.
C© 2016 The Authors. The Journal of Physiology C© 2016 The Physiological Society
1510 I. A´lvarez-Miguel and others J Physiol 595.5
2013) could be compatible with the presence of TRPC3/6
heterotetramers, we do not have a clear explanation
for the disparities observed in the recombinant system,
although several differences in the preparation and
the methodology of the study can be highlighted.
We have performed our characterization using TRPC3
overexpression in CHO cells and we have determined
both basal and stretch-activated currents using electro-
physiological techniques. By contrast, previous studies
used TRPC3-transfected HEK293 (and/or HEK293T)
cells and channel activity was measured by determining
Ca2+ entry upon stimulation of endogenous muscarinic
receptors with carbachol (Kiyonaka et al. 2009; Schleifer
et al. 2012). It is possible that changes in the associated
proteins endogenously expressed in the different cell
lines used and/or changes in the response to blockers
related to the specific activation pathway could contribute
to the observed discrepancies. Moreover, and possibly
more importantly, although we had analysed the acute
effects of Pyr compounds that were applied to the
external solution in the presence of the stimulus (for
stretch- or agonist-activated currents), in these other
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Figure 8. Diagram of the proposed changes in TRPC3/C6 composition upon hypertension
Homo- and heteromultimeric TRPC3/C6 channels contribute to basal cationic currents in VSMCs, thus modulating
resting membrane potential and hence basal [Ca2+] concentration and cell excitability. BPN cells may have a
dominant expression of TRPC6 channels, associated with either homo- or heterotetramers, which show strong
inward rectification. This will result in low basal currents at values around the resting membrane potential. In
BPH cells, the increased expression of TRPC3 channels determines a change in the properties of heteromultimers,
which will have now a larger proportion of TRPC3 subunits. TRPC3 channels show weak rectification, which will
determine an increased basal current at negative potential contributing to cell depolarization, raising the [Ca2+]
concentration and increasing basal tone.
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studies, the effects of Pyr3 on TRPC3-activated currents
or TRPC3-dependent Ca2+ entry are determined upon
chronic pre-treatment of the cells with Pyr3, which
was always applied to the external solution previous to
stimulation. Finally, the more detailed characterization of
TRPC3 modulation (Kiyonaka et al. 2009) was carried
out with Pyr3 because the more selective Pyr10 was not
available at that time.
Some or several of these aspects may contribute to
these largely unexpected differences on the sensitivity
Pyr compounds of TRPC3 and TRPC6. In addition, our
findings with the pharmacological blockade of TRPC3/6
channels could be reproduced both in heterologous and
native systems with the use of blocking antibodies (Figs 4
and 6), providing an additional level of confidence to the
results of the present study. This technique represents a
powerful approach for the identification of the molecular
correlates of native currents in the absence of more
specific blockers, and also for defining the composition
of heteromultimeric channel complexes (Sanchez et al.
2002; Moreno-Domı´nguez et al. 2009). We have been
particularly careful with this group of experiments with
intracellularly applied antibodies, both in the selection
of the technically acceptable experiments and in the use
of a large number of controls, including control anti-
bodies for transfected cells and TRPC3/6 antibodies for
untransfected cells.
Finally, our conclusions from the functional
characterization of the TRPC-mediated cationic currents
in native cells are supported by the results obtained
with PLA. These studies indicated a larger proportion of
TRPC3 subunits in BPH cells and a decreased expression
of TRPC6. This observation is consistent with a larger
number of TRPC3 homotetramers in these cells and/or
heteromultimeric TRPC3/6 complexes with a larger
proportion of TRPC3 subunits. Although these results
would also be consistent with the formation of clusters
of multimers containing only one TRPC3 subunit, based
on the functional characterization of TRPC3/6 transfected
cells, this latter possibility is doubtful.
TRPC channels show a high structural homology that
favours the formation of heteromultimeric complexes,
and this explains why the spectrum of biophysically and
functionally distinct ROC or SOC exceeds what can be
obtained with a single TRPC channel heterologously
expressed. Because the composition of native TRPC
complexes is poorly defined, the task of assigning a
well-defined molecular correlate to receptor-activated
cationic currents has proven difficult. Considering
that many TRPC are often co-expressed in the same
cell (Hofmann et al. 2002), heteromultimerization
in addition to homomultimerization represents an
attractive possibility. The presence of heteromultimeric
TRPC6/C7 channels in vascular smooth muscle has
been demonstrated using both biochemical and
functional approaches (Maruyama et al. 2006). Inter-
estingly, heteromultimeric TRPC6/C7 channels exhibit
one property (modulation of current amplitude by
changes in extracellular [Ca2+]) that is distinct from
homomultimeric TRPC6 or TRPC7, suggesting that
these channel complexes are endowed with emergent
properties. However, the evidence of TRPC subunit
heteromultimerization was obtained using cultured A7r5
cells rather than native VSMCs. A better understanding
of the mechanisms determining how TRPC subunits
combine to form functional ion channel complexes is
an essential prerequisite to evaluate their contribution to
endogenous cation currents. In many cases, the studies
using KO animals could help to define the role of
the individual channels but, in the particular case of
TRPC3 and TRPC6, these KO studies do not provide
a unifying view of their individual role or the meaning
of heteromultimeric associations. With respect to the
innvestigation of mechanosensors, several studies using
single, double and up to quadruple TRPC KOs conclude
that TRPC functions involve combined activity ofmultiple
TRPC proteins (Sexton et al. 2016). Although interfering
with one single TRPC channels does not alter behavioural
responses (Quick et al. 2012), double TRPC3/C6 KOs
show sensory deficits that are augmented in quadruple
KO (Sexton et al. 2016). These results indicate that
TRPC3/C6 channels in sensory neurons show some
functional redundancy. However, TRPC6 KO mice show
a vascular phenotype as a result of a compensatory
upregulation of VSMCs TRPC3 channels, which are not
able to functionally replace TRPC6 channels (Dietrich
et al. 2005), indicating that these two channels are not
freely interchangeable and that they have distinct and
non-redundant roles in the control of vascular tone.
Because of this compensatory up-regulation of TRPC3
channels inVSMCs, theTRPC6KOmice showed increased
vascular reactivity and augmented mean blood pressure,
which is in agreement with our present data. Importantly,
our results confirm that the changes observed in the
hypertensive animal accidentally created by Dietrich et al.
(2005)when suppressingTRPC6 channelsmay be relevant
to understand the mechanisms involved in the natural
history of essential hypertension.
Finally, regarding TRPC3 channels, their expression
has been reported to be upregulated in VSMCs in
animal models of essential hypertension, such as the
spontaneously hypertensive rat and the two-kidney,
two-clip hypertensive rats (Liu et al. 2009; Wang et al.
2016). However, the study of concomitant changes in
the expression of other TRPC channels has not received
a systematic attention. There is only one recent report
in which the role of upregulation of TRPC3 channels
and downregulation of TRPC1 channels during hyper-
tension and their contribution to changes in contractility is
explored (Noorani et al. 2011), although these two changes
C© 2016 The Authors. The Journal of Physiology C© 2016 The Physiological Society
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are studied and explained independently, with no attempt
to link them to a different proportion of heteromultimeric
TRPC channels. In this context, the present study provides
a new paradigm for interpreting and better understanding
many of the previous studies regarding the role of TRPC
channels in vascular physiology and their contribution to
altered vascular tone.
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